Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.8101550560618548,-2.332843510903594,0.0,0.0,0.0,7/22,3.93%,NR2F2;ALDH1A2;PTGDS;RBP1;CYP26B1;ABCA4;RBP4
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.8292932114526977,1.895927381898965,0.0,0.15053289786945734,0.223,7/16,7.87%,PTPRM;PTPRB;PTPRG;PTPRR;PTPRE;PTPRU;PTPRO
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.8292932114526977,1.895927381898965,0.0,0.15053289786945734,0.223,7/16,7.87%,PTPRM;PTPRB;PTPRG;PTPRR;PTPRE;PTPRU;PTPRO
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.7393135219865288,-1.8863791713182838,0.0,0.10343403323890286,0.167,5/13,6.78%,BMP6;BMP5;BMP7;BMP4;SRC
prerank,BMP receptor binding (GO:0070700),-0.7393177584569269,-1.8392158647959955,0.0,0.13861210545720992,0.298,5/12,6.78%,BMP6;BMP5;BMP7;BMP4;SRC
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.8773258627335285,1.8124553560775236,0.0017889087656529517,0.37893887493978107,0.608,2/10,0.09%,PRDM16;MECOM
prerank,FMN binding (GO:0010181),0.8479198515081248,1.8043379472716665,0.003372681281618887,0.3213486374972993,0.649,2/11,0.41%,NOS1;NOS3
prerank,amino acid binding (GO:0016597),0.6918125135757014,1.8013078448597086,0.002844950213371266,0.2697862325452612,0.671,7/31,10.91%,NOS1;NOS3;CASTOR1;ASS1;GRIN2B;CAD;GRIN3A
prerank,platelet-derived growth factor binding (GO:0048407),-0.7461140383736226,-1.8010761602302472,0.002380952380952381,0.16801467328146658,0.436,7/11,2.72%,COL1A2;COL3A1;COL1A1;PDGFRB;COL5A1;PDGFRA;COL6A1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.6085335208182773,-1.7832457238362398,0.003067484662576687,0.1638143064494299,0.5,5/21,2.89%,PDE1A;PDE5A;PDE7B;PDE3A;PDE8B
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.5697057136782394,1.7681607465084155,0.0,0.3481480549210285,0.815,29/147,7.13%,RASGRF2;EPS8L2;PREX2;SPATA13;FGD5;CYTH3;CCDC88C;RAPGEF2;KALRN;DOCK9;ARHGEF28;ELMO1;DENND3;ARHGEF15;RAPGEF1;ARHGEF2;RASGRP2;RAPGEF5;ABR;HERC2;CYTH1;NUCB2;BCR;RAPGEF4;RAPGEF6;FGD6;SMCR8;MADD;RAB3GAP2
prerank,retinoic acid binding (GO:0001972),-0.7100935321500287,-1.7651647812448463,0.010282776349614395,0.1702898719821531,0.576,2/12,2.57%,NR2F2;CYP26B1
prerank,carboxylic acid binding (GO:0031406),0.6538884741443604,1.7312243846579316,0.001394700139470014,0.46458529797002274,0.924,8/38,11.31%,NOS1;NOS3;CASTOR1;GLUD1;GRIN2B;CAD;GRIN3A;HIF1AN
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.7255712580139845,-1.7184692979660703,0.01152073732718894,0.2452714203707124,0.761,3/10,6.05%,SLC6A13;SLC6A12;SLC6A1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.5679382877050216,-1.7179907383686834,0.006211180124223602,0.21526880014187905,0.762,8/27,6.82%,SLC22A8;SLC26A7;SLC39A14;SLC26A2;ANO1;SLC39A8;SLC22A6;SLC5A5
prerank,cadherin binding (GO:0045296),0.519210608954776,1.7145062285178823,0.0,0.48947628966318674,0.947,95/315,16.50%,PTPRM;PTPRJ;EPS8L2;PTPRB;CDH13;EHD4;LIMA1;CD2AP;MRTFB;DOCK9;BMPR2;F11R;FASN;COBLL1;FLNB;ESYT2;MACF1;DAB2IP;STXBP6;TMPO;LRRFIP1;CBL;CEMIP2;IQGAP1;PPFIBP1;SWAP70;PACSIN2;CDC42EP1;PROM1;ACVR1;SLK;STK24;EHD1;PDLIM5;SHTN1;TAGLN2;STK38;CSNK1D;FNBP1L;SH3GL1;MYH9;BSG;PLEC;FXYD5;RANGAP1;STAT1;CTNNA1;TJP2;GPRC5A;PTPRO;NUMB;CCT8;PCMT1;CDH15;CDH3;APC;TJP1;CDH12;RTN4;TRIM25;EPN2;UNC45A;RPL34;HNRNPK;PTPN1;RANBP1;CDH2;EEF2;PCBP1;KLC2;WASF2;MARK2;GCN1;CTNNA2;TMOD3;TBC1D10A;SPTAN1;CAPG;RAN;RPL23A;CTNNB1;VAPA;EIF2A;EVPL;CHMP2B;DDX6;RACK1;CDH22;PKN2;PAK2;UBFD1;AHSA1;ANK3;ATXN2L;NCK1
prerank,P-type ion transporter activity (GO:0015662),0.8212391803847121,1.708458431830141,0.009917355371900827,0.4640887969669488,0.954,5/12,4.38%,ATP2A3;ATP2B4;ATP2B2;ATP2C1;ATP7A
prerank,solute:anion antiporter activity (GO:0140323),-0.6590490043201043,-1.6949018109658671,0.015228426395939087,0.23720404915362606,0.836,6/14,18.92%,SLC7A11;SLC26A7;SLC26A2;SLC4A2;SLC4A3;SLC26A6
prerank,monocarboxylic acid binding (GO:0033293),-0.6030809866653213,-1.694355313231864,0.019886363636363636,0.21421870843386986,0.836,3/18,6.72%,NR2F2;CYP26B1;NAPEPLD
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6453396534918053,1.6880875835754146,0.0110803324099723,0.5079996559919284,0.98,3/35,3.24%,BMX;FYN;FES
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.5632766695626945,-1.6743461340894505,0.006349206349206349,0.2383708177180807,0.877,5/23,2.89%,PDE1A;PDE5A;PDE7B;PDE3A;PDE8B
prerank,mitogen-activated protein kinase binding (GO:0051019),0.6773772402426776,1.6687277629908701,0.019174041297935103,0.560366265622667,0.988,6/29,8.57%,PTPRJ;ACE;DUSP1;GCH1;DUSP16;NBR1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.7946735652718805,1.6674724059456323,0.023890784982935155,0.5201856524861226,0.988,2/11,1.44%,KCNQ1;KCNE3
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.7720869869126882,1.6661434025198332,0.028286189683860232,0.4862618633974927,0.988,3/12,3.84%,VEGFC;DAB2IP;VEGFD
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.6956434017912027,-1.6497692515266884,0.019559902200488997,0.2727613211553809,0.921,7/10,23.29%,HAT1;USP22;ATF2;MSL3;NAA60;NAA40;NAA50
prerank,chemoattractant activity (GO:0042056),0.669240487908831,1.6431974175292334,0.007518796992481203,0.556259553490708,0.997,3/26,3.84%,VEGFC;PDGFB;VEGFD
prerank,calcium-activated potassium channel activity (GO:0015269),0.7709846116928827,1.6390815255218445,0.02800658978583196,0.5384646472274138,0.998,2/11,2.72%,KCNN4;KCNN3
prerank,receptor antagonist activity (GO:0048019),0.7144023437746548,1.6389814165205423,0.01732283464566929,0.505360442847464,0.998,2/17,5.02%,DKK2;WFIKKN1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6172683598361868,-1.6367489002867182,0.023809523809523808,0.2792436180452067,0.947,4/15,6.18%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,anion:anion antiporter activity (GO:0015301),-0.6035414020670395,-1.6358031996308044,0.026954177897574125,0.2613228221931382,0.947,7/17,18.92%,SLC26A7;SLC26A2;SLC25A4;SLC19A1;SLC4A2;SLC4A3;SLC26A6
prerank,growth factor activity (GO:0008083),0.5685655673318586,1.6298729494412243,0.0098159509202454,0.5164577878775652,1.0,4/74,0.88%,VEGFC;JAG1;JAG2;PDGFB
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6928976819527832,1.6231951166123275,0.01929260450160772,0.5167644502618167,1.0,2/19,0.70%,AFAP1L2;EFNA5
prerank,peptidoglycan binding (GO:0042834),0.785712702411036,1.620000239775461,0.029565217391304348,0.502993896947944,1.0,2/10,1.73%,NOD1;NOD2
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.7316577975937519,1.615371571063654,0.03387096774193549,0.49670968865171916,1.0,2/14,1.44%,KCNQ1;KCNE3
prerank,protein tyrosine phosphatase activity (GO:0004725),0.5514093242778394,1.6151556104461664,0.007361963190184049,0.47384814480861953,1.0,16/71,10.63%,PTPRM;PTPRJ;PTPRB;PTPRG;PTPRR;PTPN14;DUSP1;PTPRE;CDC25C;DUSP3;PTPN12;PTPRU;PTPRO;DUSP11;CDC14A;PTPN1
prerank,transferrin receptor binding (GO:1990459),-0.6952851477297429,-1.6093079392216583,0.02619047619047619,0.30207638133730347,0.971,5/10,16.07%,RGMA;SNX1;CD81;CHUK;SNX2
prerank,nucleoside-diphosphatase activity (GO:0017110),0.7471811420806755,1.6071448655519072,0.02586206896551724,0.4818119080567872,1.0,1/12,0.10%,ENTPD1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.6432917582847747,1.592392620122684,0.03139013452914798,0.5197677416554103,1.0,6/25,5.48%,FCHSD2;HIP1;HIP1R;TTPA;ARAP3;PLEKHA1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.71874581023246,1.5824209863214393,0.0462046204620462,0.540753594429866,1.0,7/14,16.66%,ATP2A3;NOD1;MAL;CASP1;CASP8AP2;RACK1;PYCARD
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.7451942308575233,1.5810835844326954,0.0387858347386172,0.5237762856777273,1.0,6/12,16.66%,ATP2A3;NOD1;CASP1;CASP8AP2;RACK1;PYCARD
prerank,amino acid:sodium symporter activity (GO:0005283),-0.6708885057415421,-1.5806483313324158,0.03598971722365039,0.35827816462637735,0.982,4/11,6.05%,SLC1A3;SLC6A13;SLC6A12;SLC6A1
prerank,WW domain binding (GO:0050699),0.6479727602693007,1.579212091637708,0.027220630372492838,0.5108870002867272,1.0,7/26,9.95%,RAPGEF2;CDC25C;ENAH;TCEAL9;NDFIP2;PMEPA1;TCEAL1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.6559126742739292,1.5742674918394453,0.028315946348733235,0.5109357353611476,1.0,4/23,1.66%,PLCG2;PLCB1;CCR1;PLCB4
prerank,pyridoxal phosphate binding (GO:0030170),-0.5610317777372963,-1.572047767590142,0.0335195530726257,0.3593166744405482,0.986,13/20,34.16%,ABAT;PDXK;PYGB;PYGM;ACCS;OAT;AGXT;PLPBP;CTH;PYGL;SHMT2;GLDC;SHMT1
prerank,growth factor receptor binding (GO:0070851),0.5226857404834211,1.5615762517263734,0.00831353919239905,0.5469036127140349,1.0,12/95,8.22%,VEGFC;PTPRJ;PDGFD;HIP1;PDGFB;FYN;VEGFD;ADAM17;IL1RAP;FRS3;PLSCR1;JAK2
prerank,protein tyrosine kinase binding (GO:1990782),0.538988389692996,1.5594464417416545,0.019656019656019656,0.5364040610601307,1.0,24/71,17.43%,CEACAM1;BMPR2;PITPNM3;PTPN14;CBL;NEDD9;CRK;ACVR1;ANGPT1;TRIM6;HYAL2;CD247;DUSP3;TJP2;PTPN1;GRM5;TOB1;DUSP22;GRB14;RACK1;NCK1;ELMO2;SOCS5;PTPN2
prerank,sialyltransferase activity (GO:0008373),0.6483421475926405,1.557514391009245,0.040310077519379844,0.5255944102883585,1.0,5/20,5.90%,ST6GALNAC3;ST8SIA6;ST3GAL6;ST6GALNAC2;ST6GAL2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.6104589916981908,-1.5538980411473609,0.019662921348314606,0.3885922703916142,0.999,3/14,3.00%,SLC7A11;SLC1A3;SLC25A13
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.7442704912344141,1.5524250430486548,0.03626943005181347,0.5278741607106379,1.0,8/11,20.65%,SGMS1;SGMS2;GNPTAB;PTDSS1;PIGF;DPAGT1;AASDHPPT;PIGO
prerank,sodium channel regulator activity (GO:0017080),0.5786444870883461,1.5475925014780538,0.04429530201342282,0.5296754157987804,1.0,8/37,13.00%,NOS1;ATP2B4;CAMK2D;FXYD5;SCN1B;SGK1;NEDD4L;YWHAH
prerank,Notch binding (GO:0005112),0.6402386466256754,1.5437507632068896,0.051908396946564885,0.5287016320487886,1.0,6/22,6.32%,JAG1;JAG2;NOTCH4;DLL4;CUL3;ADAM17
prerank,calcium-dependent phospholipid binding (GO:0005544),0.5653188223637489,1.54263633194527,0.020942408376963352,0.5175502726214611,1.0,9/49,6.63%,SYT15;DOC2B;MCTP1;DYSF;ESYT2;CPNE8;ANXA3;SYT7;CPNE2
prerank,alanine transmembrane transporter activity (GO:0022858),0.7144068085021495,1.5339824964310393,0.056910569105691054,0.5348246742486286,1.0,1/12,0.19%,SLC6A6
prerank,SH3 domain binding (GO:0017124),0.5351794039596336,1.5325325767542668,0.03076923076923077,0.5248015602490749,1.0,16/62,7.88%,AFAP1L2;CD2AP;ELMO1;AFAP1L1;DAB2IP;CBL;CRK;EVL;ADAM15;LANCL1;AKAP5;SHANK3;ADAM12;PTPN12;ENAH;PLSCR1
prerank,voltage-gated calcium channel activity (GO:0005245),-0.4671368860962891,-1.5282020827882383,0.02,0.4453494201651505,1.0,9/37,12.41%,CACNA2D3;CACNA1C;ITGAV;CACNG4;CACNA2D1;CACNA1G;NCS1;CACNB1;CACNB2
prerank,filamin binding (GO:0031005),0.7211999534433907,1.5177133588427114,0.05844155844155844,0.5670741756349423,1.0,3/11,2.02%,NEBL;CEACAM1;FBLIM1
prerank,actin monomer binding (GO:0003785),0.6246684613585136,1.514763472821373,0.05214723926380368,0.5635208806606633,1.0,2/22,0.46%,NOS3;LIMA1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.5578698070614359,1.5134760424660263,0.03467406380027739,0.5539339953068393,1.0,2/44,0.09%,PRDM16;MECOM
prerank,phospholipase C activity (GO:0004629),0.6197978181507445,1.5128313714715773,0.04451038575667656,0.542871481521103,1.0,4/25,1.66%,PLCG2;PLCB1;CCR1;PLCB4
prerank,transforming growth factor beta receptor binding (GO:0005160),0.6445626790460669,1.5116473654496003,0.06511627906976744,0.533230724382053,1.0,6/18,5.38%,ENG;SMAD6;SMAD7;TGFB2;FKBP1A;SMAD2
prerank,BMP binding (GO:0036122),0.7078088062675022,1.5095319528530462,0.060221870047543584,0.5278193554083832,1.0,3/11,2.97%,ENG;BMPR2;UCMA
prerank,leak channel activity (GO:0022840),-0.5565687687069422,-1.5065818884260909,0.03523035230352303,0.4890277084198686,1.0,3/18,2.94%,KCNK2;NALCN;KCNK5
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5694587097931816,-1.5059799496941617,0.05597964376590331,0.4676908450004634,1.0,7/15,22.64%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC26A6;SLC4A8;CFTR
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6090054698148755,-1.5027921044402734,0.04336734693877551,0.4565035043363484,1.0,4/13,6.18%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,GTPase activator activity (GO:0005096),0.45570980647177445,1.50095561903938,0.003076923076923077,0.547142301241312,1.0,59/313,9.67%,RASGRF2;EPS8L2;PREX2;SPATA13;FGD5;CYTH3;CCDC88C;RAPGEF2;ARHGAP31;KALRN;DOCK9;RGS3;PLCB1;ARHGEF28;RABGAP1;SIPA1L2;ELMO1;DENND3;ARHGEF15;CHN2;GNAQ;RAPGEF1;ARHGEF2;RASGRP2;RAPGEF5;ABR;ASAP2;HERC2;IQGAP1;SIPA1L3;CYTH1;RALGAPA1;ARAP3;NUCB2;BCR;TBC1D30;SGSM1;RAPGEF4;ARHGAP8;RAPGEF6;FGD6;TBC1D8;RAP1GDS1;SMCR8;MADD;RGS7;RAB3GAP2;LRRK2;RANGAP1;ARHGAP25;TBC1D12;ARRB1;TBC1D5;DENND2C;DENND6B;TBC1D1;JUN;EIF2B2;RAP1GAP2
prerank,anion transmembrane transporter activity (GO:0008509),-0.6357071412465242,-1.5001589857852182,0.03980099502487562,0.4455128211631932,1.0,5/12,8.43%,SLCO2B1;SLC39A8;SLC22A6;SLC19A1;SLC4A2
prerank,NADP binding (GO:0050661),0.5808999603503622,1.4947576446522,0.05702364394993046,0.5586334489116549,1.0,2/32,0.41%,NOS1;NOS3
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7029083162444383,1.4905880592743,0.09698996655518395,0.5608165017595454,1.0,5/11,9.55%,MAP4K2;DAB2IP;STK38;TCF3;MAP3K11
prerank,metalloendopeptidase activity (GO:0004222),-0.40031802261833477,-1.489082920733685,0.005847953216374269,0.46002767575034886,1.0,22/76,13.35%,TRABD2B;ADAMTS2;ADAMTS12;ADAMTSL3;THSD4;ADAMTSL5;MMP14;ADAMTS17;ADAMTS5;ADAMTS10;ADAMTS3;ADAM19;ADAM9;ADAMTS15;ADAMTS9;MMP2;ADAM33;ADAMTSL4;MMP16;ZMPSTE24;MMP19;ADAMTS14
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.6197128920125686,1.4887471535336747,0.07633587786259542,0.555318495203632,1.0,5/22,6.93%,DUSP12;DUSP1;PPM1F;DUSP16;DUSP3
prerank,microtubule plus-end binding (GO:0051010),0.6342802381883945,1.4871838730739297,0.06220839813374806,0.5489105793684149,1.0,9/20,11.08%,CLIP2;DST;TTBK2;CLIP1;CLASP1;MAPRE3;APC;CLASP2;NUMA1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.6966004459486982,1.48462282586207,0.07333333333333333,0.5462926837454088,1.0,3/11,11.28%,ITPR3;MCOLN1;TRPM2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.48229961078732164,-1.4793903175595007,0.043010752688172046,0.4696010118216991,1.0,12/29,22.40%,SLC13A3;SLC26A7;SLC1A5;SLC26A2;SLC25A13;SLC19A1;SLC1A4;SLC25A12;SLC26A6;SLC25A18;SLC25A14;SLC13A5
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.683972601661617,1.4766836051995609,0.07504078303425775,0.5618352154247809,1.0,4/13,3.84%,PTPRJ;PDGFD;PDGFB;VEGFD
prerank,phosphotyrosine residue binding (GO:0001784),0.5593038318104852,1.4743347066354424,0.06377204884667571,0.5593567888105082,1.0,7/37,9.11%,PLCG2;SHE;CRK;SHB;BCAR3;YES1;STAP1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.7003113469379817,1.4728101010106778,0.06988352745424292,0.5533914387808557,1.0,8/12,22.75%,PIK3R6;PIK3C2A;PIK3C3;PIK3CB;ATM;PIK3C2B;PIK3R3;PIK3CA
prerank,cAMP response element binding (GO:0035497),-0.6267539813606838,-1.4714395809042862,0.105,0.47423757059398575,1.0,6/10,13.29%,CREB5;ATF7;CREB3L1;ATF2;CREB1;HMGA2
prerank,calcium activated cation channel activity (GO:0005227),0.6431594135046874,1.4680550699935517,0.062111801242236024,0.5589342139423631,1.0,2/17,3.92%,KCNN4;ANO6
prerank,protein kinase binding (GO:0019901),0.435700596777836,1.4635499623917214,0.0010080645161290322,0.5634378865366235,1.0,114/479,16.07%,PTPRJ;PLCG2;KCNQ1;TRPV4;GATA6;PTPRR;UTRN;CEACAM1;CAVIN2;MAP4K2;TRIM14;BMPR2;ACE;CCND2;RND1;ACVRL1;NOD2;CCND3;DUSP1;DAB2IP;CAV1;CAV2;RHOB;OXSR1;EMP2;IQGAP1;NEDD9;HDAC9;HDAC7;CRK;FBXO7;GCH1;PDE3B;TIRAP;ACVR1;MSN;PDLIM5;NBEA;PKN1;STK38;TRIM6;SPAG9;SIKE1;CDC25C;WARS1;SMCR8;DUSP16;ADIPOR1;CD247;CEP68;DUSP3;IRGM;HNRNPA0;PRKCSH;ELAVL1;HSPB1;MAPRE3;TJP2;BCL2L1;TOM1L1;JAK2;APC;NBR1;STAP1;PTK2;DSP;TCF3;ADAM10;TAOK2;MAP3K11;MAD2L2;ADCY4;CCDC88A;PLCG1;NEFH;PTPN1;RAC1;TPCN2;POLA1;CADPS;ACTB;NPM1;EEF2;GRM5;PRKD2;VRK1;CALM3;IRF5;CTBP2;CAVIN3;PRC1;DUSP22;PPM1D;INKA1;PIN1;RND2;CNKSR2;HIF1A;AP1B1;RHOH;NSF;LYST;NELL1;LRBA;KIZ;FRMD5;PDCD10;RACK1;NELL2;CDKN2D;PAK2;VDAC1;RICTOR;NEK9
prerank,CARD domain binding (GO:0050700),0.6652484270904025,1.451554254515295,0.08760330578512397,0.5946013262645424,1.0,6/14,14.50%,NOD1;NOD2;CARD10;IRGM;CASP1;CARD19
prerank,MAP kinase phosphatase activity (GO:0033549),0.6745301243249618,1.4511082821461283,0.09317803660565724,0.5854610060939389,1.0,3/12,6.93%,DUSP1;DUSP16;DUSP3
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5799634576149018,1.4455664590511972,0.08345752608047691,0.5946608029472022,1.0,2/25,0.41%,NOS1;NOS3
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5390778616990652,1.4421946477874987,0.06790945406125166,0.5957865046457834,1.0,8/42,9.67%,PLCG2;SHE;CRK;SHB;BCAR3;YES1;STAP1;FBXW7
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.6235187456989443,-1.4406488408336138,0.09285714285714286,0.5532038686934214,1.0,4/10,14.78%,PRKAG2;PRKAR2A;PRKAR2B;PRKAR1A
prerank,fibroblast growth factor binding (GO:0017134),-0.5028026667903578,-1.4406215441546328,0.06685236768802229,0.5335590974945146,1.0,9/21,19.60%,FGFR2;THBS1;ITGAV;KL;CEP57;GPC1;FGFRL1;FGFR4;GLG1
prerank,serotonin receptor activity (GO:0099589),0.5972360181116361,1.4370926680412246,0.08345752608047691,0.5836733909057411,1.0,9/22,19.34%,HRH2;CHRM3;HTR5A;HTR1B;HTR2A;HTR1F;HRH3;HTR4;HTR6
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5972360181116361,1.4370926680412246,0.08345752608047691,0.5836733909057411,1.0,9/22,19.34%,HRH2;CHRM3;HTR5A;HTR1B;HTR2A;HTR1F;HRH3;HTR4;HTR6
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5972360181116361,1.4370926680412246,0.08345752608047691,0.5836733909057411,1.0,9/22,19.34%,HRH2;CHRM3;HTR5A;HTR1B;HTR2A;HTR1F;HRH3;HTR4;HTR6
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.5988279803776901,1.4370028444490217,0.09370199692780339,0.5743613645236276,1.0,9/19,19.60%,GRID1;GABRA4;GRIK5;GRIK2;GABRA2;GABRE;GRIK1;GABRG3;GRID2
prerank,aspartic-type peptidase activity (GO:0070001),-0.6349253514036666,-1.433390930473322,0.0883054892601432,0.5372124337939307,1.0,2/10,5.12%,BACE2;BACE1
prerank,protein tyrosine kinase activity (GO:0004713),0.4638068987720716,1.4306722811513615,0.04572098475967175,0.5869805530559034,1.0,15/108,9.21%,BMX;TEK;FLT1;TIE1;FYN;FLT4;MERTK;INSR;FES;FGFR3;ALK;LMTK2;JAK2;YES1;PTK2
prerank,actin binding (GO:0003779),0.4500584268704466,1.4237335461252127,0.027412280701754384,0.6007662137193761,1.0,19/170,4.46%,EPS8L2;MYRIP;NOS3;SYNPO;LIMA1;TRPV4;UTRN;CEACAM1;SYNE1;ABLIM1;NOD2;FLNB;MACF1;PARVB;KLHL2;ACTN4;FLII;VASH2;PDLIM5
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5216736512248944,1.4221199825359376,0.09203296703296704,0.5962208537063723,1.0,18/42,21.96%,IZUMO1;STXBP6;ESAM;CDC42EP1;PDLIM5;ROBO4;CD47;BSG;CD200;LRRC4C;TMOD3;MYPN;NPTN;DSCAM;CNTN4;PDLIM1;CNTN6;PAK4
prerank,wide pore channel activity (GO:0022829),0.5853096697546062,1.421643072936334,0.09717868338557993,0.5886272415990309,1.0,4/23,9.88%,GJA5;GJB1;GJA4;GJD2
prerank,ephrin receptor binding (GO:0046875),0.6061193619072136,1.4192785948266335,0.10463378176382661,0.5869361218581851,1.0,7/21,10.63%,EFNA5;FYN;CBL;CRK;EFNA1;ANKS1B;PTPN1
prerank,death receptor activity (GO:0005035),0.6863554053049165,1.41798505679645,0.09411764705882353,0.5822025414206788,1.0,3/11,5.71%,FAS;TNFRSF25;TNFRSF1B
prerank,cytokine receptor binding (GO:0005126),0.4808240489293487,1.4159633378266616,0.053268765133171914,0.5801093990087681,1.0,10/83,8.22%,VEGFC;KITLG;LIFR;TGFB2;FKBP1A;VEGFD;SMAD2;ADAM17;IL1RAP;JAK2
prerank,protein kinase C binding (GO:0005080),0.528720140291856,1.4154066396362512,0.08623087621696801,0.5736003232386907,1.0,17/43,15.51%,TRPV4;CAVIN2;HDAC9;HDAC7;TIRAP;PDLIM5;PKN1;PRKCSH;HSPB1;DSP;ADCY4;CCDC88A;PRKD2;CAVIN3;NELL1;RACK1;NELL2
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.6597475776422679,1.415347266747363,0.1065989847715736,0.5655317097231124,1.0,2/12,6.38%,CDK19;MAPK1
prerank,gap junction channel activity (GO:0005243),0.5886577508229567,1.4144995087624483,0.10236220472440945,0.5603061896370197,1.0,4/22,9.88%,GJA5;GJB1;GJA4;GJD2
prerank,FAD binding (GO:0071949),-0.47141758135292,-1.4105565972174952,0.057057057057057055,0.5937218517083825,1.0,9/24,21.31%,MICAL3;MICAL2;DDO;PRODH;CRY2;SQLE;MICAL1;NDOR1;MTHFR
prerank,protein phosphatase 2A binding (GO:0051721),0.5892541668054541,1.4074067276754523,0.08966565349544073,0.5745176020959321,1.0,13/23,22.00%,FOXO1;DAB2IP;CTTNBP2NL;MFHAS1;STRN3;GRIN3A;ARPP19;BOD1;STRN4;STRN;PPME1;SMG7;IGBP1
prerank,ATPase binding (GO:0051117),-0.3733089670357215,-1.4070503336776612,0.031746031746031744,0.5858156773648554,1.0,19/71,15.65%,ANK2;EGFR;TMTC4;SNTA1;SLC2A13;ABCA1;ATP6V0A4;ATP1B3;TOR1AIP1;PTPN3;ATP5IF1;SRC;TCIRG1;METTL21A;ATP1B1;PIH1D1;ATP1B2;WFS1;ZNHIT6
prerank,ephrin receptor activity (GO:0005003),-0.5143578898937387,-1.4062085921566998,0.0821917808219178,0.5526982689821578,1.0,13/17,38.43%,EPHA3;EPHA7;EPHB4;EPHB2;EPHB3;EPHA6;EFNB3;EPHB6;EPHA8;EFNA4;EFNA3;EPHA1;EPHA5
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5143578898937387,-1.4062085921566998,0.0821917808219178,0.5526982689821578,1.0,13/17,38.43%,EPHA3;EPHA7;EPHB4;EPHB2;EPHB3;EPHA6;EFNB3;EPHB6;EPHA8;EFNA4;EFNA3;EPHA1;EPHA5
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.6886099254265369,1.4043881882540974,0.11206896551724138,0.5765428734713773,1.0,7/10,22.75%,PIK3C2A;PIK3C3;PIK3CB;ATM;PIK3C2B;PIK3R3;PIK3CA
prerank,glutamate receptor binding (GO:0035254),0.6103096040320498,1.4030092180452582,0.11216429699842022,0.573005140108739,1.0,5/17,6.95%,HIP1;HOMER2;AKAP5;SHANK3;SHISA6
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.4379306035530313,1.4000538597449306,0.019128586609989374,0.5741624487221708,1.0,33/188,12.28%,PRDM16;SOX17;SOX13;GATA6;SMAD6;SMARCA2;TAL1;HNF1A;HNF4A;SOX18;HHEX;FLI1;KLF4;MAFK;MEF2C;ZBTB48;GATA3;CEBPA;NFE2L2;NR1D1;KLF11;JUN;EGR1;HMGB1;DHX9;ARID5A;ZBTB14;BRCA1;ARID5B;SOX10;HINFP;SOX6;SUV39H2
prerank,low-density lipoprotein particle binding (GO:0030169),0.6224399623988159,1.394462401768552,0.1109375,0.5839580623690167,1.0,2/16,5.63%,CDH13;PLTP
prerank,protein phosphatase binding (GO:0019903),0.45824061480839756,1.3913782131854626,0.05154639175257732,0.585768216089591,1.0,35/117,20.22%,KCNN4;KCNQ1;CEACAM1;FLT4;ITGA1;FBXL2;ATP2B4;FOXO1;DAB2IP;IQGAP1;AKAP5;PPP1R16B;CTTNBP2NL;SHOC2;MFHAS1;HSP90B1;PTK2;STRN3;GRIN3A;ARPP19;CTNNB1;CDC27;ANK1;BOD1;RACK1;ANAPC7;STRN4;MAPK14;PPP1R16A;PPP1R9B;STRN;ANAPC4;PPME1;SMG7;JUP
prerank,poly(U) RNA binding (GO:0008266),-0.4967063632277115,-1.3906941882247479,0.08383233532934131,0.5827391278446161,1.0,5/20,8.92%,RBMS3;RBMS1;HNRNPH1;SSB;DAZAP1
prerank,lipid phosphatase activity (GO:0042577),0.622239902844985,1.389286298278431,0.11311475409836065,0.5850255803563,1.0,3/14,3.52%,SGPP2;PLPP1;INPP5K
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.6277719220789982,1.3847062294251067,0.1273344651952462,0.5919360376520498,1.0,1/13,0.28%,KCNQ1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5418570867399539,1.3795576519782669,0.11408450704225352,0.6008852963818322,1.0,9/32,17.87%,KCNQ1;KCNE3;KCNG3;KCNC1;KCNC4;KCNA1;KCNC2;KCNH1;KCNQ3
prerank,AMP binding (GO:0016208),-0.5703057802132484,-1.37759256572155,0.11594202898550725,0.6085131434811973,1.0,2/11,0.60%,PRKAG2;MPPED2
prerank,lipoprotein particle binding (GO:0071813),0.5863132369805402,1.376204260981141,0.11684370257966616,0.6034228388781846,1.0,2/20,5.63%,CDH13;PLTP
prerank,LRR domain binding (GO:0030275),-0.5376952340501618,-1.3758293226207585,0.10677083333333333,0.5974438434289928,1.0,2/14,0.42%,ROBO1;PAWR
prerank,poly-pyrimidine tract binding (GO:0008187),-0.47304150032526365,-1.3739681791107146,0.10185185185185185,0.5874837393456686,1.0,10/23,22.51%,RBMS3;RBMS1;HNRNPH1;SSB;DAZAP1;HNRNPU;U2AF2;PABPC1;PABPC4L;KHDRBS1
prerank,myosin V binding (GO:0031489),0.6176439135407402,1.3734144304034175,0.12171052631578948,0.6048017980919217,1.0,2/15,2.22%,RAB11A;RAB6B
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.6368570526107596,1.3734104438098125,0.14453781512605043,0.5975268063841853,1.0,5/12,4.11%,LTBP4;ENG;BMPR2;ACVRL1;ACVR1
prerank,phospholipase inhibitor activity (GO:0004859),-0.5934887558117784,-1.371393118525567,0.12276214833759591,0.5799822307288521,1.0,6/10,25.64%,ANXA2;ANXA1;ANXA5;ANXA4;ANGPTL3;ANXA9
prerank,cAMP binding (GO:0030552),0.6579213656066343,1.3701453242150932,0.1419141914191419,0.6007933661179817,1.0,4/11,15.62%,RAPGEF2;RAPGEF4;POPDC3;PDE4D
prerank,phosphoric ester hydrolase activity (GO:0042578),0.5011382479333917,1.3691791769354842,0.10533159947984395,0.5967151671159872,1.0,12/49,10.01%,PTPRJ;DUSP12;ACP6;SMPDL3A;PRUNE1;APEX1;DUSP16;DUSP3;PTPRO;GDPD1;ENPP6;DUSP11
prerank,phosphatidic acid binding (GO:0070300),0.5980945034337812,1.3690939724145774,0.115625,0.589947110466348,1.0,5/19,5.77%,RAPGEF2;PACSIN2;RAPGEF6;PLTP;UQCC3
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5856860793090979,1.3686300210316529,0.13657770800627944,0.5845256017061142,1.0,5/18,4.11%,LTBP4;ENG;BMPR2;ACVRL1;ACVR1
prerank,protein phosphatase 1 binding (GO:0008157),0.5760293902588621,1.3669952756105002,0.13834586466165413,0.5829373140635419,1.0,3/21,6.72%,KCNQ1;PPP1R16B;SHOC2
prerank,clathrin adaptor activity (GO:0035615),0.6149821582798456,1.3668785093714468,0.1546875,0.5768487422953187,1.0,5/15,9.72%,HIP1;HIP1R;AP2B1;STON1;AP2M1
prerank,amyloid-beta binding (GO:0001540),0.46614721839772094,1.366331658131204,0.07044025157232704,0.5719489851878422,1.0,20/79,11.86%,FZD6;APBB2;APBA1;INSR;ATP1A3;CACNA1A;TGFB2;ADRB2;APOA1;FCGR2B;IAPP;PFDN6;ITGAM;VBP1;GRIA1;GRIN2B;PRNP;PFDN2;CLU;ACHE
prerank,neurexin family protein binding (GO:0042043),-0.6044444846332327,-1.3655114495601943,0.11380145278450363,0.583554809940581,1.0,4/10,11.37%,NLGN2;CPE;SYTL5;SYTL4
prerank,antiporter activity (GO:0015297),0.5721019703721779,1.3649959869778046,0.12878787878787878,0.5696382265531034,1.0,6/20,9.52%,SLC25A16;ATP1A3;SLC35D2;SLC35E4;CLCN3;SLC25A30
prerank,cell adhesion mediator activity (GO:0098631),0.5570103955844746,1.3626378008479543,0.13145539906103287,0.5704164093674164,1.0,11/24,20.90%,BCAM;ESAM;ROBO4;CD47;BSG;LRRC4C;MYPN;NPTN;DSCAM;CNTN4;CNTN6
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.42269078956330824,1.3577853827078528,0.028037383177570093,0.5787244721121484,1.0,32/254,9.84%,PRDM16;MECOM;SOX17;ERG;CASZ1;NR4A2;FOXO4;FOXO1;ELK3;NR1I3;KLF7;IRF2;HNF1A;HNF4A;KLF6;SOX18;HHEX;KLF4;LEF1;MAFF;FOXF2;MEF2C;SMAD2;FOSL2;GATA3;ZBTB16;CEBPA;PLSCR1;JUN;TCF3;EGR1;PLAG1
prerank,chemorepellent activity (GO:0045499),0.5522748634809517,1.3567033711251433,0.12556053811659193,0.5758538467336929,1.0,4/25,4.67%,SEMA3G;SEMA3F;APOA1;SEMA7A
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.5124250048185691,-1.3564099814731652,0.1278409090909091,0.5972396589302132,1.0,5/15,14.19%,SLC1A3;SLC1A5;SLC25A13;SLC1A4;SLC25A12
prerank,mRNA 3'-UTR binding (GO:0003730),-0.352770313613685,-1.355634355356141,0.07236842105263158,0.5855669931759406,1.0,26/79,19.02%,CELF2;RBMS3;RBMS1;DDX5;CPEB1;FXR2;NUDT21;HNRNPA2B1;PUM1;CSDC2;DAZAP1;GEMIN5;YBX3;CCT5;LARP4B;TARDBP;CPEB2;CPEB3;TUT1;PCBP4;HNRNPU;ELAVL3;LARP1;RC3H1;PABPC1;ZFP36
prerank,pre-mRNA binding (GO:0036002),-0.4427722421505084,-1.3556180150135335,0.10543130990415335,0.5716749262768948,1.0,11/28,24.13%,CELF2;DDX5;PRPF8;SRSF6;HNRNPL;HNRNPU;U2AF2;SLBP;CELF1;CELF5;U2AF1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.3741649537893814,-1.3540274266324142,0.07657657657657657,0.5626782103311441,1.0,6/53,3.00%,SLC7A11;SLC1A3;SLC7A2;SLC47A1;SLC1A5;SLC25A13
prerank,phosphatidylinositol binding (GO:0035091),0.457650269577788,1.3537107446324637,0.08759124087591241,0.5784352644926372,1.0,23/91,13.74%,HIP1;MYO1E;ITPR3;HIP1R;ESYT2;FES;FCHO2;ING2;PLEKHF2;EPB41;SH3YL1;SNX10;MCF2L;PASK;PITPNA;CCDC88A;AIDA;EXOC8;NUMA1;SNX11;SNX22;ZFYVE9;SNX24
prerank,transforming growth factor beta binding (GO:0050431),0.5484446154527097,1.3510972491631394,0.13663663663663664,0.5798530484219329,1.0,6/23,5.33%,LTBP4;ENG;ACVRL1;ACVR1;WFIKKN1;HYAL2
prerank,semaphorin receptor binding (GO:0030215),0.5606374032358791,1.3439749147942046,0.11919504643962849,0.5947853280860209,1.0,3/23,4.67%,SEMA3G;SEMA3F;SEMA7A
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.41980111588254104,1.3405938618644027,0.04967602591792657,0.5985507996453926,1.0,25/173,11.01%,PRDM16;SOX13;KLF8;DACH1;ZFP69;ELK3;KLF12;HEY1;LRRFIP1;HHEX;HEY2;MAFK;GATA3;BCL6B;ZBTB16;GTF2IRD1;NR1D1;SNAI2;ERF;FOXP1;JUN;TCF3;ZBTB14;ZBTB34;DEAF1
prerank,disordered domain specific binding (GO:0097718),0.5512703856058989,1.33925547189884,0.13973799126637554,0.5959902125932168,1.0,7/23,12.72%,FYN;SMAD2;DFFB;GAPDH;NUMA1;CALM3;KCNA1
prerank,metallopeptidase activity (GO:0008237),-0.32397933518138405,-1.3369801328712432,0.022900763358778626,0.6005092626574235,1.0,28/113,13.36%,TRABD2B;ADAMTS2;ADAMTS12;ADAMTSL3;THSD4;PAPPA;ADAMTSL5;MMP14;ADAMTS17;ANPEP;ADAMTS5;ADAMTS10;ADAMTS3;ADAM19;ADAM9;ADAMTS15;ADAMTS9;PRPF8;MMP2;ADAM33;METAP1D;ADAMTSL4;MMP16;ZMPSTE24;MMP19;METAP1;ADAMTS14;RNPEP
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5405036907594244,-1.3321349772802762,0.14666666666666667,0.6010958290357358,1.0,6/12,16.70%,XDH;AOX1;FDX1;CIAPIN1;FXN;SDHB
prerank,PDZ domain binding (GO:0030165),0.4619102479373807,1.3309549315933284,0.11069651741293532,0.6137734539039672,1.0,19/61,14.82%,CCDC88C;RAPGEF2;F11R;ATP2B4;ATP2B2;TMEM88;CADM1;SNTG2;USHBP1;PLEKHA1;ADAM17;GRIA1;ACOX1;CLCN3;SLC22A5;GNG5;TBC1D10A;NSF;FZD3
prerank,glycerophospholipid flippase activity (GO:0140333),0.6307136356999598,1.3307779928030181,0.14795918367346939,0.6082868520567785,1.0,4/11,12.78%,ATP10A;ABCB4;ATP11C;ATP8B1
prerank,potassium ion antiporter activity (GO:0022821),-0.4999863714075149,-1.3306130861654648,0.13165266106442577,0.592388691800823,1.0,3/15,6.64%,SLC24A3;SLC9A2;SLC9A9
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.6204378165378821,1.3298732962304487,0.15702479338842976,0.6051694657218207,1.0,2/13,2.53%,PIP5K1B;PIK3C2A
prerank,insulin-like growth factor I binding (GO:0031994),-0.5136670112068864,-1.3239183853062866,0.16071428571428573,0.5983511921743293,1.0,5/13,7.26%,IGFBP5;IGFBP2;IGFBP6;ITGAV;IGFBP3
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5893313523772816,1.32039989912759,0.18181818181818182,0.6277170594299197,1.0,3/15,12.63%,CCR1;CMKLR1;CX3CR1
prerank,protease binding (GO:0002020),-0.3295060488213241,-1.3202283081014758,0.04081632653061224,0.5963427055962887,1.0,22/99,13.45%,COL1A2;COL3A1;COL1A1;CCBE1;BCL2;SLC2A13;ANXA2;ITGAV;PRKN;DPP4;TIMP2;NTRK2;LCOR;FAP;F3;BDKRB2;CFLAR;ADAMTSL4;SERPINE1;ATP9A;BFAR;ECM1
prerank,insulin-like growth factor binding (GO:0005520),-0.5009270951705147,-1.317699489057478,0.140625,0.5909444662929134,1.0,5/15,7.26%,IGFBP5;IGFBP2;IGFBP6;ITGAV;IGFBP3
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.558357691434752,1.3172187186344595,0.1447562776957164,0.6250047720631884,1.0,2/21,2.26%,CDK19;CDK14
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.558357691434752,1.3172187186344595,0.1447562776957164,0.6250047720631884,1.0,2/21,2.26%,CDK19;CDK14
prerank,calcium channel inhibitor activity (GO:0019855),0.6185538500226417,1.316209695954369,0.17598684210526316,0.6221055106633993,1.0,3/11,7.19%,FKBP1A;MCUB;SLC30A1
prerank,phosphatase activity (GO:0016791),0.45617446349437524,1.3143002660660104,0.12967581047381546,0.6218183492705639,1.0,19/73,16.64%,PTPRJ;ALPL;DUSP12;PLPP1;INPP5K;MINPP1;ACP6;PRUNE1;DUSP16;DUSP3;PTPRO;DUSP11;OCRL;PLPP6;PLPP4;DUSP28;DUSP26;PLPPR1;ARMT1
prerank,GTPase activity (GO:0003924),0.4097712927979304,1.313345745762534,0.05128205128205128,0.6191923486016826,1.0,47/192,16.69%,RND1;GBP5;GNAQ;RAB11A;RAB6B;ATL2;RHOB;GNAL;GBP4;DNM3;MTG2;GCH1;KRAS;NRAS;RRAS;GNG3;ATL1;GBP3;RAB23;GNAI2;IRGM;LRRK2;RAB35;MMAA;RRAGD;RHEBL1;RRAS2;GTPBP1;RAC1;MFN1;EEF2;GNG5;GBP2;RAB19;RHOT2;RND2;GNB2;RHOH;RAN;RHEB;SRPRA;ARL8A;GNA14;EFL1;RAB27B;RIT2;GBP7
prerank,N-acyltransferase activity (GO:0016410),0.509227302475854,1.31179811349917,0.13857142857142857,0.6178610507214267,1.0,6/32,9.27%,SATL1;CERS4;GLYAT;NMT1;CERS6;CERS5
prerank,heme binding (GO:0020037),0.4533578638815343,1.310512627758226,0.12222222222222222,0.6162251673940606,1.0,6/65,9.30%,NOS1;NOS3;JAK2;HEBP1;NR1D1;HMOX2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.46866170145582153,1.3094533357837321,0.12062256809338522,0.6139671018754279,1.0,6/55,4.28%,ATP2A3;TRPV4;ATP2B4;ATP2B2;ATP2C1;ORAI1
prerank,ligand-gated calcium channel activity (GO:0099604),0.5554284254920887,1.3090778785879311,0.16104294478527606,0.6095238319982045,1.0,5/19,11.28%,ITPR3;MCOLN1;GRIN2B;GRIN2C;TRPM2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.4021006289329701,1.3057655439089002,0.04197271773347324,0.6139565812139257,1.0,60/248,16.69%,MYO1E;RND1;GBP5;GNAQ;RAB11A;RAB6B;ATL2;RHOB;GNAL;GBP4;DNM3;MTG2;GCH1;DDX4;KRAS;NRAS;KIF26A;RRAS;GNG3;ATL1;GBP3;MYH9;KIF2A;THTPA;RAB23;GNAI2;IRGM;LRRK2;HSPA1B;MYL6;RAB35;MMAA;DHX9;RRAGD;RHEBL1;RRAS2;ABCG4;GTPBP1;RAC1;MFN1;EEF2;GNG5;GBP2;CLU;RAB19;PIN1;RHOT2;RND2;GNB2;RHOH;RAN;RHEB;SRPRA;ARL8A;KIF1A;GNA14;EFL1;RAB27B;RIT2;GBP7
prerank,SH2 domain binding (GO:0042169),0.5068355926564101,1.3044724988319663,0.15758468335787923,0.612378049267417,1.0,8/31,10.33%,AFAP1L2;TRPV4;CRK;NLK;ARHGAP5;JAK2;PTK2;CCDC88A
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.5347269146056284,-1.3032140641899996,0.15089514066496162,0.6203521774234949,1.0,4/12,6.60%,SULF1;SULF2;GNS;ARSI
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.5328778878488615,-1.3017377674744257,0.15365239294710328,0.61253290630519,1.0,2/12,3.22%,B3GALT1;B3GNT2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.35671624722311873,-1.3004944986852909,0.08444444444444445,0.6041662253888122,1.0,14/55,10.94%,SLC6A13;SLC16A12;SLC7A2;SLC13A3;PDPN;SLC6A12;SLC16A6;SLC16A9;SLC38A11;SLC19A1;SLC22A4;SLC38A10;SLC38A5;SLC16A11
prerank,histone acetyltransferase activity (GO:0004402),-0.41275928249600835,-1.2995459033444148,0.09398496240601503,0.5956595681054259,1.0,14/30,23.29%,TADA2A;CREBBP;KAT2B;TAF1;HAT1;CLOCK;USP22;ATF2;NAA60;TADA3;NAA40;MCM3AP;TAF10;NAA50
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.495155516015616,1.2980192914872632,0.14788732394366197,0.6255657642291615,1.0,5/34,3.63%,CYTH3;FCHSD2;HIP1R;IQGAP1;ARAP3
prerank,kinase binding (GO:0019900),0.38978068071036803,1.2973918006582021,0.029381965552178316,0.6218245707837474,1.0,91/434,16.29%,PTPRJ;PLCG2;TRPV4;GATA6;PTPRR;UTRN;CEACAM1;TRIM14;FAS;CCND2;RND1;ACVRL1;NOD2;CCND3;ATP1A4;DAB2IP;TTC28;CAV1;CAV2;RHOB;OXSR1;EMP2;IQGAP1;HDAC7;BTG1;CRK;FBXO7;MSN;NBEA;TRIM6;BCAR3;SIKE1;CDC25C;WARS1;SMCR8;ADIPOR1;CEP68;DUSP3;IRGM;HNRNPA0;ELAVL1;HSPB1;PDE8A;MAPRE3;CEBPA;BCL2L1;TOM1L1;JAK2;WWC2;APC;STAP1;PTK2;ADAM10;CASP1;PLCG1;NEFH;PTPN1;RAC1;TPCN2;POLA1;CADPS;ACTB;NPM1;EEF2;PIK3IP1;VRK1;CALM3;IRF5;CTBP2;PRC1;INKA1;RND2;CNKSR2;HIF1A;AP1B1;RHOH;NSF;LYST;CTNNB1;LRBA;KIZ;FRMD5;PDCD10;CDKN2D;PAK2;VDAC1;RICTOR;NEK9;PFKM;SGO1;ESR1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.6264653050499117,1.2946137155208888,0.18305084745762712,0.6184506432499419,1.0,2/10,6.26%,DUSP1;DUSP16
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.6264653050499117,1.2946137155208888,0.18305084745762712,0.6184506432499419,1.0,2/10,6.26%,DUSP1;DUSP16
prerank,ion channel inhibitor activity (GO:0008200),0.4953357694778671,1.2903918990249417,0.14681440443213298,0.6251312702966921,1.0,9/35,10.96%,FKBP1A;MCUB;VTI1B;STX7;CAMK2D;SLC30A1;VAMP8;SCN1B;NEDD4L
prerank,pyrophosphatase activity (GO:0016462),0.4704619938740488,1.290133073569673,0.16129032258064516,0.620679394965316,1.0,11/50,13.99%,ENTPD1;ALPL;PLPP1;PRUNE1;DCPS;DHX9;ADPRM;PRUNE2;TRPM2;PLPP4;NUDT9
prerank,carboxy-lyase activity (GO:0016831),0.5478889273053217,1.2892362828937463,0.17518248175182483,0.6180541170601359,1.0,4/23,8.74%,AMD1;AZIN1;PCK2;ACOD1
prerank,transmitter-gated ion channel activity (GO:0022824),0.504049938094881,1.288934456009431,0.17543859649122806,0.6138213667594737,1.0,15/29,26.34%,GRID1;GABRA4;GRIK5;GRIK2;GABRA2;GABRE;GRIK1;GLRA2;GABRG3;GABRB1;GRID2;GABRB3;GRIA2;GABRA3;GRIA4
prerank,double-stranded RNA binding (GO:0003725),0.4436213189535938,1.2886280687040184,0.1312883435582822,0.6097210180149073,1.0,16/70,13.08%,ADARB1;IFIH1;LRRFIP1;VIM;TLR3;MSN;MBNL1;TUBB4B;ELAVL1;ZNF346;OAS2;ADAR;DHX9;AGO4;ILF2;FXR1
prerank,MHC class I protein binding (GO:0042288),0.6054056244120215,1.2882156219931142,0.1858974358974359,0.6062149618745815,1.0,5/13,13.20%,TUBB;TUBB4B;ATP5F1A;TAP1;TAPBP
prerank,alkali metal ion binding (GO:0031420),-0.5121953884819401,-1.2852392001209012,0.14882506527415143,0.6238711514138902,1.0,5/13,14.72%,ATP1A2;PDXK;ADPRH;HDAC4;DRG1
prerank,receptor ligand activity (GO:0048018),0.3978139564204105,1.2845118045503294,0.05753138075313807,0.6114763609819333,1.0,14/245,4.67%,VEGFC;SEMA3G;JAG1;JAG2;EDN1;PDGFB;KITLG;DAND5;TGFB2;SEMA3F;TAFA1;APOA1;VEGFD;SEMA7A
prerank,carbohydrate kinase activity (GO:0019200),-0.532917250783786,-1.2842986188660879,0.18983957219251338,0.6154301111994084,1.0,5/11,21.13%,GALK2;HK2;NAGK;GALK1;POMK
prerank,GTP binding (GO:0005525),0.4041544961338709,1.2834337543874859,0.08261802575107297,0.6093230981942273,1.0,43/172,16.73%,RND1;GBP5;INSR;ATL2;RHOB;GBP4;MTG2;GCH1;KRAS;NRAS;SCG5;RRAS;RAB39A;TUBB;GLUD1;ATL1;GBP3;TUBB4B;MFHAS1;LRRK2;RAB35;MMAA;EIF2B2;TUBA8;ARF3;RRAGD;RHEBL1;RRAS2;RAC1;GBP2;RHOT2;RND2;TUBA1A;RRAD;RHOH;RAN;RHEB;ARL8A;ARL5B;RAB27B;RIT2;GBP7;ARFIP2
prerank,calcium ion binding (GO:0005509),0.3898070167442425,1.2832941520604337,0.04531410916580844,0.6048716319544386,1.0,44/323,11.44%,CDH13;LTBP4;NOTCH4;SYT15;RAPGEF2;ITPR3;PITPNM3;MCTP1;DYSF;PLSCR4;ESYT2;EML1;CLGN;RASGRP2;AOAH;CALML4;AGRN;CEMIP2;IQGAP1;ANXA3;SYT7;SLC8A1;NUCB2;SPOCK2;STIM2;MEX3B;TPD52;ASAH2;EFCAB9;PPP3CA;HSP90B1;CASQ1;PLSCR1;CDH15;CDH3;CRACR2A;DSPP;CDH12;DHH;PRNP;CDH2;SPOCK1;TRPM2;PCP4
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.5017940617849903,1.2831930645157301,0.18352601156069365,0.6004057171414607,1.0,9/28,19.60%,GRID1;GABRA4;GRIK5;GRIK2;GABRA2;GABRE;GRIK1;GABRG3;GRID2
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3618224223491212,-1.282219057802215,0.12017167381974249,0.6101595372662546,1.0,10/47,7.99%,SLC7A11;SLC6A13;SLC7A2;SLC47A1;PDPN;SLC1A5;SLC38A11;SLC6A1;SLC22A4;SLC38A10
prerank,protein serine/threonine kinase activity (GO:0004674),0.39041928440994483,1.2780313691018734,0.044284243048403706,0.6091558538519856,1.0,67/335,12.94%,NUAK1;CDK19;KALRN;MAP4K2;STK10;BMPR2;RPS6KA5;PLK3;ACVRL1;MAP4K3;MYLK;SBK1;CDK14;SNRK;PRKD1;MAST4;OXSR1;CDC42BPA;TRIO;MAP3K6;PKN3;CDC42BPG;BCR;ACVR1;SLK;STK24;CAMK2D;MAP4K4;PKN1;STK38;STK38L;CSNK1D;NLK;TTBK2;IRAK2;MAPK1;UHMK1;MAST1;AKT3;SIK2;LRRK2;LMTK2;TLK1;STK19;PRKAA1;STK39;PASK;PIM3;NEK7;ROCK1;CSNK1G3;SGK1;TAOK2;MAP3K11;MARK3;PRKCG;RPS6KA1;MINK1;LIMK2;NEK11;PRKD2;MARK2;VRK1;TTBK1;STK33;RPS6KA3;RPS6KB1
prerank,DNA-binding transcription factor binding (GO:0140297),0.39998955912088624,1.2752061891294628,0.08485499462943072,0.6121846626292512,1.0,30/189,11.54%,PRDM16;LDB2;LMO2;FOXO4;TBXT;TAL1;HNF4A;HDAC9;HDAC7;HHEX;RBBP8;HEY2;KLF4;MEF2C;SMAD2;BBS7;CHCHD2;STAT1;HSPB1;PURA;RBL1;NFE2L2;JUN;TCF3;HMGB1;DHX9;MAD2L2;CRTC1;NPM1;DMAP1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.4369861600048366,-1.267160886232964,0.14501510574018128,0.6426192799785216,1.0,10/22,21.36%,IKBKE;TAB3;OPTN;PRPF8;OTUD7B;WDR81;ZRANB1;TNFAIP3;ZRANB3;RNF168
prerank,C2H2 zinc finger domain binding (GO:0070742),0.5941056894900134,1.2621260270760724,0.2222222222222222,0.6441187341521347,1.0,2/11,4.58%,GATA2;LEF1
prerank,transcription cis-regulatory region binding (GO:0000976),0.38176149853151203,1.26109073688604,0.03546099290780142,0.642001186230346,1.0,58/406,12.28%,PRDM16;EPAS1;SOX17;SOX13;GATA6;SMAD6;MSX1;DACH1;SMARCA2;CASZ1;ZFP69;ELK3;NR1I3;TAL1;IRF2;HNF1A;HNF4A;SOX18;HHEX;ACTN4;FLI1;KLF4;SIM2;LEF1;MAFK;ZBTB46;FOXF2;MEF2C;SMAD2;ZBTB48;FOSL2;GATA3;SETX;PURA;RBL1;CEBPA;NFE2L2;NR1D1;SNAI2;KLF11;FOXP1;JUN;TCF3;EGR1;HMGB1;ARID5A;ZBTB14;XRN2;DEAF1;NPM1;PHOX2A;E2F7;BRCA1;ARID5B;SOX10;HINFP;SOX6;SUV39H2
prerank,I-SMAD binding (GO:0070411),0.5823615991158898,1.2606831299759778,0.2197986577181208,0.6381883435990849,1.0,5/13,14.25%,SMAD6;SMAD7;SMAD2;SMURF1;CTNNB1
prerank,myosin binding (GO:0017022),0.45410071574154376,1.2591202276847329,0.16443850267379678,0.6377879592228336,1.0,14/55,16.81%,MYRIP;SHROOM4;MYBPC3;RAB11A;RAB6B;SPATA6;LMTK2;NKD2;SHROOM1;CXCR4;RAB27B;STXBP5L;PYCARD;STXBP5
prerank,glucose transmembrane transporter activity (GO:0005355),0.5605280481266806,1.2578612072423827,0.20063694267515925,0.636625998666386,1.0,2/17,3.02%,SLC2A1;SLC5A10
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.5771558491292541,1.257284800309333,0.21300813008130082,0.6334470916696372,1.0,9/12,30.69%,GABRA4;GABRA2;GABRE;GABRG3;GABRB1;GABRB3;GABRA3;GABRB2;GABRA5
prerank,translation elongation factor activity (GO:0003746),0.5665594514101452,1.2571942718623215,0.23015873015873015,0.6290088986289453,1.0,8/14,26.99%,TUFM;GTPBP1;EEF2;GTPBP2;EEFSEC;GFM1;TSFM;EEF1A1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.529176283017941,-1.256886108978998,0.2,0.6511636479529381,1.0,5/11,23.64%,SIL1;BAG1;BAG3;GRPEL2;BAG2
prerank,adenyl nucleotide binding (GO:0030554),-0.529176283017941,-1.256886108978998,0.2,0.6511636479529381,1.0,5/11,23.64%,SIL1;BAG1;BAG3;GRPEL2;BAG2
prerank,adenylate cyclase binding (GO:0008179),-0.5420870194235083,-1.2564360999199873,0.19852941176470587,0.6418335534636692,1.0,4/10,7.03%,ADCY5;AKAP12;ADCY2;CALM2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.5121484888887217,-1.2556931858630673,0.2125,0.6333085876385116,1.0,8/12,22.80%,CYFIP2;EIF4E2;NCBP1;EIF4E3;GEMIN5;LARP1;NCBP3;NCBP2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.45057774428535546,-1.2552979546735223,0.16897506925207756,0.6241101507811252,1.0,17/18,54.99%,HSD17B8;HSD11B1;HSD17B10;HSD17B2;HSD3B7;HSD17B14;HSD17B1;DHRS11;HSD17B7;SRD5A2;HSD3B2;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3;RDH5
prerank,GABA-A receptor activity (GO:0004890),0.5462994500879773,1.2543726107182438,0.22632423756019263,0.632150338944927,1.0,7/18,21.41%,GABRQ;GABRA4;GABRA2;GABRE;GABRG3;GABRB1;GABRB3
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4361347539062442,1.2488365207697152,0.16521739130434782,0.6426656297530583,1.0,10/72,4.08%,KCNQ1;HIP1;PLCB1;HIP1R;STXBP6;TTPA;FLII;SYT7;TIRAP;FCHO2
prerank,SUMO transferase activity (GO:0019789),-0.4606428843120683,-1.2485499522127466,0.18384401114206128,0.6330719549507323,1.0,8/16,27.53%,PIAS3;HDAC4;CBX4;MDM2;TOPORS;PIAS4;UBE2I;NSMCE2
prerank,chemokine receptor activity (GO:0004950),0.5124204741565683,1.2474173100017398,0.19648093841642228,0.6423132625000337,1.0,4/24,14.74%,CCR1;CMKLR1;CX3CR1;CXCR4
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3556850952905089,-1.2466572796866582,0.11885245901639344,0.6278235799259803,1.0,12/48,11.69%,TRPM3;NALCN;PIEZO2;SLC12A2;SLC41A1;TRPM6;ATP6V1B2;ABCC9;TRPC6;DMAC2L;CALHM5;TRPV2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.40821074571682125,1.2466354803533592,0.14925373134328357,0.6400525158282913,1.0,26/100,18.31%,CYTH3;FCHSD2;HIP1;HIP1R;DAB2IP;TTPA;IQGAP1;ARAP3;TECPR1;CERT1;PLEKHA5;MYO10;SNX11;SAP30L;SNX22;BTK;SNX24;PHLDA3;RUBCN;CLVS1;KIF16B;ZFYVE16;ARFIP2;KCNH1;GOLPH3L;GOLPH3
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.5228779833519728,-1.2463387233693577,0.19656019656019655,0.6190856052710655,1.0,3/11,7.11%,SLC25A47;SLC25A20;SLC22A4
prerank,channel activity (GO:0015267),0.46198757941567803,1.2452720262827746,0.18767123287671234,0.6391383986365179,1.0,3/41,2.73%,TRPV4;AQP11;MCUB
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.3839975741049635,-1.242877669512101,0.16666666666666666,0.6189813304301303,1.0,14/33,16.43%,SCAF8;RRN3;PAF1;ERCC5;ERBB2;CTR9;URI1;UVSSA;RTRAF;GTF2B;HNRNPU;PCF11;MAF1;WAC
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.598355656834771,1.242792044577229,0.23809523809523808,0.6416070017582814,1.0,3/10,8.80%,APEX1;EXD2;FEN1
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5244542263085045,-1.239151578031344,0.2116788321167883,0.6196481457888119,1.0,2/10,7.47%,B3GALT1;B4GALT1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.4446935492471122,1.237779767457311,0.17496807151979565,0.6506597158856914,1.0,7/54,6.37%,ACER2;HDAC9;GLS2;GLS;HDAC11;ASAH2;SIRT4
prerank,microtubule binding (GO:0008017),0.37752139353595005,1.2270765679088653,0.121875,0.6762520219334801,1.0,52/222,15.66%,CCDC88C;TRPV4;IRAG2;MTUS1;RAB11A;EML1;ARHGEF2;MACF1;SAXO1;MAP4;DNM3;CLIP2;DST;KIF26A;VASH2;MAP4K4;FAM161A;EML6;TTBK2;CAMSAP2;CLIP1;KIF2A;CLASP1;MAST1;WHAMM;LRRK2;MAPRE3;HOOK1;REEP2;STARD9;APC;CCDC181;GAPDH;UXT;GAS2L3;CLASP2;PRNP;CCDC88A;NEFH;POLB;REEP1;NUMA1;REEP3;PRC1;KIF26B;MAP1LC3A;NAV3;SYBU;VAPA;MAP2;KIF16B;KIF1A
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.5112767273759001,-1.2256824274248501,0.21727748691099477,0.6472888828369442,1.0,4/11,20.69%,PPP1R1A;PPP1R14B;PPP1R2;PPP1R11
prerank,calcium channel activity (GO:0005262),-0.3127888097813069,-1.221778780458237,0.10824742268041238,0.6488044883456054,1.0,16/84,12.41%,SLC24A3;CACNA2D3;CACNA1C;ANXA2;TRPC3;ITGAV;CACNG4;CACNA2D1;P2RX4;NCS1;TRPC6;TRPC4;CACNB1;PKD1;TRPV2;CACNB2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.42455032527475955,1.2212109648495788,0.21400264200792601,0.688311072948015,1.0,11/60,7.26%,TEK;FLT1;TIE1;FLT4;MERTK;ACVRL1;INSR;ACVR1;FGFR3;ALK;LMTK2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.4622679462598914,-1.2156592365588852,0.18611111111111112,0.6566223450181315,1.0,8/16,22.40%,SLC13A3;SLC1A5;SLC25A13;SLC1A4;SLC25A12;SLC25A18;SLC25A14;SLC13A5
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5266037111075383,1.2112769182119512,0.23076923076923078,0.7122417715211345,1.0,6/18,18.52%,TNFAIP8;RPS6KA1;RPS6KA3;NOL3;VIL1;XIAP
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.49304636195577867,-1.2069610984952752,0.22493887530562348,0.6712452418027607,1.0,6/12,18.57%,SHC1;IRS1;PIK3R1;SH2B1;GAB2;SH2B2
prerank,tRNA methyltransferase activity (GO:0008175),0.5365579701123306,1.205463915682204,0.25274725274725274,0.7242315249155556,1.0,5/16,11.12%,TRDMT1;TRMT5;METTL2A;METTL2B;ALKBH8
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5217736633691472,1.203586970596879,0.2640901771336554,0.7249996575545776,1.0,8/17,17.26%,GRIA1;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;GRIK1;GRIN2A
prerank,gamma-tubulin binding (GO:0043015),-0.4148875460257465,-1.2018570649933358,0.1897590361445783,0.6765507520990166,1.0,9/21,21.29%,BRSK1;TUBGCP4;DIXDC1;OFD1;DDX3X;NDRG1;TUBGCP5;BLOC1S2;RACGAP1
prerank,sodium:proton antiporter activity (GO:0015385),-0.48381306483110237,-1.201462988400445,0.23366834170854273,0.668448103828465,1.0,5/11,19.40%,SLC9A2;SLC9B2;SLC9A9;SLC9A1;SLC9A6
prerank,potassium ion leak channel activity (GO:0022841),-0.4630435232103127,-1.2012853125244842,0.2421875,0.6598833054843546,1.0,2/15,2.94%,KCNK2;KCNK5
prerank,ligand-gated channel activity (GO:0022834),0.47022962986560846,1.1999681336059087,0.24167872648335745,0.7303647674204778,1.0,11/29,19.60%,GRID1;GRIA1;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;GRIK1;GRIN2A;GABRB1;GRID2
prerank,ligand-gated ion channel activity (GO:0015276),0.4666207376865005,1.1996471272310498,0.2317596566523605,0.7264859807473002,1.0,11/30,19.60%,GRID1;GRIA1;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;GRIK1;GRIN2A;GABRB1;GRID2
prerank,RNA cap binding (GO:0000339),-0.4445145402458138,-1.198711156567563,0.23140495867768596,0.6579174581246763,1.0,9/16,18.59%,CYFIP2;EIF4E2;NCBP1;EIF4E3;GEMIN5;EIF3D;SNUPN;LARP1;NCBP3
prerank,Toll-like receptor binding (GO:0035325),0.5702842584666427,1.1961002398917557,0.27986348122866894,0.7319829360514829,1.0,2/11,3.82%,DAB2IP;TIRAP
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4308400389697761,1.194053461390393,0.22467532467532467,0.7329805975581432,1.0,6/53,8.17%,NOS1;NOS3;CYB5R1;ETFDH;ETFA;ACOX1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.4377697591959352,-1.1935144747079487,0.24649859943977592,0.6550390249233282,1.0,6/16,16.45%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP5F1B;ATP6V1A
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.4377697591959352,-1.1935144747079487,0.24649859943977592,0.6550390249233282,1.0,6/16,16.45%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP5F1B;ATP6V1A
prerank,galactosyltransferase activity (GO:0008378),0.573907832720203,1.1934526401444976,0.2750809061488673,0.7300045785109751,1.0,4/11,14.64%,B4GALT4;A4GALT;B4GALT6;A3GALT2
prerank,guanyl ribonucleotide binding (GO:0032561),0.3732384310602535,1.1927269639377205,0.15995762711864406,0.7273381333421026,1.0,44/196,16.73%,RAPGEF2;RND1;GBP5;INSR;ATL2;RHOB;GBP4;MTG2;GCH1;KRAS;NRAS;SCG5;RRAS;RAB39A;TUBB;GLUD1;ATL1;GBP3;TUBB4B;MFHAS1;LRRK2;RAB35;MMAA;EIF2B2;TUBA8;ARF3;RRAGD;RHEBL1;RRAS2;RAC1;GBP2;RHOT2;RND2;TUBA1A;RRAD;RHOH;RAN;RHEB;ARL8A;ARL5B;RAB27B;RIT2;GBP7;ARFIP2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4472007907626946,1.1918602189428176,0.24864130434782608,0.7250880955942279,1.0,4/42,4.81%,CCNY;CCND2;CCND3;CCNE1
prerank,tubulin binding (GO:0015631),0.3613570569486482,1.1900626054893937,0.14943705220061412,0.7257555976030649,1.0,65/295,15.66%,CCDC88C;TRPV4;STMN2;FYN;RABGAP1;IRAG2;MTUS1;RAB11A;EML1;ARHGEF2;SAXO1;MAP4;DNM3;TTLL7;CLIP2;DST;KIF26A;VASH2;MAP4K4;FAM161A;EML6;PRUNE1;PHF6;GABARAPL1;CLIP1;KIF2A;CLASP1;MAST1;WHAMM;LRRK2;VBP1;MAPRE3;HOOK1;TTLL1;REEP2;STARD9;APC;CCDC181;GAPDH;UXT;GAS2L3;CLASP2;PRNP;CCDC88A;NEFH;POLB;REEP1;NUMA1;BRCA1;DIP2B;TTLL5;REEP3;TTLL11;PRC1;RAD51D;EFHC2;KIF26B;MAP1LC3A;NAV3;SYBU;VAPA;MAP2;ARL8A;KIF16B;KIF1A
prerank,GTPase regulator activity (GO:0030695),0.36803104761372357,1.1895350321396727,0.16435432230522945,0.7224985181977109,1.0,49/212,13.94%,PREX2;RAPGEF2;ARHGAP31;RGS3;PLCB1;RABGAP1;SIPA1L2;CHN2;GNAQ;ABR;ASAP2;IQGAP1;SIPA1L3;RALGAPA1;ARAP3;BCR;TBC1D30;SGSM1;ARHGAP8;TBC1D8;RAP1GDS1;SH3BP4;RGS7;RAB3GAP2;LRRK2;RANGAP1;ARHGAP25;TBC1D12;ARRB1;TBC1D5;TBC1D1;JUN;RAP1GAP2;CCDC88A;RANBP2;RANBP1;RALGAPB;OCRL;ARHGAP27;DOCK1;ITGB1BP1;USP6NL;TBC1D10A;TBC1D4;TBC1D9;RHOH;RGS12;RALGAPA2;SOS1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.47531106850055493,1.1854986335435547,0.2532188841201717,0.7293708052001261,1.0,15/30,28.79%,TNFAIP8;PTTG1;RPS6KA1;SPOCK1;RPS6KA3;NOL3;VIL1;CST3;XIAP;UBE2O;CARD16;SNCA;SERPINB9;PRDX5;CD27
prerank,nuclear receptor coactivator activity (GO:0030374),-0.34247518445462166,-1.184923551168656,0.22127659574468084,0.6700931368519004,1.0,16/52,13.96%,PPARGC1B;ZMIZ1;PRKCB;TACC1;CCAR1;FGF2;MED13;RNF4;MED14;RBM14;CCDC62;CALCOCO1;ZMIZ2;USP22;ATXN7L3;ELK1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.3736072231902223,-1.1831871473545175,0.2006079027355623,0.6664892193833873,1.0,8/29,16.10%,PRKAG2;KAT2B;SPRED1;SPRED2;PRKAR2A;PRKAR2B;PRKAR1A;CDKN1A
prerank,mannose binding (GO:0005537),-0.4806912520302154,-1.1828128233342354,0.2526595744680851,0.659313205019905,1.0,8/12,46.02%,LMAN1;CLN5;LMAN2;ACR;COLEC11;LMAN2L;LMAN1L;CLEC4D
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.4945160767969658,1.1780690062435166,0.282798833819242,0.746506325343536,1.0,2/22,3.89%,ATP2A3;ATP2C1
prerank,CoA-ligase activity (GO:0016405),0.5294191001139775,1.177665181351388,0.27980922098569155,0.742992838693659,1.0,5/14,14.78%,ACSM3;ACSBG1;ACSS2;AACS;SLC27A2
prerank,cGMP binding (GO:0030553),0.5756002669464182,1.1776245989632257,0.2998324958123953,0.73853317433966,1.0,1/11,0.63%,RAPGEF2
prerank,calcium:sodium antiporter activity (GO:0005432),-0.5083350545068452,-1.1739666023553403,0.2655086848635236,0.6735365999741756,1.0,2/10,3.22%,SLC24A3;SLC8A3
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.5629230101696693,1.1723520049119378,0.27638190954773867,0.7493902099178896,1.0,4/10,17.50%,GABRA4;GABRA2;GABRE;GABRG3
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.5329312404347134,1.1716862686128027,0.29194630872483224,0.7468055315310974,1.0,7/13,26.48%,GABRA4;GABRA2;GABRE;GLRA2;GABRG3;GABRA3;GLRB
prerank,anion channel activity (GO:0005253),0.41291635856867126,1.170128011600573,0.24905183312262957,0.7466692397351697,1.0,16/61,19.81%,LRRC8C;CLIC4;ANO6;GABRQ;BEST1;TTYH3;CLCN3;GABRA4;GABRA2;GABRE;VDAC1;GLRA2;GABRG3;GABRB1;VDAC3;CLCN7
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.48371394075073665,1.1678851267803756,0.2852897473997028,0.7482658007731792,1.0,6/23,15.50%,HIP1;HIP1R;PLEKHA5;PHLDA3;CLVS1;KIF16B
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.4551760398447119,-1.1677074933311338,0.2647814910025707,0.6820985943341491,1.0,5/12,19.40%,SLC9A2;SLC9B2;SLC9A9;SLC9A1;SLC9A6
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.3812560059769411,-1.167151460947819,0.24115755627009647,0.6756264745916324,1.0,10/27,22.43%,SLC41A1;SLC8A3;SLC9A2;SLC9B2;SLC9A9;SLC9A1;SLC8A2;SLC9A6;KCNK1;SLC4A8
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.34967780946864424,1.1670844247022134,0.11044176706827309,0.7459332959205086,1.0,81/597,13.59%,PRDM16;SOX17;SOX13;ERG;IRF6;GATA6;GATA2;SMAD6;MSX1;KLF2;SMARCA2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;ELK3;NR1I3;KLF12;HEY1;TAL1;OLIG2;IRF2;ZNF296;HNF1A;HNF4A;KLF3;KLF6;SOX18;HHEX;FLI1;HEY2;HMBOX1;KLF4;LEF1;MAFK;IRF9;MAFF;MEF2C;ZBTB48;GATA3;BCL6B;RXRG;ORC3;CEBPA;NFE2L2;NR1D1;SNAI2;KLF11;FOXP1;JUN;TCF7L1;EGR1;HMGB1;DHX9;ARID5A;ZBTB14;POLA1;PHOX2A;E2F7;BRCA1;NR4A1;ARID5B;KLF13;SOX10;ORC5;HINFP;SOX6;TLX3;SUV39H2;IRF5;ELF2;TGIF1;POU3F2;ZNF32;UNCX;TBX20;NFATC1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5597453047524502,1.1647415194839177,0.3117744610281924,0.748166888463973,1.0,4/10,9.23%,IZUMO1;CD47;CD200;DSP
prerank,cation channel activity (GO:0005261),-0.2956274781537087,-1.164401500504241,0.12345679012345678,0.6749714475064155,1.0,11/94,6.36%,SLC24A3;TRPM3;NALCN;PIEZO2;KCNK5;ANXA2;TRPC3;ANO1;TRPM6;ABCC9;KCNQ4
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.2801830797951052,-1.162181767362157,0.09649122807017543,0.6728493504118968,1.0,23/134,8.86%,SLC1A3;SLC6A13;SLC16A12;SLC7A2;SLC13A3;PDPN;SLC26A7;SLC1A5;SLCO2B1;SLCO3A1;SLC26A2;SLC25A13;GJA1;SFXN2;SLC39A8;SLC22A6;SLC6A1;SLC19A1;SLC52A1;SLC6A9;SLC27A1;MPC2;SLCO2A1
prerank,ligand-gated anion channel activity (GO:0099095),0.4977108851694193,1.160549261461664,0.2912,0.755608516282488,1.0,11/17,30.69%,GABRA4;GABRA2;GABRE;GLRA2;GABRG3;GABRB1;GABRB3;GABRA3;GLRB;GABRB2;GABRA5
prerank,calcium channel regulator activity (GO:0005246),0.4387427157197239,1.1559239835614277,0.2834008097165992,0.7644000754646115,1.0,6/37,9.30%,PRKG1;FKBP1A;MCUB;STIM2;SLC30A1;SGK1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.35273529518874575,1.1551928886320988,0.20041322314049587,0.7620563611176032,1.0,54/269,14.74%,FZD6;SMAD6;ASB4;SMAD7;FOXO1;CASP8;HERC2;FBXO7;SUMO2;SUMO3;TUBB;GPI;NLK;SMAD2;TRAF1;TNFRSF1B;ARIH1;CUL3;GABARAPL1;ARRDC1;UBE2D1;MFHAS1;MC4R;STAT1;HSPA1B;PRR5L;ARRB1;UBA52;APC;ACTG1;RPS27A;JUN;RTN4;FBXW7;RBX1;CUL2;NKD2;NFKBIA;BAG6;LAPTM5;CCT2;SNCAIP;BRCA1;TMBIM6;CLU;DTX3L;UBE2T;YOD1;UBE2J2;HIF1A;UQCRC1;MAP1LC3A;RAD18;CXCR4
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.3786362288228983,-1.1545574672551129,0.24172185430463577,0.6849406321020253,1.0,5/26,10.93%,B3GALT1;B3GNT2;GBGT1;CHPF2;EXTL2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3880550148861551,1.1520828869329556,0.26555023923444976,0.7666732326743861,1.0,10/91,4.08%,KCNQ1;HIP1;PLCB1;HIP1R;STXBP6;TTPA;FLII;SYT7;TIRAP;FCHO2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5217759322237698,1.1449386689768646,0.29827315541601257,0.7829439653506807,1.0,5/14,11.08%,RECK;SPOCK2;TIMP3;SPOCK3;SPOCK1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5332941323218522,1.1442084192583482,0.32114467408585057,0.7807138533964806,1.0,2/12,8.59%,RRH;ELOVL4
prerank,R-SMAD binding (GO:0070412),0.4994004241058139,1.1419171276605924,0.315541601255887,0.7827710689211781,1.0,9/18,19.63%,SMAD6;SMAD2;JUN;PMEPA1;SMURF1;DROSHA;MEN1;SMAD4;TRIM33
prerank,ankyrin binding (GO:0030506),0.4866540169618465,1.1418412132001605,0.3099688473520249,0.7784956769207387,1.0,4/19,7.89%,RHCG;SLC8A1;PLEC;NRCAM
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.469587744383781,1.1416598256526664,0.3009118541033435,0.7745833781741952,1.0,4/21,12.92%,KCNQ1;AKAP5;WASF2;AKAP1
prerank,ubiquitin protein ligase binding (GO:0031625),0.3499975901567408,1.1405711704326755,0.225,0.77317522820408,1.0,51/254,14.74%,FZD6;SMAD6;ASB4;SMAD7;FOXO1;CASP8;HERC2;FBXO7;SUMO2;TUBB;GPI;NLK;SMAD2;TRAF1;TNFRSF1B;ARIH1;CUL3;GABARAPL1;ARRDC1;UBE2D1;MFHAS1;MC4R;HSPA1B;PRR5L;ARRB1;UBA52;APC;ACTG1;RPS27A;JUN;RTN4;FBXW7;RBX1;CUL2;NKD2;NFKBIA;BAG6;LAPTM5;CCT2;SNCAIP;BRCA1;TMBIM6;CLU;UBE2T;YOD1;UBE2J2;HIF1A;UQCRC1;MAP1LC3A;RAD18;CXCR4
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.35499574523863897,-1.1405491414892415,0.2608695652173913,0.7141106415247621,1.0,8/35,7.53%,MPPED2;PLCE1;PLCL1;ENPP1;ENPP3;NAPEPLD;PLCB3;GPLD1
prerank,potassium channel activity (GO:0005267),0.38399127819115386,1.1385573248146903,0.284688995215311,0.7748026438841357,1.0,17/89,17.87%,KCNN4;KCNQ1;KCNH8;KCNG3;KCNK12;KCNC1;KCNH7;GRIK5;GRIK2;KCNK9;KCNC4;KCNA1;GRIK1;KCNC2;KCNH5;KCNH1;KCNQ3
prerank,glutamate receptor activity (GO:0008066),0.4761841129363874,1.1382706640928053,0.3234375,0.7712910347907297,1.0,9/19,22.79%,GRID1;GRIA1;GRIK5;GRIK2;GRM5;GRIK1;GRM7;GRID2;GRIA2
prerank,endodeoxyribonuclease activity (GO:0004520),0.4735710903769037,1.134656097059304,0.2884902840059791,0.7770206409362675,1.0,6/20,14.21%,RBBP8;APEX1;ENDOV;FEN1;ERCC4;EXOG
prerank,metal ion binding (GO:0046872),0.34030534503859156,1.1338596392830338,0.17540322580645162,0.7749909220732512,1.0,70/477,12.46%,CDH13;LTBP4;NOTCH4;SYT15;RAPGEF2;ITPR3;PITPNM3;MCTP1;DYSF;PLSCR4;ESYT2;EML1;CLGN;RASGRP2;SNRK;AOAH;CALML4;OXSR1;CDC42BPA;AGRN;CEMIP2;IQGAP1;MAP3K6;ANXA3;SYT7;CDC42BPG;SLC8A1;NUCB2;SPOCK2;PIR;STK38;STK38L;NLK;STIM2;MEX3B;TPD52;ASAH2;APEX1;EFCAB9;THTPA;EXD2;ENDOV;MAST1;SIK2;LRRK2;PPP3CA;HSP90B1;MT2A;MTPAP;CASQ1;PLSCR1;CDH15;CDH3;CRACR2A;FEN1;DSPP;CDH12;DHH;HSPE1;PRNP;CDH2;SPOCK1;TRPM2;XXYLT1;PCP4;TESMIN;GSS;MARK2;CALM3;TPM4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.4941893231111481,-1.1336467960735244,0.3325,0.7250883243803291,1.0,1/10,0.45%,DPYSL3
prerank,histone acetyltransferase binding (GO:0035035),0.4783257844739516,1.1317728166618795,0.3123076923076923,0.7767437705762809,1.0,5/21,15.06%,EPAS1;STAT1;EGR1;HIF1A;KANSL1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.357701109907368,-1.1302779823433713,0.25925925925925924,0.7258729434655271,1.0,15/32,24.21%,KDM7A;EGLN3;FTO;TET2;P4HTM;TET1;KDM4A;TMLHE;RIOX2;JMJD4;KDM8;PHF8;PHYHD1;BBOX1;PHYH
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.4460601434464635,1.1231406697285016,0.3181818181818182,0.7974323016830405,1.0,2/29,5.33%,ACER2;HYAL2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.5442226225803002,1.1221833593864485,0.35323383084577115,0.7959697764985002,1.0,5/11,16.66%,CASP8;CASP2;CASP1;CASP7;PYCARD
prerank,actinin binding (GO:0042805),0.47070004327596343,1.122106388516662,0.3264705882352941,0.7918795600043838,1.0,4/21,4.79%,MAGI1;PROM1;PDLIM5;CSRP2
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.3584819662872198,-1.1198875668791592,0.2795031055900621,0.7461484969687352,1.0,4/26,4.38%,PTN;PPP1R1A;SET;BOD1L1
prerank,sequence-specific DNA binding (GO:0043565),0.3360228280333244,1.1186403861632481,0.1871871871871872,0.7977804502303788,1.0,77/590,13.59%,PRDM16;EPAS1;SOX13;ERG;IRF6;GATA6;GATA2;MSX1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;FOXO1;ELK3;NR1I3;KLF12;HEY1;OLIG2;IRF2;ZNF296;HNF4A;KLF3;KLF6;SOX18;HHEX;FLI1;HEY2;HMBOX1;KLF4;LEF1;MAFK;IRF9;SP4;MAFF;FOXF2;MEF2C;GATA3;BCL6B;RXRG;CHCHD2;NFE2L2;NR1D1;SNAI2;ERF;KLF11;FOXP1;MBD1;KMT2B;JUN;TCF7L1;STN1;EGR1;ARID5A;ZBTB14;TET3;PHOX2A;E2F7;NR4A1;KLF13;SOX10;CHTOP;TLX3;IRF5;ELF2;CBFB;TGIF1;POU3F2;ZNF32;UNCX;TBX20;HIF1A;NFATC1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.512312626225602,1.118369559237983,0.33222591362126247,0.7942440549822013,1.0,3/12,9.57%,TRAF1;STAT1;BABAM2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.4766391219695815,1.1174341682646391,0.3359375,0.792694882720117,1.0,3/18,4.46%,STXBP6;CDC42EP1;PDLIM5
prerank,RNA methyltransferase activity (GO:0008173),0.49139305655139803,1.115175405882184,0.35062893081761004,0.7948044403537365,1.0,7/19,22.51%,TRDMT1;MRM2;TRMT5;FBLL1;FTSJ3;METTL4;FBL
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.444248229283573,1.1129777342369656,0.32732732732732733,0.796395488609356,1.0,12/27,24.81%,POLR2G;POLR3B;POLR1F;POLR2D;POLR1D;POLR2I;MED21;POLR2C;POLR2B;POLR2J;PRIMPOL;POLR1C
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.470027317219596,-1.1109260445104943,0.32018561484918795,0.7638897899647339,1.0,4/10,8.86%,SLCO2B1;SLCO3A1;SLC22A6;SLCO2A1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.44190794174485126,-1.11018128519037,0.35051546391752575,0.7578009638928755,1.0,3/12,2.89%,PDE7B;PDE3A;PDE8B
prerank,metal ion:proton antiporter activity (GO:0051139),-0.42619711191726306,-1.1091197495008747,0.3177083333333333,0.7526673458514302,1.0,5/13,19.40%,SLC9A2;SLC9B2;SLC9A9;SLC9A1;SLC9A6
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.33423083452163854,1.1078801187054301,0.2204246713852376,0.8065993351274892,1.0,93/431,16.73%,MAP4K2;RPS6KA5;RND1;GBP5;ACVRL1;MAP4K3;INSR;ATP1A1;ATP1A3;SNRK;ATL2;RHOB;OXSR1;CDC42BPA;SYN3;GBP4;MAP3K6;MTG2;GCH1;CDC42BPG;KRAS;NRAS;ACVR1;SCG5;ATP7A;RRAS;RAB39A;MAP4K4;STK38;TUBB;STK38L;NLK;GLUD1;ATL1;GBP3;MYH9;PGK1;PXK;TUBB4B;UHMK1;MAST1;P2RX7;AKT3;MFHAS1;SIK2;LRRK2;LMTK2;HSPA1B;ATP5F1A;MTPAP;NVL;TLK1;OAS2;ABCF2;RAB35;CAD;MMAA;EIF2B2;TUBA8;MLKL;DHX9;ARF3;TAP1;RRAGD;RHEBL1;RRAS2;MINK1;RAC1;ABCC6;GBP2;NEK11;GSS;MARK2;BTK;VPS4A;RHOT2;RND2;TUBA1A;RRAD;RHOH;RAN;RHEB;MAP3K20;PANK3;RRM1;ARL8A;ARL5B;PFKM;RAB27B;P2RY1;RIT2;GBP7;ARFIP2
prerank,hexose transmembrane transporter activity (GO:0015149),0.5250277344900326,1.1032187090448764,0.37185929648241206,0.8156237267275176,1.0,1/12,1.22%,SLC2A1
prerank,C-C chemokine receptor activity (GO:0016493),0.4687334149959517,1.1023013655998684,0.3614457831325301,0.8141352804172887,1.0,3/21,14.74%,CCR1;CX3CR1;CXCR4
prerank,triglyceride lipase activity (GO:0004806),0.46142053437253905,1.1019230625107814,0.3581183611532625,0.8109076375439308,1.0,2/20,5.21%,PNLIP;LCAT
prerank,protein homodimerization activity (GO:0042803),0.3318698630644844,1.1004053335890236,0.2296890672016048,0.8110393756964119,1.0,87/589,12.46%,PECAM1;FBLN5;HIP1;CEACAM1;RASIP1;STK10;PDGFB;TRIM14;FLT4;SYNE1;HIP1R;F11R;TBX1;NOD1;GBP5;B2M;IZUMO1;RBPMS;DAB2IP;CAV2;TGFB2;LRRFIP1;ADRB2;HNF4A;CADM1;SPPL2A;GBP4;HHEX;ACTN4;GCH1;EXT1;BLOC1S6;DEFA6;ACVR1;SLK;SSBP1;CAMK2D;TRIM6;KARS1;TPD52;IRAK2;GBP3;MYH9;WARS1;TOX3;EXD2;ZBTB16;LRRK2;TMEM192;ELAVL1;STAT1;HSPB1;MTPAP;CEBPA;PTPRO;HOOK1;BCL2L1;FLRT3;ZHX3;TENM3;ACOX1;TPD52L1;MIGA1;MMAA;NECTIN1;TCF3;ADAM10;MAP3K11;TYR;TAP1;TYROBP;CLCN1;CCDC88A;ABCG4;TENM4;NPM1;HIF1AN;GBP2;INPP5F;GSS;ACHE;RBM11;TRIM8;SOX6;FBXO4;HMGCS1;TPM4
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.32818690140939155,-1.0966420914588826,0.3111111111111111,0.7793691287336966,1.0,9/38,12.29%,SERPING1;TFPI;ANXA2;SERPINE2;SERPINH1;SERPIND1;SERPINE1;SERPINA2;SERPINF1
prerank,NAD binding (GO:0051287),-0.3578241891050464,-1.0963396074388894,0.33226837060702874,0.7719721557437068,1.0,6/26,14.40%,ALDH1A1;ME1;SIRT3;BDH2;HPGD;SIRT2
prerank,receptor tyrosine kinase binding (GO:0030971),0.39101452399130976,1.0924272061729252,0.34430379746835443,0.8291763650525747,1.0,15/56,17.43%,PITPNM3;PTPN14;CBL;ANGPT1;HYAL2;DUSP3;STAP1;PTPN1;TOB1;GRB14;RACK1;NCK1;ELMO2;SOCS5;PTPN2
prerank,glycine binding (GO:0016594),0.5205534949751102,1.0922321632051033,0.4055459272097054,0.8255612744037082,1.0,4/11,20.05%,GRIN2B;GRIN3A;GLRA2;GNMT
prerank,rRNA binding (GO:0019843),0.40300235746763907,1.0922099905476106,0.34946236559139787,0.8214471092280544,1.0,22/42,29.74%,TST;MRPL18;NGRN;RPS14;DDX28;RPS9;CAVIN1;RPS5;DDX21;FASTKD5;ANG;MRPL11;NOP53;MRPS27;RPF2;MRPS18C;ERI1;RPS13;RPL11;ERAL1;MRPS18A;FASTKD2
prerank,symporter activity (GO:0015293),-0.46403464725081595,-1.0915895881423543,0.3625,0.7770350485609075,1.0,10/10,53.63%,SLC5A5;MFSD2A;SLC4A4;SLC46A2;SLC28A2;SLC5A6;SLC28A3;SLC5A8;SLC28A1;SLC5A12
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5367603886345691,1.0903136530580269,0.38785834738617203,0.8225792005168511,1.0,4/10,15.26%,CASP8;CASP2;CASP1;CASP7
prerank,adenylyltransferase activity (GO:0070566),0.45731878167841905,1.0890365192762228,0.35176651305683565,0.8222021874359139,1.0,6/21,8.15%,GPHN;KARS1;SELENOO;MTPAP;TENT4A;OAS2
prerank,endopeptidase activator activity (GO:0061133),0.5353331025425694,1.0881848331611705,0.3945945945945946,0.8205562392864819,1.0,4/10,20.86%,APH1A;VSIR;PSMD14;APH1B
prerank,exoribonuclease activity (GO:0004532),0.5116218951952476,1.0872510117671856,0.3652037617554859,0.819051702671009,1.0,6/12,22.43%,ZC3H12A;EXOSC3;EXOSC8;EXOSC9;EXOSC10;EXOSC1
prerank,1-phosphatidylinositol binding (GO:0005545),0.48997609308469303,1.086195038448153,0.375,0.8176817064083595,1.0,5/15,17.41%,EPB41;SNX10;ZFYVE9;ZFYVE16;SCARB1
prerank,sterol binding (GO:0032934),-0.29567259110249716,-1.0854635095033036,0.2922374429223744,0.7860640104149851,1.0,18/56,17.12%,APOD;SIDT1;ABCA1;GRAMD1C;RORA;OSBPL8;SCP2;PTCH1;OSBP2;ERLIN1;INSIG2;CD81;GRAMD1A;OSBPL7;OSBPL11;NR1H3;SCAP;GRAMD1B
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4419333065408909,-1.0824238487924431,0.3746556473829201,0.786647271956989,1.0,5/12,7.81%,IGF1;SHC1;IRS1;PIK3R1;IGF2
prerank,GTPase binding (GO:0051020),0.34164093303239423,1.0814749727568316,0.33724653148345785,0.8265004704530372,1.0,43/195,15.77%,FGD5;UNC13B;RASIP1;RABGAP1;ARHGEF2;CAV1;IQGAP1;TBC1D30;EHD1;SGSM1;RAPGEF4;RAB34;RAPGEF6;PKN1;FGD6;FNBP1L;SIKE1;SH3BP4;WHAMM;RAB3GAP2;LRRK2;RANGAP1;STK19;MYO1C;NCKAP1;RRAGD;CYFIP1;STRN3;EXOC8;RANBP2;RANBP1;RANBP9;OCRL;USP6NL;GNB2;RHOH;RAB11FIP4;BNIP3;LCP1;YBX1;PAK2;AP3M1;PEX5L
prerank,metalloexopeptidase activity (GO:0008235),-0.30134614532793697,-1.0771869012232904,0.3373015873015873,0.7935299076725428,1.0,14/51,13.36%,AEBP1;CPQ;MMP14;ANPEP;CPE;AGBL3;METAP1D;CPXM2;MMP16;CPXM1;ZMPSTE24;ENPEP;METAP1;RNPEP
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.32240975124870674,1.0770417581367981,0.245,0.8346736960638996,1.0,82/831,9.64%,PRDM16;MECOM;EPAS1;SOX17;SOX13;KLF8;ERG;IRF6;GATA6;GATA2;TAL2;MSX1;DACH1;EBF1;KLF2;CASZ1;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;ZFP69;EGR3;FOXO1;ELK3;NR1I3;KLF12;HEY1;TAL1;OLIG2;KLF7;IRF2;ZNF296;ZNF235;LRRFIP1;HNF1A;HNF4A;KLF3;KLF6;SOX18;HHEX;ACTN4;TEAD4;HEY2;KLF4;SIM2;LEF1;MAFK;IRF9;ZBTB46;SP4;MAFF;FOXF2;MEF2C;SMAD2;ZBTB48;FOSL2;GATA3;BCL6B;RXRG;ZBTB16;GTF2IRD1;STAT1;PURA;EBF3;RBL1;CEBPA;NLRC5;NFE2L2;NR1D1;SNAI2;KLF11;ZBTB40;FOXP1;JUN;TCF7L1;TCF3;EGR1;ZNF182;DHX9
prerank,microtubule minus-end binding (GO:0051011),0.4915537826656474,1.074871211916096,0.3898305084745763,0.8364733189911517,1.0,3/13,11.08%,MACF1;CAMSAP2;NUMA1
prerank,acetylation-dependent protein binding (GO:0140033),-0.37616420970956754,-1.0729896584814178,0.35327635327635326,0.7895857888420605,1.0,8/20,19.99%,PSME4;BRDT;TAF1;ZMYND8;BRD3;BRD9;BRD2;BRD7
prerank,lysine-acetylated histone binding (GO:0070577),-0.37616420970956754,-1.0729896584814178,0.35327635327635326,0.7895857888420605,1.0,8/20,19.99%,PSME4;BRDT;TAF1;ZMYND8;BRD3;BRD9;BRD2;BRD7
prerank,alpha-tubulin binding (GO:0043014),0.4284610170314167,1.0712360323317198,0.375,0.842320665219961,1.0,3/31,3.59%,TRPV4;FYN;TTLL7
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3210043001254917,1.0706667345547147,0.273,0.8397636677796144,1.0,76/731,9.99%,PRDM16;MECOM;SOX17;SOX13;KLF8;ERG;IRF6;GATA6;GATA2;TAL2;DACH1;EBF1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;FOXO1;ELK3;NR1I3;KLF12;HEY1;TAL1;OLIG2;KLF7;IRF2;ZNF296;ZNF235;LRRFIP1;HNF1A;HNF4A;KLF3;KLF6;SOX18;HHEX;TEAD4;HEY2;KLF4;LEF1;MAFK;IRF9;SP4;MAFF;FOXF2;MEF2C;SMAD2;ZBTB48;FOSL2;GATA3;BCL6B;RXRG;TRIM24;ZBTB16;GTF2IRD1;STAT1;EBF3;CEBPA;NLRC5;NFE2L2;NR1D1;SNAI2;KLF11;ZBTB40;FOXP1;JUN;TCF7L1;TCF3;EGR1;ZNF182;DHX9;PLAG1;ZBTB14
prerank,lysine N-methyltransferase activity (GO:0016278),-0.3786376056253018,-1.0701586960660712,0.3438395415472779,0.7896586694061478,1.0,13/20,35.03%,EHMT1;SETD7;METTL21A;EEF1AKMT1;SETD4;EEF1AKMT2;ANTKMT;KMT5A;ATPSCKMT;ETFBKMT;EEF1AKMT3;EHMT2;METTL21C
prerank,tau protein binding (GO:0048156),0.4015359811714221,1.0694337353663435,0.37725381414701803,0.8391953047892536,1.0,18/40,21.11%,FYN;TTBK2;SMAD2;PRKAA1;ROCK1;TAOK2;MARK3;ACTB;CLU;MARK2;TTBK1;PIN1;PPP2CB;MAP2;GSK3A;DYRK1A;GSK3B;MARK4
prerank,MHC protein binding (GO:0042287),0.4591619582348775,1.0692308215146666,0.3963963963963964,0.8356859721662239,1.0,5/20,13.20%,TUBB;TUBB4B;ATP5F1A;TAP1;TAPBP
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.3626262500633149,-1.0689800603919517,0.33436532507739936,0.7853870370698458,1.0,3/24,5.83%,DAPK1;CAMK1D;CAMK1
prerank,Tat protein binding (GO:0030957),0.5184218872647561,1.0679807725131294,0.4012841091492777,0.8353589123835743,1.0,5/10,23.33%,GABARAPL1;ACTB;NPM1;DNAJA1;DLL1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3201582850620314,1.0677774346297129,0.274,0.8320152709173368,1.0,75/732,9.99%,PRDM16;MECOM;SOX17;SOX13;KLF8;ERG;IRF6;GATA6;GATA2;TAL2;DACH1;EBF1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;FOXO1;ELK3;NR1I3;KLF12;HEY1;TAL1;OLIG2;KLF7;IRF2;ZNF296;ZNF235;LRRFIP1;HNF1A;HNF4A;KLF3;KLF6;SOX18;HHEX;TEAD4;HEY2;KLF4;LEF1;MAFK;IRF9;SP4;MAFF;FOXF2;MEF2C;SMAD2;ZBTB48;FOSL2;GATA3;BCL6B;RXRG;ZBTB16;GTF2IRD1;STAT1;EBF3;CEBPA;NLRC5;NFE2L2;NR1D1;SNAI2;KLF11;ZBTB40;FOXP1;JUN;TCF7L1;TCF3;EGR1;ZNF182;DHX9;PLAG1;ZBTB14
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.38221735920176486,-1.0671375994392462,0.3494318181818182,0.7829746297843345,1.0,5/20,9.81%,LPGAT1;MOGAT3;AGPAT4;LPCAT2;DGAT1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.42199627789231237,1.065481207241494,0.3943452380952381,0.834417062659204,1.0,8/28,18.54%,DAB2IP;TRAF1;MADD;STAT1;BABAM2;CASP8AP2;SIVA1;BID
prerank,phosphatase binding (GO:0019902),0.3540184467130409,1.0650548822512176,0.37946943483275664,0.8316317470668458,1.0,12/105,7.44%,KCNN4;CEACAM1;FLT4;ITGA1;FBXL2;IQGAP1;SH3YL1;CHCHD3;SMAD2;MAPK1;SHOC2;HSP90B1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3692178877718705,1.0646593683992898,0.3756476683937824,0.828863170634141,1.0,9/60,7.26%,TEK;FLT1;TIE1;FLT4;MERTK;INSR;FGFR3;ALK;LMTK2
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.41666039135701644,1.063309672357292,0.37746478873239436,0.8286786928168867,1.0,2/32,6.04%,SLC6A6;SFXN1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.4204673661649935,1.0611306706096328,0.39124087591240875,0.8307513002729567,1.0,12/27,24.81%,POLR2G;POLR3B;POLR1F;POLR2D;POLR1D;POLR2I;TENT2;MED21;POLR2C;POLR2B;POLR2J;POLR1C
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.4110829173782784,-1.060127964340697,0.40954773869346733,0.7950994386843117,1.0,9/14,28.04%,ALDH4A1;MTHFD1;BLVRB;MTHFR;PYCR2;ALDH1L1;ALDH1L2;DHFR;PYCR3
prerank,small GTPase binding (GO:0031267),0.33737798660078905,1.059547747383,0.3617486338797814,0.8310642506909686,1.0,30/170,11.65%,FGD5;UNC13B;RABGAP1;ARHGEF2;CAV1;IQGAP1;TBC1D30;EHD1;SGSM1;RAPGEF4;RAB34;RAPGEF6;PKN1;FGD6;SIKE1;SH3BP4;WHAMM;RAB3GAP2;LRRK2;RANGAP1;STK19;MYO1C;NCKAP1;CYFIP1;STRN3;EXOC8;RANBP2;RANBP1;RANBP9;OCRL
prerank,mannosyltransferase activity (GO:0000030),-0.3682320085747657,-1.0594667563772233,0.38461538461538464,0.7895798056929677,1.0,7/21,20.25%,TMTC4;TMTC1;PIGB;POMT1;ALG8;ALG9;PIGZ
prerank,phosphatidylcholine transporter activity (GO:0008525),0.46692596592298197,1.0588846575588131,0.40553745928338764,0.829010616386569,1.0,6/17,15.39%,ATP10A;PLTP;ABCB4;PITPNA;ATP8B1;ABCA7
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.3800573703765072,-1.0588010405935513,0.36538461538461536,0.7841142737057604,1.0,4/20,5.81%,SLC39A14;SLC30A10;SLC39A8;SLC39A13
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3916102677927016,1.057047176446184,0.3910171730515192,0.8301955220426418,1.0,6/46,4.59%,GCNT1;MFNG;POMGNT1;EXT1;MGAT5;GCNT2
prerank,single-stranded RNA binding (GO:0003727),0.39337700533567055,1.0569804274115246,0.39444444444444443,0.8266452355156094,1.0,9/43,13.08%,IFIH1;RBM7;ENDOV;POLR2G;DHX9;POLR2D;AGO4;RBM11;FXR1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.420458342699612,1.053125006115568,0.3996983408748115,0.8332172545952925,1.0,2/27,1.78%,ATP2A3;ATP2B4
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.4059089915714341,1.0483755284609249,0.3953804347826087,0.8422921328230747,1.0,11/34,22.04%,REXO2;EXD2;EXOSC3;CNOT6L;CNOT1;XRN2;ANGEL2;CNOT2;EXOSC9;EXOSC10;DIS3L2
prerank,hydro-lyase activity (GO:0016836),-0.31454198236701,-1.0473871444008371,0.3705179282868526,0.8087261843089852,1.0,16/41,29.83%,GMDS;HACD1;CA2;ACO1;ENO2;ECHDC3;EHHADH;ECHDC2;ENO3;ACO2;FAHD2A;ALAD;ECHS1;CA4;HACD3;L3HYPDH
prerank,death domain binding (GO:0070513),0.4889285851824589,1.0452545404215363,0.4190800681431005,0.8468333520952912,1.0,6/11,19.51%,DAP;CRADD;IRGM;BCL2L1;RACK1;MCL1
prerank,adenyl ribonucleotide binding (GO:0032559),0.3187097795036231,1.0446533634993656,0.3888888888888889,0.8447687894314752,1.0,51/291,12.82%,RAPGEF2;MAP4K2;RPS6KA5;ACVRL1;MAP4K3;INSR;ATP1A1;ATP1A3;SNRK;OXSR1;CDC42BPA;SYN3;MAP3K6;CDC42BPG;ACVR1;ATP7A;RAPGEF4;MAP4K4;STK38;STK38L;NLK;GLUD1;MYH9;PGK1;PXK;UHMK1;MAST1;P2RX7;AKT3;SIK2;LMTK2;HSPA1B;ATP5F1A;MTPAP;NVL;TLK1;OAS2;ABCF2;CAD;EIF2B2;MLKL;DHX9;TAP1;ACSS2;MINK1;ABCC6;NEK11;GSS;MARK2;BTK;VPS4A
prerank,miRNA binding (GO:0035198),0.4117992070231334,1.0436950266588652,0.4023494860499266,0.8435362710206993,1.0,9/30,17.51%,PUM2;ZC3H12A;ELAVL1;ZNF346;ZC3H7A;AGO4;DDX21;YBX1;TUT7
prerank,5'-3' exonuclease activity (GO:0008409),0.46441837404216046,1.043014782836791,0.42789223454833597,0.8416328960625685,1.0,7/14,20.19%,TRIR;FEN1;XRN2;XRN1;EXOG;DXO;CPSF3
prerank,RNA polymerase II complex binding (GO:0000993),-0.33183137703586785,-1.0414024719493211,0.3670886075949367,0.8186861774919167,1.0,12/32,16.43%,SCAF8;PAF1;ERCC5;PCIF1;CTR9;URI1;UVSSA;RTRAF;GTF2B;HNRNPU;PCF11;WAC
prerank,outward rectifier potassium channel activity (GO:0015271),0.48962183786483243,1.039132162323915,0.42033898305084744,0.8482874116540858,1.0,1/11,0.28%,KCNQ1
prerank,kinase activity (GO:0016301),0.34312963019558246,1.0387456741917545,0.4098360655737705,0.845589441688215,1.0,28/109,17.90%,ITPKB;IP6K3;PRKD1;PIK3C2A;IPPK;IDNK;PGM2L1;MAP4K4;PGK1;LRRK2;RFK;STK39;DGKH;PIK3C3;NMRK1;PIK3CB;PAPSS1;PANK3;AGK;DGKI;CKMT1A;TRRAP;PKN2;GK5;DOLK;TRIB3;CERKL;PIK3C2B
prerank,chloride transmembrane transporter activity (GO:0015108),-0.3800133696007874,-1.038448813387479,0.382051282051282,0.8195393003716265,1.0,6/16,22.93%,SLC26A7;SLC26A2;SLC26A6;SLC4A8;CFTR;CLCN6
prerank,ATP binding (GO:0005524),0.31764065997695273,1.036620014805944,0.4120707596253902,0.8475822223014047,1.0,47/266,12.82%,MAP4K2;RPS6KA5;ACVRL1;MAP4K3;INSR;ATP1A1;ATP1A3;SNRK;OXSR1;CDC42BPA;SYN3;MAP3K6;CDC42BPG;ACVR1;ATP7A;MAP4K4;STK38;STK38L;NLK;MYH9;PGK1;PXK;UHMK1;MAST1;P2RX7;AKT3;SIK2;LMTK2;HSPA1B;ATP5F1A;MTPAP;NVL;TLK1;OAS2;ABCF2;CAD;EIF2B2;MLKL;DHX9;TAP1;MINK1;ABCC6;NEK11;GSS;MARK2;BTK;VPS4A
prerank,tau-protein kinase activity (GO:0050321),0.43706003934981313,1.0345931893787264,0.43431221020092736,0.8493724384291735,1.0,12/20,21.11%,FYN;TTBK2;PRKAA1;ROCK1;TAOK2;MARK3;MARK2;TTBK1;GSK3A;DYRK1A;GSK3B;MARK4
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.40502185139754265,-1.0328748960025782,0.4187192118226601,0.8275290276251693,1.0,8/15,25.05%,KMT2C;ASH2L;SETD1A;SETD1B;WDR5;SETD4;KMT2D;SETMAR
prerank,DNA binding (GO:0003677),0.30994354587264367,1.032328245121172,0.40480961923847697,0.8514787103053492,1.0,99/694,13.78%,PRDM16;MECOM;EPAS1;SOX13;ERG;IRF6;TAL2;KLF2;SMARCA2;TBX1;NR4A2;FOXO4;FOXO1;KLF12;AIM2;IRF2;LRRFIP1;HNF1A;HNF4A;ARID3B;APP;HHEX;FLI1;RBBP8;HEY2;HMBOX1;ING2;SIM2;LEF1;BCLAF3;SYCP2;MAFK;SSBP1;SP4;MAFF;FOXF2;SMAD2;RPL7;APEX1;GATA3;RTF1;CHCHD2;CHRAC1;SETX;ENDOV;RYBP;ZBTB16;ZC3H12A;STAT1;PURA;CEBPA;NFE2L2;POLR2G;TIGD3;SNAI2;FEN1;ERF;POGK;MBD1;JUN;TCF7L1;TCF3;STN1;EGR1;HMGB1;MLF1;DHX9;TIGD2;HP1BP3;ARID5A;ZBTB14;POLR2D;BRIP1;APLP2;NUP35;POLA1;POLG2;PCBP1;BRCA1;NR4A1;SMARCAD1;SAP30L;ILF2;MTERF2;ARID5B;SOX10;HINFP;SOX6;IRF5;XRN1;CBFB;GLYR1;POU3F2;GTF2A1;CR2;HIF1A;RAD1;ERCC4;RAD51D
prerank,transition metal ion binding (GO:0046914),0.31294148219103535,1.0322152093055323,0.4265450861195542,0.8481573865971421,1.0,60/397,12.28%,NOS1;MYRIP;NOS3;ACE;CRIP2;GDA;ARHGEF2;POMGNT1;DUSP12;MSRB3;KLF7;IFIH1;ATOX1;GCH1;MGAT5;KLF4;FBXL5;ATP7A;LANCL1;TNFSF10;SHANK3;RNF125;SMPDL3A;ARG1;ASAH2;ARIH1;IL1A;PCK2;PGGT1B;TRIM24;CLIP1;EXD2;KDM3A;KPNB1;MT2A;MTPAP;PLSCR1;GRIN2B;CAD;FEN1;MBD1;KMT2B;DHH;EGR1;TYR;ADPRM;PRNP;PTPN1;TET3;TAB2;TNKS;MGAT1;ALKBH8;HIF1AN;XXYLT1;ISCA2;SAP30L;GALNT4;TRIM8;SUV39H2
prerank,phosphatidylglycerol binding (GO:1901611),0.46800577229648244,1.0320257700810438,0.42105263157894735,0.8450057530306785,1.0,3/13,8.63%,PLTP;UQCC3;PITPNA
prerank,calcium-release channel activity (GO:0015278),0.4470285885222957,1.0318061534208918,0.4219001610305958,0.8420009430713216,1.0,4/17,11.28%,ITPR3;MCOLN1;TPCN2;TRPM2
prerank,titin binding (GO:0031432),0.477962367978833,1.0310748713995928,0.4383116883116883,0.8403083076311919,1.0,3/13,12.45%,MYBPC3;CAMK2D;CALM3
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4134962224071543,1.030974791979052,0.44461077844311375,0.8369952759879493,1.0,3/24,7.42%,ITPKB;IP6K3;CMPK1
prerank,histone demethylase activity (GO:0032452),-0.33929556072543504,-1.0290101096628976,0.3825503355704698,0.8310538287010399,1.0,10/27,20.14%,KDM7A;JARID2;JMJD1C;JMJD6;FBXL19;KDM4A;KDM6B;RIOX2;KDM8;PHF8
prerank,chloride channel regulator activity (GO:0017081),0.46398616840026685,1.0281950597899523,0.4473257698541329,0.8404460354803127,1.0,4/14,9.30%,VTI1B;STX7;VAMP8;SGK1
prerank,cytokine activity (GO:0005125),-0.24663491025868625,-1.0270983029434708,0.3584905660377358,0.8290985141315911,1.0,14/131,9.67%,BMP6;IL34;WNT4;BMP5;BMP7;BMP4;WNT6;WNT5A;TNFRSF11B;FGF2;CXCL16;WNT9A;VEGFA;IL17D
prerank,potassium:proton antiporter activity (GO:0015386),-0.4209724421124892,-1.0249072126061864,0.4174757281553398,0.8279604664421394,1.0,4/10,19.40%,SLC9A2;SLC9A9;SLC9A1;SLC9A6
prerank,phosphate ion binding (GO:0042301),0.49978095375641307,1.0233474378419245,0.46140939597315433,0.8493908365199528,1.0,5/10,25.15%,CHST14;RELA;ADSS2;MTHFD2;RPH3A
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.3783344201351003,1.0195312522971345,0.42090784044016505,0.8557304878319766,1.0,14/40,22.51%,PCMTD1;COMTD1;PCMT1;METTL2A;METTL2B;SETD3;FBLL1;GAMT;METTL18;ARMT1;METTL4;GNMT;LCMT1;FBL
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.3186167140186747,-1.017909806699121,0.3859060402684564,0.8397172483498343,1.0,13/33,17.12%,SCAF8;PAF1;ERCC5;CTR9;LLPH;URI1;UVSSA;RTRAF;GTF2B;HNRNPU;PCF11;WAC;AR
prerank,"DNA binding, bending (GO:0008301)",0.4589826519371878,1.0171647826799877,0.4444444444444444,0.8578533303453657,1.0,5/14,14.54%,HHEX;LEF1;HMGB1;SAP30L;HMGB2
prerank,C-C chemokine binding (GO:0019957),0.4290842977369318,1.01635170757674,0.4750733137829912,0.8563142456244046,1.0,3/22,14.74%,CCR1;CX3CR1;CXCR4
prerank,double-stranded DNA binding (GO:0003690),0.3043043292070602,1.012068393147386,0.46693386773547096,0.8636011778665812,1.0,70/531,13.59%,ERG;IRF6;GATA6;GATA2;MSX1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;ELK3;NR1I3;KLF12;HEY1;AIM2;OLIG2;IRF2;ZNF296;HNF4A;KLF3;KLF6;SOX18;FLI1;RBBP8;HEY2;HMBOX1;KLF4;LEF1;IRF9;MAFF;MEF2C;SMAD2;ZBTB48;APEX1;GATA3;BCL6B;RXRG;STAT1;PURA;NR1D1;SNAI2;FEN1;KLF11;FOXP1;MBD1;JUN;TCF7L1;EGR1;HMGB1;DHX9;ZBTB14;POLG2;PHOX2A;E2F7;NR4A1;KLF13;SOX10;TLX3;IRF5;ELF2;TGIF1;POU3F2;ZNF32;UNCX;TBX20;NFATC1
prerank,voltage-gated potassium channel activity (GO:0005249),0.34379126128833726,1.0119586614672924,0.4600484261501211,0.8603475774336015,1.0,5/80,3.68%,KCNQ1;KCNE3;KCNH8;KCNN3;KCNG3
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4624129707374096,1.011728941059552,0.4467408585055644,0.8575098341678837,1.0,3/15,7.29%,PIK3R6;CISH;SOCS6
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.3999535616243907,-1.0101786748502894,0.4444444444444444,0.8539237139353849,1.0,4/14,10.74%,USP9X;USP13;MINDY3;OTUD7B
prerank,iron ion binding (GO:0005506),-0.2968727941642096,-1.009702282994738,0.4279475982532751,0.8479355915031964,1.0,13/48,14.64%,AGMO;KDM7A;NFU1;EGLN3;FTO;TET2;JMJD6;AOX1;FDX1;TET1;ETHE1;FXN;SCD
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3936495263166916,1.0047360836210666,0.44367176634214184,0.8717397394654343,1.0,7/33,12.67%,REXO2;EXD2;EXOSC3;CNOT6L;XRN2;ANGEL2;XRN1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.377664564639798,1.004475144240183,0.46563814866760167,0.8688355888394417,1.0,7/37,10.20%,GARS1;VARS1;VARS2;KARS1;FARSB;WARS1;FARS2
prerank,kinesin binding (GO:0019894),0.4041924262087109,1.0036795276216586,0.45440729483282677,0.8672384516176141,1.0,8/27,16.27%,TTBK2;SPAG9;NEFH;ACTB;KLC2;PRC1;ARHGEF10;PLEKHM2
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.4153829988377083,-1.0033974708075075,0.4323040380047506,0.8586635492720036,1.0,3/12,5.36%,BACE2;BACE1;HM13
prerank,omega peptidase activity (GO:0008242),-0.2560494138406935,-1.0030463622369863,0.41420118343195267,0.852471508001895,1.0,28/89,21.75%,USP33;USP20;ASRGL1;USP9X;USP13;USP11;USP50;USP1;USP3;MINDY3;OTUD6B;GGT5;OTUD7B;USP22;UCHL1;CYLD;USP8;ZRANB1;STAMBPL1;GGT7;OTUD1;USP34;VCPIP1;JOSD2;USP2;TNFAIP3;USP46;USP31
prerank,mechanosensitive ion channel activity (GO:0008381),0.46882931830040486,1.0022646896869254,0.47351524879614765,0.8672532591618369,1.0,2/12,7.94%,PIEZO1;TMC7
prerank,ribosomal large subunit binding (GO:0043023),-0.4077774752179725,-1.0015720939447694,0.48507462686567165,0.8493579272589806,1.0,5/11,18.56%,NEMF;MRRF;CPEB2;NMD3;MALSU1
prerank,TBP-class protein binding (GO:0017025),0.4197590620819718,1.0008158849058024,0.45022288261515603,0.8673847797554843,1.0,9/21,17.58%,HHEX;BRF2;GTF2A1;PSMC1;TAF1B;PSMC5;TAF11;ESR1;DRAP1
prerank,ATPase regulator activity (GO:0060590),-0.30193389019986056,-1.0002275036385528,0.4610169491525424,0.8460267789006741,1.0,16/38,23.64%,ATP1B3;TOR1AIP1;SIL1;ATP5IF1;FNIP1;DNAJB2;BAG1;BAG3;ATP1B1;TSC1;ATP1B2;GRPEL2;KATNB1;DNAJB4;DNAJC15;BAG2
prerank,endopeptidase activity (GO:0004175),-0.23014861647897078,-0.9991230726510669,0.4222222222222222,0.8420702621143666,1.0,59/257,19.13%,TRABD2B;ADAMTS2;ADAMTS12;ADAMTSL3;THSD4;ADAMTSL5;BACE2;MMP14;HTRA3;ADAMTS17;RHBDL3;ADAMTS5;ADAMTS10;DPP4;USP33;USP20;BACE1;ADAMTS3;FAP;ADAM19;USP9X;ADAM9;USP13;USP11;ADAMTS15;ADAMTS9;F3;MMP2;ADAM33;USP1;CASP3;PSMB3;ADAMTSL4;MMP16;KLK2;ZMPSTE24;MMP19;UCHL1;SENP1;ADAMTS14;PCSK7;PSMA3;PSMB4;USP8;CTSC;ADAMTS16;MMP11;PSMB7;USP34;MBTPS1;CTSL;CASP4;MASP1;RHBDF1;HTRA4;ACE2;HTRA2;ADAMTS19;KDM8
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.44635905199946896,0.996919189055074,0.46440129449838186,0.8732948385238031,1.0,7/16,26.63%,MTMR10;MTMR11;INPP5F;SYNJ1;MTMR14;MTMR2;MTMR9
prerank,ion channel activity (GO:0005216),0.33547488839888984,0.9963788474947967,0.4727272727272727,0.871214652024419,1.0,13/80,11.28%,TRPV4;PIEZO1;MCUB;GRID1;GRIA1;MCOLN1;TMC7;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;TRPM2
prerank,water transmembrane transporter activity (GO:0005372),0.4715744603787312,0.996333424967211,0.47249190938511326,0.8678847307372946,1.0,1/11,2.23%,AQP11
prerank,nuclear export signal receptor activity (GO:0005049),0.4706474159131394,0.9957620345173644,0.4607679465776294,0.8659072412917611,1.0,4/11,14.41%,XPO6;XPO1;RAN;NUP42
prerank,RNA polymerase binding (GO:0070063),0.4253350820064543,0.9929175845815092,0.47900466562986005,0.8692793745398368,1.0,6/18,15.68%,STOM;TCERG1L;DHX9;BRCA1;ANP32B;PKN2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.4520820812061123,0.9919684667228635,0.4868421052631579,0.8682436924514624,1.0,6/14,26.63%,MTMR10;MTMR11;SYNJ1;MTMR14;MTMR2;MTMR9
prerank,frizzled binding (GO:0005109),-0.31355620829065095,-0.9918172529708394,0.4229390681003584,0.8553637261556616,1.0,7/34,10.20%,WNT4;RNF43;WNT6;WNT5A;WNT9A;FZD7;SDCBP
prerank,regulatory RNA binding (GO:0061980),0.3711412814987086,0.9917548654925245,0.4631432545201669,0.8654126144780926,1.0,10/38,17.51%,PUM2;ZC3H12A;ELAVL1;ZNF346;ZC3H7A;DHX9;AGO4;DDX21;YBX1;TUT7
prerank,phospholipase activator activity (GO:0016004),-0.4267895929594841,-0.9913861596444637,0.4630541871921182,0.8496427505206422,1.0,3/10,6.78%,ARHGAP6;STX4;SRC
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.39217233448468597,-0.991320561034343,0.48704663212435234,0.8429800202551022,1.0,2/14,2.86%,SLC26A7;SLC26A2
prerank,metalloaminopeptidase activity (GO:0070006),-0.3709761980902203,-0.9911103504011217,0.45555555555555555,0.8368314166103838,1.0,5/16,13.36%,MMP14;ANPEP;MMP16;ENPEP;RNPEP
prerank,kinase activator activity (GO:0019209),-0.31735559717887346,-0.9895587528007129,0.4557377049180328,0.8345665862692692,1.0,3/30,5.62%,PRKAG2;WNK1;GPRC5C
prerank,androgen receptor binding (GO:0050681),-0.33205416677997285,-0.9887430374574532,0.46994535519125685,0.8301713297544653,1.0,4/25,5.23%,DDX5;PRKCB;SNW1;NSD1
prerank,snRNA binding (GO:0017069),-0.28874048856496,-0.9869419226487849,0.4791666666666667,0.828489796636038,1.0,15/42,25.89%,SNRNP70;PRPF8;COIL;GEMIN5;PRPF31;SNRPA1;TUT1;SNRPA;HNRNPU;SNRPD3;LSM11;TOE1;NCBP2;LSM10;LARP7
prerank,chloride channel inhibitor activity (GO:0019869),0.47983057124076267,0.9853573138300479,0.4844290657439446,0.8779563497361509,1.0,3/10,7.40%,VTI1B;STX7;VAMP8
prerank,protein heterodimerization activity (GO:0046982),0.30712328552118695,0.9848641514051382,0.5,0.8756886655955948,1.0,36/178,16.40%,EPAS1;HIP1;PDGFB;NR4A2;ATP1A1;RALGAPA1;FBXO7;EXT1;MEF2C;IRAK2;BCL2L1;ZHX3;TENM3;MIGA1;TCF3;RRAGD;ABCG4;TENM4;CYBA;RALGAPB;NR4A1;TPM4;YWHAH;FXR1;GTF2A1;SDCBP2;HIF1A;RALGAPA2;USF2;RAN;ITGA3;FZD9;VAPA;TCOF1;TENM2;TENM1
prerank,syntaxin binding (GO:0019905),0.3539428372616675,0.9846926853969546,0.4923469387755102,0.8727080524514742,1.0,19/61,18.29%,UNC13B;RAB11A;CACNA1A;BLOC1S6;STX7;TMED10;LRRK2;VAMP8;TMED9;SYPL1;STXBP3;NSF;CPLX1;SNPH;STXBP5L;STXBP5;PTPN2;SYT1;SYT2
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.3475114231976837,-0.9845429308973849,0.4585635359116022,0.8283931155628619,1.0,3/21,5.87%,FGF1;FGF2;KL
prerank,phospholipase binding (GO:0043274),-0.3967321703505864,-0.9833244095845614,0.4725,0.825195731215997,1.0,3/13,6.78%,ARHGAP6;PRKN;SRC
prerank,cholesterol binding (GO:0015485),-0.27388004670389776,-0.979295155215537,0.48412698412698413,0.8293894788023609,1.0,14/47,17.12%,APOD;SIDT1;ABCA1;GRAMD1C;OSBPL8;SCP2;PTCH1;OSBP2;ERLIN1;CD81;GRAMD1A;OSBPL7;NR1H3;GRAMD1B
prerank,transcription coactivator binding (GO:0001223),-0.3490832453746471,-0.9784559644910369,0.49411764705882355,0.8254589321853406,1.0,5/20,17.12%,RORA;THRB;SMAD3;TERT;AR
prerank,cyclic nucleotide binding (GO:0030551),0.4174357959140721,0.9765073983669489,0.493993993993994,0.8890947215592999,1.0,5/21,17.25%,RAPGEF2;RAPGEF4;POPDC3;PDE4D;KCNH1
prerank,adrenergic receptor binding (GO:0031690),0.4402788923782562,0.9761957149504795,0.48589341692789967,0.8865466691668904,1.0,2/16,5.18%,RAPGEF2;AKAP5
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.41296668725827995,-0.9738955252228454,0.4646924829157175,0.8307322521092216,1.0,3/10,12.41%,CACNA1C;CACNB1;CACNB2
prerank,retinoic acid receptor binding (GO:0042974),0.42319785139841243,0.9737776577252303,0.46909667194928684,0.8888942441512748,1.0,4/17,10.22%,NR4A2;ACTN4;ARID5A;CNOT1
prerank,translation initiation factor activity (GO:0003743),0.3770172157453012,0.9729610817084512,0.4965612104539202,0.8874912103206853,1.0,13/36,17.85%,EIF3B;EIF2B2;EIF1;EIF3K;EIF3I;EIF3F;EIF3G;EIF3A;EIF2S1;EIF2A;EIF3H;COPS5;EIF3M
prerank,acid-thiol ligase activity (GO:0016878),0.4475489812602591,0.9715076330491716,0.49586776859504134,0.88766417368061,1.0,4/13,14.78%,ACSM3;ACSS2;AACS;SLC27A2
prerank,DNA secondary structure binding (GO:0000217),0.3809245682844957,0.9701380917069887,0.49644381223328593,0.8877150285152036,1.0,11/31,24.06%,RBBP8;MEF2C;HMGB1;RAD51D;RAD18;HMGB2;XPC;MEN1;BLM;GEN1;WRN
prerank,ligand-gated cation channel activity (GO:0099094),0.3274590563329824,0.969807790848513,0.49514563106796117,0.8850993003969087,1.0,11/75,11.28%,KCNN3;P2RX7;GRIA1;MCOLN1;GRIN2B;GRIN2C;ASIC2;GRIK5;GRIK2;GRIN3A;TRPM2
prerank,pentosyltransferase activity (GO:0016763),-0.29900955511616334,-0.9679028014108341,0.4772727272727273,0.8393344129831783,1.0,13/36,24.63%,LARGE1;PARP8;LACC1;SIRT3;ART3;PNP;SIRT2;QPRT;PARP3;PARP1;PARP6;PPAT;PARP2
prerank,peptidase activator activity (GO:0016504),0.39792426590238733,0.9676113446999209,0.4835164835164835,0.8867436392914577,1.0,6/22,11.78%,CAV1;MAL;APH1A;VSIR;PSMD14;CASP8AP2
prerank,active ion transmembrane transporter activity (GO:0022853),-0.2979674848697335,-0.9660786862342855,0.5155709342560554,0.8378187577401368,1.0,9/37,12.97%,SLC22A8;SLCO2B1;SLCO3A1;SLC22A6;SLC22A4;SLCO2A1;COX10;COX7A2L;UQCRQ
prerank,metallocarboxypeptidase activity (GO:0004181),-0.30575434548880875,-0.9656849919847137,0.48562300319488816,0.8327533840631813,1.0,8/26,18.90%,AEBP1;CPE;AGBL3;CPXM2;CPXM1;AGBL1;CPA6;ACE2
prerank,transcription corepressor binding (GO:0001222),-0.31580260223005774,-0.9630699937984848,0.5031645569620253,0.8335064885521741,1.0,8/27,15.93%,MTF2;RORA;LCOR;USP11;EHMT1;HDAC6;NEK6;PER3
prerank,syntaxin-1 binding (GO:0017075),0.4092149207577284,0.9629629256518263,0.4954954954954955,0.8943095020731768,1.0,9/22,18.19%,UNC13B;LRRK2;SYPL1;STXBP3;NSF;CPLX1;SNPH;STXBP5;SYT1
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4381392503482773,0.9626738217118063,0.5242718446601942,0.8916442920934422,1.0,7/15,22.75%,PIK3C2A;PIK3C3;PIK3CB;ATM;PIK3C2B;PIK3R3;PIK3CA
prerank,MHC class II protein complex binding (GO:0023026),-0.40595898867767866,-0.9599498916965575,0.5,0.8358729995752963,1.0,3/11,17.89%,CD81;ATP1B1;CD74
prerank,methylation-dependent protein binding (GO:0140034),-0.26102167240489,-0.9587091705142197,0.5407725321888412,0.8334202853715891,1.0,18/57,20.27%,TDRD3;KDM7A;PYGO1;MTF2;MORC4;ZMYND8;WDR5;NCAPG2;RRP8;MSH6;BPTF;MPHOSPH8;MSL3;KDM4A;MORC3;KDM8;PHF8;ATRX
prerank,GABA receptor activity (GO:0016917),0.4084383914713586,0.958195904845658,0.4984567901234568,0.8989747899335934,1.0,7/21,21.41%,GABRQ;GABRA4;GABRA2;GABRE;GABRG3;GABRB1;GABRB3
prerank,nucleotide diphosphatase activity (GO:0004551),-0.37490207636348044,-0.9572544178426611,0.5162162162162162,0.8310917309473396,1.0,3/14,4.91%,NUDT4;FHIT;ENPP1
prerank,leucine zipper domain binding (GO:0043522),-0.41119906731677713,-0.9571495082036457,0.5175,0.8255273777477976,1.0,1/10,0.42%,PAWR
prerank,voltage-gated ion channel activity (GO:0005244),0.4289581780363088,0.955886819093247,0.5120385232744783,0.9013176057748178,1.0,6/14,24.23%,ANO6;VDAC1;CACNA1E;VDAC3;HCN1;VDAC2
prerank,vitamin D receptor binding (GO:0042809),-0.367653371046137,-0.9556317668264663,0.5181058495821727,0.8237198402972881,1.0,5/14,15.66%,SNW1;MED13;MED14;MED16;TAF7
prerank,peptidase inhibitor activity (GO:0030414),-0.30073083558599023,-0.9549052637501003,0.5324232081911263,0.819603870404682,1.0,7/33,11.61%,TFPI;GPC3;TIMP2;PSMF1;RENBP;SERPIND1;ITIH2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3790839200047594,0.9547784637334048,0.5081481481481481,0.9005967027313229,1.0,12/28,24.98%,APEX1;ENDOV;FEN1;RPP38;EDC3;ELAC2;DROSHA;POP1;NUDT16;RNASEH2A;RNASEH1;NUDT16L1
prerank,solute:proton symporter activity (GO:0015295),-0.35855850225416874,-0.954550567681449,0.5224719101123596,0.8148204713326572,1.0,4/16,11.75%,SLC2A13;SLC17A5;SLC39A8;SLC2A10
prerank,nucleosomal DNA binding (GO:0031492),-0.3323453957010303,-0.9513092549233878,0.49117647058823527,0.8169497716042544,1.0,8/21,22.69%,CHD4;SMARCB1;HDAC1;HMGA2;MTA2;MBD3;H1-0;ACTL6A
prerank,methylated histone binding (GO:0035064),-0.25882871088332726,-0.9495306727897418,0.5610859728506787,0.8154212134526416,1.0,20/62,20.27%,TDRD3;KDM7A;PYGO1;MTF2;MORC4;TAF1;ZMYND8;WDR5;NCAPG2;RRP8;MSH6;BPTF;MPHOSPH8;MSL3;KDM4A;TAF7;MORC3;KDM8;PHF8;ATRX
prerank,tropomyosin binding (GO:0005523),0.42219035039741964,0.9471595826386758,0.5189274447949527,0.9150303037930704,1.0,1/16,0.60%,NEBL
prerank,3'-5' exonuclease activity (GO:0008408),0.3501675029239842,0.9460935425527565,0.5089743589743589,0.9141586924799185,1.0,11/45,17.49%,REXO2;APEX1;EXD2;TRIR;EXOSC3;CNOT6L;XRN2;ANGEL2;RAD1;EXD1;EXOSC9
prerank,fatty acid synthase activity (GO:0004312),0.4670945137575228,0.9458243260319502,0.5405405405405406,0.9115148432690275,1.0,4/10,21.90%,ELOVL4;ELOVL7;ELOVL5;OXSM
prerank,ubiquitin-protein transferase activity (GO:0004842),0.28767136085184997,0.9434682874109531,0.6116803278688525,0.9135981232696697,1.0,75/346,19.79%,LMO7;ASB4;TRIM14;RNF103;ZNRF1;TRIM69;CBL;HERC2;FBXO7;UBA7;FBXL14;FBXL5;TRIM11;TRIM6;RNF38;TRAF1;RNF125;RNF185;ARIH1;CUL3;UBE2Q1;UBE2D1;TRIM24;KLHL20;WWP1;UBE3A;RNF128;RNF141;RNF115;RBX1;ZNRF3;SIAH2;CUL2;TRIM25;TRIM47;RNF144B;TRIM17;FBXW2;NEDD4L;OBI1;BRCA1;DTX3L;RSPRY1;FBXO4;SMURF1;KCTD10;UBE2T;RMND5B;UBE2J2;RNF103-CHMP3;FBXO3;FBXO2;UBE2E1;TRIM2;UBE3B;NHLRC1;UBE2D3;IRF2BP1;TRAIP;RNF139;KLHL9;SEL1L;RNF150;FBXO6;FBXO10;MKRN1;XIAP;FBXL6;MALT1;ANAPC4;RNF166;MKRN2;BARD1;MAEA;RNF5
prerank,aminopeptidase activity (GO:0004177),-0.3058960131275594,-0.9427775352425931,0.5401234567901234,0.8262093177759146,1.0,7/26,13.36%,MMP14;ANPEP;METAP1D;MMP16;ENPEP;METAP1;RNPEP
prerank,ubiquitin-dependent protein binding (GO:0140036),0.45940982526294594,0.9414505760485614,0.5244299674267101,0.9149132092731481,1.0,3/10,11.23%,ANKRD13A;DNAJC2;LAPTM5
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.3450470004996565,-0.9409710950860063,0.5353260869565217,0.8251888450159547,1.0,2/18,0.60%,ALDH1A1;ALDH1A2
prerank,neuropeptide receptor binding (GO:0071855),0.4236198238145695,0.9403207926357441,0.5611390284757118,0.9143861148992951,1.0,4/14,23.17%,GAL;APLN;NMU;NTS
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.44090545249367774,0.9379858816513076,0.5347682119205298,0.916336056053758,1.0,9/13,31.65%,TRMT5;TRMT10B;TRMT1L;TRMT1;THUMPD2;TRMT10A;TRMT10C;FTSJ1;TRMT11
prerank,myosin II binding (GO:0045159),0.462497498072972,0.9375747047402723,0.5590682196339434,0.9139601358555177,1.0,4/10,16.81%,SHROOM4;SHROOM1;STXBP5L;STXBP5
prerank,exonuclease activity (GO:0004527),0.3460336387142357,0.9345612130805155,0.5558441558441558,0.9175937232802542,1.0,14/46,17.71%,REXO2;APEX1;EXD2;ZC3H12A;TRIR;EXOSC3;FEN1;XRN2;EXOSC8;RAD1;EXOG;EXD1;EXOSC9;DXO
prerank,G protein-coupled receptor activity (GO:0004930),0.28777719549367203,0.9327968005457852,0.625130890052356,0.9182830304251267,1.0,26/239,12.93%,ADGRL4;S1PR1;ADGRE5;F2RL1;ADRB2;RRH;LGR5;GPR157;QRFPR;LANCL1;MRGPRE;LPAR6;GPR143;HCRTR1;NPR1;MC4R;CMKLR1;MTNR1B;ADGRA1;ELOVL4;ADGRB1;GLP1R;XPR1;GRM5;CX3CR1;GPR26
prerank,cytokine receptor activity (GO:0004896),0.3133521114638397,0.9324939848427481,0.5855745721271394,0.915746940037531,1.0,9/83,7.41%,CCR1;LIFR;IFNGR1;CSF2RB;IL17RD;IFNAR1;IL1RAP;CMKLR1;IL20RB
prerank,Wnt-activated receptor activity (GO:0042813),0.4083505452022445,0.9317511759773919,0.5420098846787479,0.9143393644907071,1.0,5/15,14.82%,FZD6;TSPAN12;LRP5;FZD9;FZD3
prerank,mRNA methyltransferase activity (GO:0008174),0.42654921637614523,0.9302073218092415,0.5369127516778524,0.9145355476992867,1.0,3/12,13.27%,TRMT61A;TRMT61B;METTL14
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.3963679599326908,-0.9287195885227519,0.5613207547169812,0.8489711434798639,1.0,2/10,9.62%,DSE;RENBP
prerank,SUMO binding (GO:0032183),0.4250311377446486,0.9287015868726118,0.5345394736842105,0.9146183648802252,1.0,4/13,18.76%,HERC2;CASP8AP2;HABP4;USPL1
prerank,cation transmembrane transporter activity (GO:0008324),0.3370289926710368,0.9281055827990573,0.5474642392717816,0.9127929885122019,1.0,4/48,8.63%,SLC6A6;SFXN1;SLC7A1;SLC15A4
prerank,GTPase inhibitor activity (GO:0005095),-0.3638506536724998,-0.9273184303549878,0.5488721804511278,0.8467355376409275,1.0,5/13,13.27%,SLIT2;IQGAP2;IPO5;CPEB2;RTKN
prerank,vinculin binding (GO:0017166),0.438865798759223,0.9271523544034075,0.5298126064735945,0.9117385955284592,1.0,3/11,12.53%,UTRN;CTNNA1;SORBS3
prerank,gated channel activity (GO:0022836),0.42746933509837093,0.925545750609807,0.5712,0.9120182777823083,1.0,2/14,7.94%,PIEZO1;TMC7
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.3830138930452058,0.9253146072358462,0.5712187958883994,0.9094171462507559,1.0,8/22,20.23%,LANCL1;HSP90B1;AP2M1;CLU;MESD;LDLRAP1;SYT1;DNAJA1
prerank,endopeptidase inhibitor activity (GO:0004866),0.31761245378179964,0.9236707559514771,0.5812574139976275,0.9099964219638286,1.0,13/82,11.08%,RECK;SERPINI1;APP;SPOCK2;TIMP3;SPOCK3;FURIN;PTTG1;GAPDH;ROCK1;PRNP;SPINT2;SPOCK1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.42024259286567045,0.9220881696279397,0.5673076923076923,0.9105152357062455,1.0,4/15,14.60%,HS3ST1;HS3ST6;HS3ST5;NDST4
prerank,histone deacetylase binding (GO:0042826),-0.2368955349032155,-0.9220176679535741,0.6363636363636364,0.8535449376613978,1.0,20/88,15.36%,GLI3;CHD4;PRKN;TOP2B;NIPBL;KAT2B;NUDT21;DACT1;LCOR;CAMTA2;NACC1;BHLHE41;ZMYND15;HDAC4;HDAC1;AKAP8L;HDAC6;SIRT2;MTA2;BCOR
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4033871808410369,0.9208277387136792,0.5623987034035657,0.9102319754222657,1.0,3/16,12.22%,PIR;HGD;ALOXE3
prerank,signal sequence binding (GO:0005048),0.34855707465801405,0.9203892556896998,0.5569272976680384,0.9080947259220004,1.0,13/35,21.92%,AP2B1;TOMM20L;KPNB1;BABAM2;AP2M1;NFKBIA;NUP153;KPNA3;CABP1;PEX5L;IPO4;KCNIP2;BRAP
prerank,chloride channel activity (GO:0005254),0.32512118546354063,0.9199142837989188,0.5775749674054759,0.9060870606683462,1.0,14/59,19.81%,CLIC4;ANO6;GABRQ;BEST1;TTYH3;CLCN3;CLCN1;GABRA4;GABRA2;GABRE;GLRA2;GABRG3;GABRB1;CLCN7
prerank,phosphatase inhibitor activity (GO:0019212),-0.32117839728143593,-0.9167708333700332,0.5867768595041323,0.8604369095293146,1.0,3/20,4.38%,PTN;SET;BOD1L1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.40383542564189867,0.9162086866086608,0.55895865237366,0.9113256126355646,1.0,3/18,7.29%,PIK3R6;CISH;SOCS6
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4310252831776951,0.9140462207982377,0.5658536585365853,0.9128774443463852,1.0,4/11,22.37%,SLC17A9;SLC35B3;SLC25A25;SLC25A42
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.28731475080151725,0.9121975398321661,0.6384120171673819,0.9137183986284426,1.0,42/181,20.25%,LDB2;LMO2;TBXT;TAL1;HNF4A;ACTN4;RBBP8;HEY2;KLF4;BBS7;COMMD7;GABARAPL1;STAT1;HSPB1;RBL1;NFE2L2;JUN;TCF3;DHX9;MAD2L2;NFKBIA;ACTB;NPM1;HIF1AN;DMAP1;DTX3L;TBX20;HIF1A;NFATC1;CTNNB1;DUSP26;SPEN;MAPK14;SIN3A;TBX6;RELA;CRY1;MEF2A;NCOA7;JUP;DNAJA1;GSK3B
prerank,lipase activity (GO:0016298),0.3364624607039672,0.911768025996001,0.5699067909454061,0.9116083162731771,1.0,4/43,8.33%,PITPNM3;PNLIP;LCAT;ABHD6
prerank,carbohydrate:cation symporter activity (GO:0005402),0.43614246926472844,0.9080613281192917,0.5896551724137931,0.9166264960423305,1.0,2/11,8.42%,SLC5A10;SLC2A9
prerank,general transcription initiation factor binding (GO:0140296),0.3787254765688017,0.9072359752946373,0.5819793205317577,0.9153724152172439,1.0,10/25,18.51%,HHEX;BRF2;GTF2A1;PSMC1;TAF1B;PSMC5;TAF11;ESR1;DRAP1;RELA
prerank,G protein-coupled receptor binding (GO:0001664),0.28954931606675427,0.9064371084447997,0.6499442586399108,0.9141008615989067,1.0,10/132,8.00%,CCDC88C;S1PR1;ACE;GNAQ;GNAL;HOMER2;GNAI2;HSPA1B;ARRB1;REEP2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.3819549166104337,-0.9043547684023734,0.5886524822695035,0.8838840107187542,1.0,5/11,25.40%,NAA60;NAA40;NAA50;NAA10;NAA15
prerank,ATP hydrolysis activity (GO:0140603),0.3406085491749861,0.9033520399034078,0.5950752393980848,0.9173372881194487,1.0,7/41,11.83%,MYO1E;DDX4;KIF26A;HSPA1B;DHX9;ABCG4;CLU
prerank,Hsp90 protein binding (GO:0051879),0.3516421682504719,0.9025994948202373,0.6017191977077364,0.9157992945695793,1.0,8/33,19.18%,NOD2;UNC45B;PTGES3;UNC45A;HIF1A;AHSA1;PPID;ERN1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.37284132582360213,-0.9010330701752859,0.5886524822695035,0.8857963918096159,1.0,8/11,53.61%,CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.38417445680842865,-0.8984776964372153,0.5728643216080402,0.8860148786327339,1.0,5/10,20.14%,KDM7A;KDM4A;RIOX2;KDM8;PHF8
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.2318398276030182,-0.897251852767968,0.7150837988826816,0.8830401761668927,1.0,25/83,21.75%,USP33;USP20;USP9X;USP13;USP11;USP50;USP1;USP3;MINDY3;OTUD6B;OTUD7B;USP22;UCHL1;CYLD;USP8;ZRANB1;STAMBPL1;OTUD1;USP34;VCPIP1;JOSD2;USP2;TNFAIP3;USP46;USP31
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3708493234155068,0.8958270157609074,0.5922190201729106,0.9273193304939344,1.0,8/24,22.78%,DAB2IP;CERT1;PLEKHA5;ARFIP2;GOLPH3L;GOLPH3;PLEKHA3;OSBPL5
prerank,thyroid hormone receptor binding (GO:0046966),-0.2873526234109739,-0.8957644558451555,0.6076388888888888,0.8809671276692341,1.0,10/28,19.65%,TRIP12;TACC1;NSD1;MED13;JMJD1C;GTF2B;MED16;TAF7;GTF2H1;GAS2L1
prerank,thioesterase binding (GO:0031996),0.4195080646007143,0.8911130787919724,0.5807017543859649,0.9340516803750941,1.0,2/11,10.68%,TRAF1;RAC1
prerank,store-operated calcium channel activity (GO:0015279),0.41741631426604336,0.8886399252176689,0.6070826306913997,0.9360491533743179,1.0,4/10,14.44%,ORAI1;STIM2;TRPC7;TRPC5
prerank,N-acetyltransferase activity (GO:0008080),0.3844363347914595,0.8886332777390482,0.6122448979591837,0.9330422527034304,1.0,1/19,1.42%,SATL1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.36254561221626375,0.8867563571091726,0.6187683284457478,0.9339269178984512,1.0,3/26,7.46%,SLC6A6;SLC16A2;SLC16A4
prerank,manganese ion binding (GO:0030145),0.3282371140917617,0.8863414180189574,0.6258234519104084,0.9316917409072767,1.0,11/48,12.01%,POMGNT1;MGAT5;ARG1;PCK2;EXD2;MTPAP;FEN1;ADPRM;MGAT1;XXYLT1;GALNT4
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.2741584589116238,-0.8816994945324659,0.6394052044609665,0.9065395484790577,1.0,11/34,18.12%,NSD3;EHMT1;SETD7;DOT1L;METTL21A;KMT5B;EEF1AKMT1;SUV39H1;SETD4;N6AMT1;EEF1AKMT2
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.3289580619517433,0.8814689242830666,0.6344086021505376,0.9387179295255113,1.0,4/38,8.37%,HIP1;DAB2IP;TECPR1;PLEKHA5
prerank,carboxypeptidase activity (GO:0004180),-0.26429717841411215,-0.8806825767043871,0.640926640926641,0.9032560718636095,1.0,9/35,18.90%,AEBP1;CPE;AGBL3;CPXM2;NAALAD2;CPXM1;AGBL1;CPA6;ACE2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.4020077324502042,0.8797028411484799,0.6095551894563427,0.9392025054390565,1.0,3/13,8.63%,SLC7A7;SLC7A1;SLC15A4
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.40995930824051346,0.8796475155973578,0.6106623586429726,0.936332622909386,1.0,4/12,22.37%,SLC17A9;SLC35B3;SLC25A25;SLC25A42
prerank,E-box binding (GO:0070888),0.33707035078812014,0.8789146848201503,0.6312154696132597,0.934727508620315,1.0,5/34,9.35%,NEUROG2;TAL1;GATA3;SNAI2;TCF3
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.3248941364032465,-0.8782880330503561,0.6129032258064516,0.903144091975337,1.0,9/17,33.10%,AK5;CMPK2;AK1;NME2;NME6;NOL9;AK3;NME1;AK9
prerank,protein kinase activator activity (GO:0030295),0.3099489088714229,0.8767909120984091,0.6572890025575447,0.9360464789657572,1.0,15/60,19.75%,AFAP1L2;IQGAP1;MADD;IRGM;GPRC5A;GRM5;MARK2;CALM3;PAK2;RICTOR;DAXX;EPO;CD24;MAP2K1;CAB39
prerank,endopeptidase regulator activity (GO:0061135),0.3327678806803941,0.8760629129101749,0.6364883401920439,0.9344646549846137,1.0,11/40,22.35%,RECK;APH1A;SPINT2;VSIR;PSMD14;SLPI;CST3;PROS1;APH1B;USP14;A2M
prerank,RNA binding (GO:0003723),0.2600341369402503,0.8738406392696774,0.931,0.9359263267221724,1.0,388/1321,24.57%,NANOS1;NANOS3;SORBS2;SYNE1;FASN;ESRP2;NOVA2;ZYX;FLNB;FKBP4;ADARB1;MACF1;RBPMS;IFIH1;LRRFIP1;VIM;MAP4;NPM3;BOP1;DHX32;DIAPH1;ACTN4;PELP1;KCTD12;TLR3;RPS21;RPL27;DDX4;TNS1;PUM2;MSN;RBM7;CCDC9B;SUMO2;SRP14;MBNL1;DHX37;ZCCHC9;SSBP1;DDX39A;KARS1;DDX41;RPL7;MRPL4;PPIE;MEX3B;MYEF2;KHDRBS3;APEX1;PHF6;MYH9;ASS1;FNDC3B;PABPC5;RTF1;BUD13;TUBB4B;PSMD4;LSM1;SETX;ENDOV;PLEC;HNRNPA0;ZC3H12A;MRPL41;ELAVL1;RANGAP1;NGRN;HSPB1;HSP90B1;HSPA1B;CCDC124;AATF;PURA;CTNNA1;KPNB1;EXOSC3;ATP5F1A;MTPAP;ZNF346;NVL;DNAJC2;U2SURP;ZC3H7A;OAS2;DCP1B;MRPS31;SCAF4;POLR2G;RPS14;MRPL1;RPS27A;RBM28;RPL35;ETF1;DDX28;ADAR;CACTIN;EIF3B;JUN;DSP;ZFP36L2;WDR46;RTN4;HMGB1;RPL21;DHX9;DKC1;HSPE1;CELF4;DUSP11;TRIM25;PRPF38A;TASOR;POLR2D;MRPL15;EIF1AX;EIF1;RPL37;ARHGEF1;FARS2;CNOT1;RPS28;RPL34;LARP1B;TUFM;HNRNPK;GTPBP1;AGO4;PTPN1;RPS9;XRN2;FIP1L1;ALKBH8;NPM1;EEF2;PTBP3;CAVIN1;ASCC3;PCBP1;BRCA1;MRPL23;TIAL1;RPS25;EIF3I;RBM11;ILF2;DHX40;GLRX3;HELZ2;VIRMA;NHP2;MARK2;CHTOP;RPL30;EIF3G;GCN1;NUFIP2;CCT4;TRMT2A;MSI2;SMNDC1;METAP2;FBLL1;SRSF9;RPS5;XRN1;RPL27A;AKAP1;GPATCH4;NOL8;FXR1;RPP38;RBM45;METTL14;HABP4;SRP9;DDX56;DDX21;NOL3;CLNS1A;HNRNPH2;FASTKD5;PSMC1;SART1;MRPL14;MRPL32;MRPS12;TFB2M;RAN;RPL23A;ELAVL2;COL14A1;TRMT10B;NUP42;SYF2;HMGB2;SF3B4;MAP3K20;CCT6A;RPS15;SRPRA;EIF3A;CRNKL1;EIF2S1;EIF2A;PIN4;RPL19;DDX55;EDC3;FAU;RPS18;YBX1;MRPL39;DDX6;RPL32;TEFM;RACK1;PTCD2;MTIF2;EIF3H;SLPI;PKN2;TCOF1;DHX38;SF3A1;ELAC2;UBFD1;SPEN;RBM15;TMSB4X;UTP18;ATXN2L;DROSHA;RPL37A;RPL18A;HADHB;LRPPRC;RPL22L1;MRPL54;EXD1;SRPK1;UNC50;POLDIP3;RPL7L1;TRNAU1AP;SEPSECS;SAFB2;NSUN5;TRMT1L;EXOSC9;TUT7;POP1;KHNYN;DXO;SPTBN1;LAS1L;RSRC2;CCDC47;DDX39B;RPUSD2;LSM14B;TIA1;NOL4;CSTF2;MKRN1;SRP19;DDX47;PTBP2;TDRD9;ZC3H15;MRM3;G3BP1;HNRNPUL1;SF3B6;NAP1L4;DCAF13;FTSJ3;LSM2;ZC3HAV1;MYO18A;IBA57;MKRN2;BARD1;PA2G4;MRPS30;DARS1;GFM1;ZC3H8;ANG;SMG7;SYNCRIP;RRP9;PPHLN1;YTHDC1;CPSF3;MRPL11;NOL7;STAU2;ACAA2;RCAN3;PWP2;C1D;SF3B2;TRMT1;DHX58;RSL24D1;ANKRD17;BAG4;RPL18;MRPS35;MRPS28;EIF2AK2;RPL39;SF3A3;MTCL1;IMP4;ZFP36L1;MBNL2;NSUN6;UBA1;CRKL;RPS19;NOLC1;EXOSC10;ZCCHC17;MRPS9;CSDE1;HEXIM1;FAM50A;RPL31;RPS8;LRRC47;JAKMIP1;NSRP1;RTCA;MEX3D;NOP53;ZNF106;EXOSC1;UBAP2;NQO1;FBL;SEC63;MRPS27;URB1;RPF2;TYW5;EDF1;ZNF638;NUDT16;TOP3B;TBRG4;KIN;ZCRB1;CNBP;TSFM;EIF4G1;WDR43;TCP1;POLR2B;DHX36;DHX57;PATL2;CPNE3;IREB2;HLTF;ZNF326;PRPF40B;UBE2O;FRG1;TUBA1B;ANXA11;CCT3;LRRC59;RPL3;RAE1;OASL;UTP20;OTUD4;USO1;EIF4ENIF1;RIMS1;MYO5A;MRTO4;GRN;PRPF6;ALYREF
prerank,nuclear import signal receptor activity (GO:0061608),-0.3350448005308114,-0.8737137400165286,0.625,0.9079404045731105,1.0,5/15,14.92%,KPNA1;TNPO3;RANBP6;IPO5;TNPO2
prerank,potassium channel regulator activity (GO:0015459),0.31808992334317066,0.8724248583413795,0.6605263157894737,0.935711026927022,1.0,7/49,12.11%,KCNE3;ADRB2;DPP6;DPP10;SGK1;NEDD4L;ARPP19
prerank,UDP-glycosyltransferase activity (GO:0008194),0.30501283611271723,0.8704656447245267,0.6896551724137931,0.9367151200898498,1.0,7/70,8.01%,GCNT1;MFNG;POMGNT1;EXT1;GCNT2;POGLUT1;B3GNT3
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.3959612662661861,0.869325578944808,0.6079447322970639,0.936046392779489,1.0,6/13,17.88%,SH3BP4;ARHGDIA;CCDC88A;RANBP1;ITGB1BP1;GDI1
prerank,protein kinase C activity (GO:0004697),0.39268505214839844,0.8681389631003981,0.6313213703099511,0.935412068930796,1.0,3/14,10.21%,PRKD1;PKN1;PRKCG
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.354893752059983,-0.866000077887006,0.651595744680851,0.9190621666030407,1.0,4/12,21.72%,DHRS4;AIFM2;NDUFS7;CRYZ
prerank,ionotropic glutamate receptor binding (GO:0035255),0.41445326721808384,0.8648977685214336,0.6038062283737025,0.9387278092587634,1.0,4/10,19.90%,SHANK3;SHISA6;NSF;SHANK2
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.26984408765655077,-0.8612405229555304,0.6775244299674267,0.923773359133527,1.0,4/31,6.36%,SLC12A2;KCNK5;ABCC9;KCNQ4
prerank,voltage-gated cation channel activity (GO:0022843),0.2831720023970967,0.8586709706668559,0.6845878136200717,0.9479782926388889,1.0,18/97,17.87%,KCNQ1;KCNH8;CACNA1A;KCNG3;GRIN2B;KCNC1;KCNH7;GRIN2C;TPCN2;GRIN3A;KCNC4;KCNA1;CACNA1E;KCNC2;KCNH5;KCNH1;GRIN2A;KCNQ3
prerank,DNA replication origin binding (GO:0003688),0.35285022127717186,0.8583681024140546,0.6539634146341463,0.9455891111845232,1.0,5/23,15.09%,ORC3;DHX9;POLA1;ORC5;KAT7
prerank,hormone receptor binding (GO:0051427),0.386939797393473,0.8581213787492937,0.6398659966499163,0.9431816606569494,1.0,3/14,18.21%,JAK2;NPPC;NCOA6
prerank,zinc ion binding (GO:0008270),0.26085646583178823,0.8515466239942359,0.8055842812823164,0.953031310208767,1.0,39/293,12.28%,MYRIP;ACE;CRIP2;GDA;ARHGEF2;DUSP12;MSRB3;KLF7;IFIH1;GCH1;KLF4;LANCL1;TNFSF10;SHANK3;RNF125;SMPDL3A;ASAH2;ARIH1;PGGT1B;TRIM24;CLIP1;KPNB1;MT2A;PLSCR1;GRIN2B;CAD;MBD1;KMT2B;DHH;EGR1;PTPN1;TET3;TAB2;TNKS;ALKBH8;HIF1AN;SAP30L;TRIM8;SUV39H2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4126436387082599,0.8503389922976642,0.6526315789473685,0.9524371479318293,1.0,1/10,1.85%,GDA
prerank,chemokine activity (GO:0008009),-0.27150273811837144,-0.8500454512966452,0.7162162162162162,0.942167737194503,1.0,23/31,51.88%,CXCL16;CCL25;CXCL12;CKLF;CCL19;CCL2;CCL14;CCL28;CX3CL1;CCL5;CXCL5;CCL11;CXCL1;PF4;CCL7;PPBP;CCL8;CCL1;CCL3;XCL1;CXCL13;CXCL2;CCL13
prerank,steroid hydroxylase activity (GO:0008395),0.3775273145193329,0.8498393438119914,0.6609642301710731,0.9504958782277534,1.0,1/16,2.19%,CYP39A1
prerank,bHLH transcription factor binding (GO:0043425),-0.3061796396549199,-0.8495885462042846,0.6647398843930635,0.9373966250080621,1.0,4/19,11.12%,FHL2;CREBBP;SMAD3;BHLHE41
prerank,diacylglycerol kinase activity (GO:0004143),0.40211408207477906,0.8493720809156279,0.6463195691202872,0.9485397600712903,1.0,5/11,25.02%,DGKH;AGK;DGKI;DGKA;DGKB
prerank,MAP-kinase scaffold activity (GO:0005078),0.3989802880239296,0.847687543791813,0.6475409836065574,0.9487829931022238,1.0,2/11,5.67%,IQGAP1;SPAG9
prerank,poly(A) binding (GO:0008143),-0.2979003953507713,-0.8474744937031345,0.6955223880597015,0.9360215662427332,1.0,2/21,1.44%,RBMS3;RBMS1
prerank,cation:chloride symporter activity (GO:0015377),-0.37093752785248446,-0.8465657395700448,0.6736111111111112,0.9323064214274713,1.0,2/10,6.05%,SLC12A2;SLC6A1
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.298669896545428,-0.8445456166737112,0.690625,0.9308099889638883,1.0,7/20,24.78%,CASK;AK6;MAGI3;CMPK2;AK1;LRGUK;DLG1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.28363601498230584,0.8417000709569425,0.7117224880382775,0.9571822264335684,1.0,22/85,23.73%,AOAH;PNLIP;LCAT;PGAP1;PNPLA6;APMAP;ABHD6;GDPD1;ACHE;PON2;PON3;ABHD2;PLA2G12A;PLAAT3;BCHE;PNPLA2;ABHD4;LYPLA1;MGLL;ESD;GDE1;LYPLAL1
prerank,lipoprotein particle receptor binding (GO:0070325),0.3301455107168534,0.8380499893124613,0.6768802228412256,0.9609539534243366,1.0,7/27,14.09%,APOA1;LANCL1;HSP90B1;AP2M1;CLU;MESD;LDLRAP1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.29833770350687955,-0.8356279898098837,0.7209302325581395,0.9429144066817129,1.0,7/20,17.93%,USP9X;UFSP2;SENP3;USP50;SENP1;OTULINL;SENP2
prerank,protein kinase inhibitor activity (GO:0004860),-0.24383024059509978,-0.8353587205192163,0.7575757575757576,0.938051221385615,1.0,14/42,22.93%,PARVA;DNAJC3;DUS2;SPRED1;SPRED2;GMFB;SH3BP5;QARS1;CDKN1A;PRKRIP1;IBTK;CIB1;TAOK3;GSKIP
prerank,poly-purine tract binding (GO:0070717),-0.2713469834676745,-0.8338205017614728,0.7129629629629629,0.9353997148309091,1.0,12/27,27.36%,RBMS3;RBMS1;DAZAP1;DDX1;DDX3X;HNRNPU;PABPC1;PABPC4L;KHDRBS1;EIF4A3;HNRNPDL;PNPT1
prerank,hexosyltransferase activity (GO:0016758),0.2784875022698358,0.8327564825927699,0.7526132404181185,0.9680557949283606,1.0,9/101,8.21%,GCNT1;MFNG;POMGNT1;B4GALT4;EXT1;GCNT2;POGLUT1;B3GNT3;A4GALT
prerank,ribonuclease activity (GO:0004540),0.2972467144797721,0.83134586492349,0.7220812182741116,0.9676736668913107,1.0,22/56,24.62%,INTS11;ZC3H12A;EXOSC3;RNASE1;EXOSC8;RNASE6;EXOG;ELAC2;NOB1;EXOSC9;KHNYN;RNASE12;ERN1;ANG;RNASE4;CPSF3;EXOSC10;DIS3L2;EXOSC1;RNASEH2A;RNASE7;RNASEH1
prerank,semaphorin receptor activity (GO:0017154),0.38928013682241747,0.8267550644643898,0.6735042735042736,0.9730717081862463,1.0,2/11,3.97%,PLXNA4;PLXND1
prerank,GDP binding (GO:0019003),0.29188717106983814,0.8262249093858941,0.7365119196988708,0.9711124447278162,1.0,18/63,22.09%,KRAS;NRAS;RRAS;RAB35;RRAGD;RHEBL1;RRAS2;RAN;RHEB;RAB27B;RIT2;RAB27A;RAB5C;RRAGC;RAB31;RAB12;RALB;RAP1B
prerank,NF-kappaB binding (GO:0051059),0.33844577532666764,0.8257025475378392,0.6850746268656717,0.9692079919542356,1.0,8/24,25.64%,COMMD7;NFKBIA;NPM1;HIF1AN;RELA;GSK3B;RNF25;HDAC2
prerank,motor activity (GO:0003774),0.2894778595550928,0.8251047056561953,0.7255154639175257,0.9674297402381232,1.0,11/60,15.66%,MYO1E;KIF26A;MYH9;KIF2A;MYL6;STARD9;PIN1;KIF24;KIF26B;KIF16B;KIF1A
prerank,retinoid X receptor binding (GO:0046965),0.39193542140315907,0.8235164562913119,0.6689536878216124,0.967579625974942,1.0,2/11,9.81%,NR4A2;ARID5A
prerank,deoxyribonuclease activity (GO:0004536),0.3696214241766488,0.8209416120871781,0.694078947368421,0.9694149420477531,1.0,3/14,13.69%,APEX1;DFFB;ERCC4
prerank,magnesium ion binding (GO:0000287),0.26418157129486175,0.8205165953948117,0.7865921787709497,0.9674350543038561,1.0,44/135,24.28%,SNRK;OXSR1;CDC42BPA;MAP3K6;CDC42BPG;STK38;STK38L;NLK;THTPA;EXD2;ENDOV;MAST1;SIK2;LRRK2;MTPAP;PLSCR1;FEN1;XXYLT1;GSS;MARK2;RAN;RHEB;MAP3K20;SRPK1;CIB2;DXO;ERN1;PLSCR3;RRAGC;AASDHPPT;CDC42BPB;NT5C3A;ABL2;DIS3L2;GEN1;NUDT16;IDH3G;DHX36;MVK;BRSK2;WRN;MTHFD2;TESC;PPA2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.25596939857660594,-0.8204903375863716,0.754325259515571,0.9547397389853743,1.0,8/31,16.94%,UBE2E2;UBE2N;TAF1;BIRC6;UBE2L3;UBE2G2;UBE2QL1;UBE2L6
prerank,lipase activator activity (GO:0060229),0.39035641026509343,0.8172244859371611,0.6917922948073701,0.970777497267131,1.0,3/10,13.99%,FYN;BTK;APOH
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.3512550641866603,-0.8170255240362623,0.7067307692307693,0.9561688502405072,1.0,4/10,9.31%,DPP4;FAP;PRCP;NAALAD2
prerank,histone methyltransferase binding (GO:1990226),0.39056402589234496,0.8167893077235835,0.7031746031746032,0.968725805472434,1.0,3/11,16.33%,LCORL;CTNNB1;CBX1
prerank,nuclear localization sequence binding (GO:0008139),0.34721400324978857,0.8144344647623012,0.6831091180866966,0.9700704490264415,1.0,7/18,21.92%,KPNB1;NFKBIA;NUP153;KPNA3;CABP1;IPO4;BRAP
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.3771624461445405,0.8135486411079532,0.688783570300158,0.9688326377942049,1.0,4/13,23.27%,DDT;ECI1;SREBF2;IDI1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.32361703052040264,-0.8110826920601666,0.7111650485436893,0.9620100155413572,1.0,2/13,5.00%,AGPAT4;LPCAT2
prerank,intracellular chloride channel activity (GO:0061778),0.35968280961594823,0.8057679182912462,0.7034700315457413,0.9767637381161443,1.0,2/16,7.57%,ANO6;TTYH3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.35968280961594823,0.8057679182912462,0.7034700315457413,0.9767637381161443,1.0,2/16,7.57%,ANO6;TTYH3
prerank,histone methyltransferase activity (GO:0042054),-0.24970358129887815,-0.8053062169612819,0.7972508591065293,0.9673731202828076,1.0,8/32,16.44%,NSD3;KMT2C;EHMT1;SETD7;DOT1L;KMT5B;SUV39H1;N6AMT1
prerank,MAP kinase activity (GO:0004707),-0.31519432245080997,-0.80219815531928,0.735897435897436,0.9675972153545478,1.0,2/14,7.38%,MAPK4;MAPK6
prerank,G protein-coupled peptide receptor activity (GO:0008528),-0.2154899654045126,-0.8008061330522335,0.8770949720670391,0.9645033344148011,1.0,30/73,34.48%,LGR4;NPR3;EDNRA;SORCS2;BDKRB2;SORCS3;PTH1R;CYSLTR1;EDNRB;CYSLTR2;MC5R;GPR37L1;GLP2R;OPRK1;APLNR;VIPR2;CALCRL;CCKBR;NPSR1;TSHR;GALR1;S1PR2;LHCGR;GPR37;F2R;GRPR;PTH2R;KISS1R;GIPR;MAS1
prerank,phospholipase A2 activity (GO:0004623),-0.2675134932422708,-0.8006849137681914,0.799373040752351,0.9593731707317709,1.0,15/26,47.48%,PLA2G4A;PLA2G15;PLA2G6;PLA2G4C;PLA2G7;PLA2G4F;PLAAT1;PLA2G4B;PLA2G5;PLB1;ABHD3;PLA2G3;PLAAT5;PNPLA3;PLA2G4E
prerank,dynactin binding (GO:0034452),-0.33354982952938594,-0.8000639577517298,0.689119170984456,0.9549417315778911,1.0,3/12,19.12%,SNX6;BICD2;SNX5
prerank,cysteine-type endopeptidase activity (GO:0004197),0.2707269980893906,0.7993244014605503,0.7812879708383961,0.9850409228765667,1.0,20/78,21.84%,CASP8;USP38;CASP2;CASP1;USP12;CAPN5;USP29;USP9Y;CASP7;PYCARD;USP35;CTSK;CTSO;CAPN1;MALT1;CTSH;USP47;CAPNS1;USP14;USP30
prerank,beta-tubulin binding (GO:0048487),0.3125822579839708,0.7985932835263369,0.7248908296943232,0.9834125348511807,1.0,4/31,9.10%,TRPV4;TTLL7;GABARAPL1;UXT
prerank,ubiquitin-specific protease binding (GO:1990381),0.3386500748182141,0.7964297028804137,0.7275494672754946,0.984231561005274,1.0,3/19,13.00%,SPATA2;BAG6;CHMP3
prerank,GABA receptor binding (GO:0050811),0.3781915817473883,0.7957503040362981,0.7147887323943662,0.9825870009527607,1.0,2/11,6.18%,AKAP5;GABARAPL1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.3341375842379085,-0.7955339696659436,0.7353689567430025,0.9574573748501476,1.0,1/11,0.37%,EGFR
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.25634342777052577,-0.7920049533198502,0.7885196374622356,0.9583067690475738,1.0,13/27,28.25%,PPARA;PRKN;DCUN1D3;ARIH2;UBE3D;RNF180;DCUN1D4;ZMYM2;SIAH1;TOLLIP;FOXL2;SIAH3;AUP1
prerank,estrogen receptor binding (GO:0030331),0.307746772571083,0.7884943472923392,0.7609289617486339,0.9919249829178092,1.0,12/32,19.36%,LEF1;SRARP;ARID5A;CNOT1;CTNNB1;ESR1;MMS19;NCOA6;STRN;PPID;DCAF13;WBP2
prerank,ADP binding (GO:0043531),-0.2637927938839871,-0.7879570600604127,0.8057324840764332,0.9598641560051436,1.0,5/25,13.18%,PRKAG2;ME1;GCLC;MYO9B;MSH6
prerank,deubiquitinase activity (GO:0101005),-0.20027202340309863,-0.7841013741210804,0.9217877094972067,0.9607483075261036,1.0,25/88,21.75%,USP33;USP20;USP9X;USP13;USP11;USP50;USP1;USP3;MINDY3;OTUD6B;OTUD7B;USP22;UCHL1;CYLD;USP8;ZRANB1;STAMBPL1;OTUD1;USP34;VCPIP1;JOSD2;USP2;TNFAIP3;USP46;USP31
prerank,voltage-gated chloride channel activity (GO:0005247),0.3672213044358143,0.7807789226367142,0.696917808219178,1.0,1.0,3/10,10.31%,ANO6;CLCN3;CLCN1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.27649474118722517,0.7805817653750904,0.7703045685279187,0.9992546413219734,1.0,11/60,14.97%,DUSP1;LRRC39;PPM1F;LRRK2;PPP3CA;PP2D1;CDC14A;PDP1;PPM1D;PPM1L;PPP2CB
prerank,cholesterol transfer activity (GO:0120020),0.339009256697836,0.7795554200353725,0.7418351477449455,0.9980929668005711,1.0,2/16,5.63%,APOA1;PLTP
prerank,telomeric DNA binding (GO:0042162),0.3006511493803377,0.7794259387003288,0.7447405329593267,0.9955316215498253,1.0,11/32,24.06%,HMBOX1;ZBTB48;APEX1;PURA;STN1;CTC1;TERF2IP;SMG7;BLM;TERF2;WRN
prerank,ubiquitin binding (GO:0043130),-0.2024966320550801,-0.7779373216056913,0.9262672811059908,0.9652499741734202,1.0,31/73,30.63%,PRKN;USP33;UBE2N;SMAD3;USP13;UBXN7;RNF31;UBXN2B;DNAJB2;TSG101;UCHL1;MDM2;OTULINL;SIRT2;SHARPIN;UBE2L6;UBAP1;TNFAIP3;RNF168;GGA3;TOLLIP;UBXN11;TOP2A;MVB12B;NEDD4;N4BP1;AUP1;RAD23A;NUP62;BIRC2;OTUB2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.279802870619577,0.7768499226537753,0.7810026385224275,0.9969680067176346,1.0,7/51,9.52%,SLC25A16;SLCO1C1;SLC35D2;SLC35E4;SLC16A2;CLCN3;SLC25A30
prerank,signaling receptor complex adaptor activity (GO:0030159),0.288284275798985,0.7767064883182019,0.7762619372442019,0.9944077246126822,1.0,6/38,9.11%,SPATA2;CARD10;SHANK3;SPAG9;LRRK2;STAP1
prerank,hormone activity (GO:0005179),0.27515375929971697,0.7755807284246269,0.7879581151832461,0.9934104418326506,1.0,7/54,19.39%,EDN1;GAL;NPPC;APLN;SST;PENK;VGF
prerank,copper ion binding (GO:0005507),0.29129218890794817,0.7751512070578,0.7616511318242344,0.9914114799285416,1.0,12/42,22.31%,ATOX1;SNCG;ATP7A;IL1A;TYR;PRNP;CUTA;HEPH;ATP7B;ANG;CCS;SOD1
prerank,O-acyltransferase activity (GO:0008374),0.30329785294212114,0.775094479547926,0.7382271468144044,0.9887880308212788,1.0,5/30,10.81%,MBOAT2;LPCAT4;LCAT;LPCAT3;MOGAT1
prerank,sterol transfer activity (GO:0120015),0.3344274717421081,0.7745348824709638,0.7507692307692307,0.9869389650525003,1.0,2/17,5.63%,APOA1;PLTP
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.3756740302318269,0.7741339695818943,0.7221238938053097,0.984893821701812,1.0,6/10,20.39%,SETD3;ASH1L;NSD2;PRDM9;SETD2;SMYD2
prerank,mRNA binding (GO:0003729),0.23829830706938565,0.7722990212920468,0.8931937172774869,0.9851406554807189,1.0,26/249,11.45%,NANOS1;NANOS3;ESRP2;NOVA2;ADARB1;RBPMS;PUM2;RPL7;PPIE;MYEF2;KHDRBS3;PABPC5;HNRNPA0;ZC3H12A;ELAVL1;DCP1B;RPS14;RPL35;ETF1;ELAVL4;DHX9;CELF4;HNRNPK;ANGEL2;PTBP3;PCBP1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.34950732414909563,0.7722207456600089,0.734006734006734,0.9825655499898774,1.0,5/14,28.38%,CAPN5;CAPN1;CAPNS1;CAPN10;CAPN2
prerank,ion gated channel activity (GO:0022839),-0.25958958582703195,-0.7700342036035803,0.8184818481848185,0.9725938108272209,1.0,3/24,8.27%,KCNT2;ANO1;KCNT1
prerank,nucleotidyltransferase activity (GO:0016779),-0.2757093536915757,-0.7677702080413388,0.781437125748503,0.970790129931597,1.0,8/19,21.03%,CRPPA;REV1;TENT4B;TERT;TUT1;PAPSS2;TUT4;CGAS
prerank,mRNA 5'-UTR binding (GO:0048027),-0.2546980653744898,-0.7628095500216062,0.8422619047619048,0.9730887064846215,1.0,7/24,20.09%,CCT5;DDX3X;LARP1;NCL;LARP6;MRPS11;GNL3
prerank,nuclear receptor binding (GO:0016922),0.2527096506948595,0.7624588496703159,0.8614318706697459,0.9950598543948445,1.0,29/111,19.36%,NR4A2;ACTN4;LEF1;SRARP;PKN1;BRD8;KDM3A;STAT1;FOXP1;ARID5A;CNOT1;NR4A1;MED30;YWHAH;HIF1A;CTNNB1;MED17;MED4;TAF11;ESR1;DAXX;MMS19;NCOA6;STRN;CRY1;PPID;DCAF13;NCOA7;WBP2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.3012255784556337,0.761801269258538,0.7678832116788321,0.9934281190512819,1.0,11/30,23.50%,ATP7A;SLC31A1;SLC30A1;SLC39A6;SLC25A28;ATP7B;SLC30A3;SLC39A3;SLC30A4;SLC39A12;TTYH1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.360292422639946,0.7599407874623281,0.7330016583747927,0.9935805304584056,1.0,3/11,14.44%,ITPR3;TRPC7;TRPC5
prerank,sulfotransferase activity (GO:0008146),0.2951221424545679,0.7587351984577569,0.7841225626740947,0.9926966697407682,1.0,4/33,6.88%,HS3ST1;CHST14;SULT6B1;CHST11
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.2898513359341915,-0.7587141224366628,0.78125,0.9739183888726283,1.0,5/15,35.76%,PLA2G4A;PLA2G4C;PLA2G4F;PLA2G4B;PLA2G5
prerank,protein kinase regulator activity (GO:0019887),0.25316355969232596,0.7584851454050924,0.8416666666666667,0.9904879693146244,1.0,20/95,19.75%,CCNY;CCND2;CCND3;CCNE1;SMCR8;MADD;ELP4;GPRC5A;APC;NPM1;MARK2;SPRY4;CSNK2B;SH3BP5L;NCK1;DAXX;CXCL10;EPO;ELP3;CAB39
prerank,epidermal growth factor receptor binding (GO:0005154),0.31322913837766314,0.7575893590109196,0.7536656891495601,0.9891559120420647,1.0,3/25,10.33%,HIP1;PLSCR1;CCDC88A
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.2311322203015114,-0.7564077288897915,0.8629629629629629,0.9721196352902539,1.0,8/34,16.94%,UBE2E2;UBE2N;TAF1;BIRC6;UBE2L3;UBE2G2;UBE2QL1;UBE2L6
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.23024139598316767,-0.7542325661418328,0.8571428571428571,0.9702737424757784,1.0,10/35,17.43%,RRN3;SMARCB1;TAF4;TAF1;DR1;HDAC1;GTF2B;PIH1D1;POU2F1;UBTF
prerank,protein phosphatase regulator activity (GO:0019888),0.2706745992810498,0.753889524949374,0.8144329896907216,0.9920336466546017,1.0,24/53,25.05%,MGAT5;PPP1R16B;SHOC2;LMTK2;PPP2R5C;PPP2R2C;ARPP19;CALM3;PPP1R15B;PPP4R1;RCAN2;BOD1;PPP1R16A;PPP1R9B;PPP1R7;PPME1;RCAN3;EIF2AK2;PPP2R5E;IGBP1;PPP1R15A;LGALS3;PPP2R2A;PPP2R1A
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.2707132832440011,-0.7499977988537406,0.8194444444444444,0.9710394916156011,1.0,8/17,34.17%,DPYD;BDH2;BLVRB;PTGR1;SRD5A3;PECR;PTGR2;MECR
prerank,death receptor binding (GO:0005123),0.3392634224633783,0.7469639367610836,0.7712933753943217,0.9997235126020924,1.0,5/15,20.14%,DAB2IP;MADD;CASP8AP2;BID;BDNF
prerank,nuclease activity (GO:0004518),0.26951039995722575,0.7463997966604508,0.8093385214007782,0.9977821900487498,1.0,19/52,26.06%,APEX1;ZC3H12A;PLSCR1;DFFB;FEN1;RNASE1;XRN2;RNASE6;EXOG;RNASE12;ANG;RNASE4;DIS3L2;RNASEH2A;WRN;RNASE7;RNASEH1;ISG20L2;OGG1
prerank,proton transmembrane transporter activity (GO:0015078),-0.22215156439205974,-0.7455230895617969,0.89198606271777,0.9718680370970014,1.0,11/39,21.67%,ATP6V1B2;CLCN5;DMAC2L;COX10;COX7A2L;UQCRQ;CLCN4;UQCRH;SLC9A1;SLC11A2;ATP6V1F
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.23266440608046246,-0.744305821353699,0.8639240506329114,0.9636018468689855,1.0,14/34,27.31%,NDUFS3;NDUFA13;NDUFC2;NDUFV2;NDUFB10;NDUFS7;NDUFS6;NDUFB8;NDUFA1;NDUFB3;NDUFS5;NDUFS8;NDUFB2;NDUFS2
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.23266440608046246,-0.744305821353699,0.8639240506329114,0.9636018468689855,1.0,14/34,27.31%,NDUFS3;NDUFA13;NDUFC2;NDUFV2;NDUFB10;NDUFS7;NDUFS6;NDUFB8;NDUFA1;NDUFB3;NDUFS5;NDUFS8;NDUFB2;NDUFS2
prerank,alpha-actinin binding (GO:0051393),0.30250636907988315,0.7435434356873233,0.8039513677811551,0.9993799697956373,1.0,2/24,4.46%,MAGI1;PDLIM5
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3288545168022195,0.7398070189268793,0.7770491803278688,1.0,1.0,4/16,22.37%,SLC44A1;SLC22A5;SLC29A4;SLC25A42
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.32022776026329114,-0.7386853426492958,0.7865429234338747,0.9660200800393711,1.0,4/10,25.40%,NAA60;NAA50;NAA10;NAA15
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.30572300865246965,0.7369642514355783,0.7929515418502202,1.0,1.0,7/22,10.94%,CPSF1;HNRNPA0;ZC3H12A;ELAVL1;ELAVL4;ZFP36L2;EXOSC8
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.30435975346600536,-0.736033524580465,0.8054862842892768,0.9645865248204604,1.0,4/12,20.14%,KDM7A;JMJD1C;KDM4A;PHF8
prerank,four-way junction DNA binding (GO:0000400),0.32431278048768314,0.7327409180947133,0.8030075187969925,1.0,1.0,7/17,24.06%,HMGB1;RAD51D;HMGB2;MEN1;BLM;GEN1;WRN
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.2875885688667084,0.7314511031388178,0.8151382823871907,1.0,1.0,9/28,20.31%,LRRK2;SGK1;PRKCG;RPS6KA1;RPS6KB1;MAPK14;MAPKAPK5;MAP2K1;MAP3K9
prerank,NADPH binding (GO:0070402),-0.2941643950332816,-0.7312369774357043,0.8241469816272966,0.9657343407990965,1.0,6/13,28.01%,DUS2;NDOR1;CRYZ;CBR3;GRHPR;DHFR
prerank,glutathione transferase activity (GO:0004364),0.3014918047779579,0.730563204399092,0.7966616084977238,1.0,1.0,2/23,4.89%,GSTA2;LANCL1
prerank,hyaluronic acid binding (GO:0005540),0.3601768088424693,0.728156400335343,0.7965217391304348,1.0,1.0,2/10,5.51%,HYAL2;LAYN
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.2866662804503236,-0.7242245142750532,0.7989690721649485,0.969445720202613,1.0,5/14,22.46%,AK5;CMPK2;AK1;NME2;NME6
prerank,lysophospholipase activity (GO:0004622),-0.25997014723187273,-0.723577965795285,0.8198757763975155,0.9654123126753069,1.0,7/20,21.08%,PLA2G4A;PNPLA7;ASPG;ABHD12;PLA2G6;ENPP2;PLA2G4C
prerank,sodium channel activity (GO:0005272),0.27598953250485597,0.7222322217063063,0.8393632416787264,1.0,1.0,8/37,18.28%,SCN11A;SCN1B;ASIC2;GRIK5;GRIK2;SCN9A;GRIK1;SCN1A
prerank,transaminase activity (GO:0008483),-0.29687888469792295,-0.7204945145827045,0.8064516129032258,0.9642401804583471,1.0,4/11,20.59%,ABAT;OAT;GOT1;AGXT
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.33690190292291605,0.7192448663195129,0.7713815789473685,1.0,1.0,3/12,17.38%,CNOT6L;CNOT1;CNOT2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.23650710090520324,-0.7184840533036704,0.8690807799442897,0.9618840045363961,1.0,8/25,24.63%,PARP8;SIRT3;ART3;SIRT2;PARP3;PARP1;PARP6;PARP2
prerank,glucuronosyltransferase activity (GO:0015020),0.3071285533249113,0.7182444094531791,0.8273273273273273,1.0,1.0,2/19,8.93%,EXT1;B3GAT2
prerank,hexosaminidase activity (GO:0015929),0.3381999298211097,0.715854375118223,0.8102310231023102,1.0,1.0,2/12,5.33%,CEMIP2;HYAL2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.27349537043823996,-0.7120456612875887,0.8459595959595959,0.964842883634826,1.0,2/14,17.80%,DHRS3;AKR1A1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.2693140081370299,-0.7099525020826882,0.8497536945812808,0.9624759679992445,1.0,2/15,5.00%,AGPAT4;LPCAT2
prerank,phospholipase activity (GO:0004620),0.24862364495401992,0.7080526313256612,0.8848560700876095,1.0,1.0,6/67,8.69%,PITPNM3;PLCB4;SMPDL3A;PNPLA6;ABHD6;GDPD1
prerank,ubiquitin protein ligase activity (GO:0061630),0.2207665482539386,0.7079008155588731,0.964968152866242,1.0,1.0,34/228,15.05%,TRIM14;ZNRF1;TRIM69;CBL;HERC2;TRIM11;TRIM6;RNF38;RNF125;RNF185;ARIH1;CUL3;UBE2D1;TRIM24;WWP1;UBE4A;UBE3A;RNF128;RNF115;RBX1;ZNRF3;SIAH2;TRIM25;RNF144B;TRIM17;NEDD4L;DTX3L;SMURF1;FBXO2;TRIM2;UBE3B;NHLRC1;UBE2D3;IRF2BP1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.3379710368608527,0.7070261175679994,0.806873977086743,1.0,1.0,7/12,26.25%,STAT1;TBPL1;GTF2A1;RELA;H3-3A;FOS;RUVBL2
prerank,DNA polymerase binding (GO:0070182),0.30880857469938416,0.7066673083155458,0.8535825545171339,1.0,1.0,3/18,10.98%,HMGB1;PTGES3;POLG2
prerank,damaged DNA binding (GO:0003684),0.25927287362688645,0.705808202480566,0.8753315649867374,1.0,1.0,9/44,15.10%,RBBP8;APEX1;FEN1;HMGB1;RAD1;ERCC4;RAD18;HMGB2;XPC
prerank,histone deacetylase activity (GO:0004407),0.3011539806750434,0.7045799662492965,0.8216939078751857,1.0,1.0,2/19,5.29%,HDAC9;HDAC11
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.19927889351493483,-0.7017068362336905,0.9708333333333333,0.9667656503789949,1.0,14/49,22.77%,IKBKE;TAB3;OPTN;PRPF8;ABRAXAS2;OTUD7B;HDAC6;WDR81;SHARPIN;ZRANB1;TNFAIP3;ZRANB3;RNF168;ZFAND2B
prerank,palmitoyltransferase activity (GO:0016409),0.2791480649634109,0.7010656375538761,0.819327731092437,1.0,1.0,10/28,30.32%,ZDHHC22;ZDHHC14;ZDHHC5;ZDHHC23;ZDHHC13;GLUL;ZDHHC15;GOLGA7;ZDHHC7;ZDHHC20
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.24089444298177132,0.6986439528684907,0.9165644171779141,1.0,1.0,16/74,16.50%,PIK3C2A;IPPK;IDNK;PGM2L1;TRPT1;RFK;DGKH;PIK3C3;NMRK1;PIK3CB;PAPSS1;PANK3;AGK;DGKI;GK5;DOLK
prerank,phospholipid transfer activity (GO:0120014),0.2900331393691947,0.6974855178201066,0.848531684698609,1.0,1.0,4/21,8.63%,PLTP;GLTP;CERT1;PITPNA
prerank,neuropeptide binding (GO:0042923),0.3071384620270308,0.6973951539737294,0.8320493066255779,1.0,1.0,3/18,20.71%,MC4R;GPR149;SORL1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2647405685044288,0.6954800968496214,0.8637640449438202,1.0,1.0,5/35,16.15%,TRDMT1;TRPT1;TRMT5;ELAC2;GATB
prerank,acetyltransferase activity (GO:0016407),0.2734413755555908,0.6933725172260153,0.8465909090909091,1.0,1.0,2/31,5.21%,SATL1;LCAT
prerank,RNA stem-loop binding (GO:0035613),-0.2786132169852116,-0.6906635796299554,0.8625,0.9731546490335237,1.0,5/12,19.32%,DDX3X;EPRS1;CPEB3;RC3H1;LARP6
prerank,protein phosphatase activator activity (GO:0072542),-0.27353910625388483,-0.6900777664827418,0.8698979591836735,0.969082459288401,1.0,3/13,10.38%,CALM2;IGFBP3;B3GAT3
prerank,acylglycerol lipase activity (GO:0047372),0.3246440626440889,0.6881059510925276,0.8217317487266553,1.0,1.0,3/11,22.82%,ABHD6;ABHD2;MGLL
prerank,cysteine-type peptidase activity (GO:0008234),0.2359766801670298,0.6875272797724814,0.9186189889025894,1.0,1.0,17/73,21.84%,CASP8;USP38;CASP2;TINAGL1;CASP1;USP12;USP29;USP9Y;CASP7;USP35;CTSK;CTSO;MALT1;CTSH;USP47;USP14;USP30
prerank,single-stranded DNA binding (GO:0003697),0.22910776097282665,0.6846868587096145,0.9249706916764361,1.0,1.0,17/93,15.87%,RBBP8;SSBP1;RTF1;PURA;POLR2G;STN1;HMGB1;DHX9;POLR2D;NUP35;POLA1;PCBP1;ERCC4;RAD51D;HMGB2;XPC;SPRTN
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.26275180035681134,0.6834388410805131,0.8719879518072289,1.0,1.0,5/33,10.43%,RNF125;RNF185;ARIH1;SIAH2;RNF144B
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.2618681655567495,-0.6818959979935878,0.8591954022988506,0.9723495819916991,1.0,4/15,16.67%,SH3PXD2B;PLA2G4A;PLEKHF1;JPH2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.28241390877957046,0.6803385823507807,0.8613138686131386,1.0,1.0,4/21,10.98%,CHRAC1;POLK;POLA1;POLB
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.20956267671646872,0.6752536625742787,0.9747368421052631,1.0,1.0,33/232,15.05%,TRIM14;ZNRF1;TRIM69;CBL;HERC2;TRIM11;TRIM6;RNF38;RNF125;RNF185;ARIH1;CUL3;UBE2D1;TRIM24;WWP1;UBE3A;RNF128;RNF115;RBX1;ZNRF3;SIAH2;TRIM25;RNF144B;TRIM17;NEDD4L;DTX3L;SMURF1;FBXO2;TRIM2;UBE3B;NHLRC1;UBE2D3;IRF2BP1
prerank,sequence-specific mRNA binding (GO:1990825),0.3295774654019816,0.6740351414696922,0.8327464788732394,1.0,1.0,2/10,9.64%,ETF1;DHX9
prerank,acyl-CoA hydrolase activity (GO:0047617),0.29510969069523185,0.6728232990954053,0.8491704374057315,1.0,1.0,2/17,10.04%,PPT1;ACOT13
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.27934287569299737,-0.6722048497774754,0.8708860759493671,0.9763340703365606,1.0,6/12,23.25%,TENT5A;TENT4B;TUT1;TENT5D;PAPOLB;PAPOLA
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.3186240662858579,0.6691397626098493,0.8562091503267973,1.0,1.0,11/11,68.16%,HCN1;KCNA10;CNGA1;CNGB1;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4;HCN2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.2788230023334963,0.6676975638473072,0.880248833592535,1.0,1.0,2/21,11.89%,GRIA1;GRM5
prerank,ATPase activator activity (GO:0001671),0.28462631027245255,0.6660212148305121,0.8586956521739131,1.0,1.0,6/20,20.23%,MYBPC3;DNAJB6;AHSA1;TOR1AIP2;DNAJC10;DNAJA1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.2258272714056746,0.6657322111939962,0.9392466585662211,1.0,1.0,19/75,25.34%,ABCC4;GFUS;LDHC;GLYR1;LDHD;ME3;LDHAL6B;ADH5;HADHB;CBR1;HADHA;HADH;KCNAB1;KCNAB2;HSD17B4;AKR1B10;RDH11;RDH12;HMGCR
prerank,phosphatidate phosphatase activity (GO:0008195),0.30713044325825684,0.664585097904402,0.8491803278688524,1.0,1.0,3/13,15.81%,PLPP1;PLPP4;PLPPR1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.321021133820386,0.6643417299580564,0.8535353535353535,1.0,1.0,2/11,9.69%,UBE4A;RBX1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.3276367534385962,0.6617763620899065,0.8599348534201955,1.0,1.0,3/10,16.68%,ANKRD13A;LAPTM5;DAXX
prerank,CCR chemokine receptor binding (GO:0048020),-0.21401172777627342,-0.6603761562417519,0.959866220735786,0.9817757417481127,1.0,20/28,51.88%,CNIH4;CCL25;CCL19;CCR2;CCL2;CCL14;CCRL2;CX3CL1;CCL5;CCL11;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13;CCL13
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.3117832264426355,0.6594621885063762,0.8583617747440273,1.0,1.0,1/11,5.95%,APEX1
prerank,kinase inhibitor activity (GO:0019210),-0.20391974683696085,-0.6592115383699525,0.9665551839464883,0.978028542454793,1.0,8/33,16.25%,PARVA;DNAJC3;DUS2;GMFB;SH3BP5;QARS1;CDKN1A;PRKRIP1
prerank,N-methyltransferase activity (GO:0008170),0.2799241585870684,0.6579652038173774,0.8798798798798799,1.0,1.0,7/20,20.58%,METTL5;SETD3;TFB2M;METTL18;TRMT1L;GNMT;TRMT1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.2721683416691631,0.6548731353494672,0.888728323699422,1.0,1.0,8/24,30.32%,ZDHHC22;ZDHHC14;ZDHHC23;GLUL;ZDHHC15;GOLGA7;ZDHHC7;ZDHHC20
prerank,voltage-gated anion channel activity (GO:0008308),0.2912708675793265,0.6547813587369092,0.8736,1.0,1.0,5/15,19.52%,ANO6;CLCN3;CLCN1;VDAC1;VDAC3
prerank,microtubule motor activity (GO:0003777),-0.18585408182244356,-0.6541367917407244,0.978448275862069,0.9774570626966832,1.0,28/51,36.89%,KIF3C;KIF21A;KIF13B;SMC3;KIF13A;DYNLRB1;KIF3A;KIF9;KIF7;KIF5C;KIF11;KIF5B;KIF21B;KIF1C;CENPE;KIF27;KIF6;KIF18B;KIFC1;KIF22;KIF4A;KIF14;KIFC3;KIF1B;KIF19;DNAH17;KIF20A;DYNC1I1
prerank,tRNA binding (GO:0000049),-0.1959739984280876,-0.6538238907039956,0.9736842105263158,0.9731047027872359,1.0,11/43,17.16%,NEMF;SSB;TERT;AIMP1;TRMT9B;EIF2AK4;IGHMBP2;RPUSD4;DALRD3;ELP5;PTCD1
prerank,chemokine binding (GO:0019956),0.25877815488619443,0.6534845990652682,0.8944444444444445,1.0,1.0,4/30,14.74%,CCR1;HMGB1;CX3CR1;CXCR4
prerank,voltage-gated sodium channel activity (GO:0005248),-0.22830674978520427,-0.6516179470194804,0.9408450704225352,0.970157156964917,1.0,3/22,6.67%,SCN7A;SCN2A;CACNA1G
prerank,chemokine receptor binding (GO:0042379),-0.20009419786611765,-0.6472282865108475,0.9709090909090909,0.9688781037264851,1.0,18/35,43.90%,CXCL16;CCL25;CXCL12;CKLF;CCL19;CCL2;CCL14;CCL28;CCRL2;CX3CL1;CCL5;CXCL5;CCL11;CXCL1;PF4;CCL7;PPBP;CCL8
prerank,methyl-CpG binding (GO:0008327),-0.22105601923961143,-0.645287834894453,0.9519230769230769,0.9658364330484862,1.0,8/22,27.95%,MECP2;CXXC5;TET1;MBD3;ZBTB33;WDR77;ZCWPW1;ZBTB38
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.23055492112966045,0.6430099712364382,0.9496688741721855,1.0,1.0,16/57,23.04%,NDUFS4;NDUFA12;NDUFB5;COX5A;NDUFB7;CYB561A3;UQCRFS1;CYBRD1;UQCRC1;COX15;COX6A1;NDUFB4;CYB5A;NDUFA9;NDUFV1;NDUFC1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3077771856081708,0.6411323971016656,0.8815566835871405,1.0,1.0,1/11,5.80%,ARG1
prerank,MAP kinase kinase activity (GO:0004708),0.2830594412184471,0.6399151630000303,0.8805732484076433,1.0,1.0,7/15,26.58%,LRRK2;MAPK14;MAPKAPK5;MAP2K1;MAP3K9;MAPKAPK3;MAP2K4
prerank,DNA polymerase activity (GO:0034061),0.26191623130046554,0.639573175768408,0.8892086330935252,1.0,1.0,4/22,10.98%,CHRAC1;POLK;POLA1;POLB
prerank,O-methyltransferase activity (GO:0008171),-0.2708034154132696,-0.6386715347273574,0.8905109489051095,0.9662827757925267,1.0,5/10,28.35%,CMTR1;ASMT;BCDIN3D;COMT;CMTR2
prerank,transcription coregulator binding (GO:0001221),0.2334170874497896,0.637319809819574,0.9424083769633508,1.0,1.0,10/50,18.51%,LMO2;ZBTB16;NR1D1;CHD6;CTBP2;CTNNB1;ESR1;CNOT2;SMAD4;RELA
prerank,cytochrome-c oxidase activity (GO:0004129),0.28294806468878825,0.634534001144625,0.8923327895595432,1.0,1.0,4/15,20.57%,COX5A;COX15;COX6A1;CYB5A
prerank,solute:sodium symporter activity (GO:0015370),0.2554899888147036,0.6302638036030945,0.9092240117130308,1.0,1.0,2/27,9.08%,SLC5A10;SLC4A9
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.2657251912791013,-0.6267748864623212,0.9049881235154394,0.9697934108875478,1.0,5/10,32.31%,KAT2B;CDKN1A;CDKN2C;INCA1;CDKN2B
prerank,ferrous iron binding (GO:0008198),-0.21789025830919095,-0.62350633265961,0.9418604651162791,0.9675372379781441,1.0,4/21,14.38%,EGLN3;FTO;TET2;FXN
prerank,Hsp70 protein binding (GO:0030544),0.24376708177161605,0.6200590028640032,0.938622754491018,1.0,1.0,7/31,20.23%,NOD2;DNAJC2;MVD;PPID;DNAJC10;ERN1;DNAJA1
prerank,ribosome binding (GO:0043022),0.22946289112892915,0.6186061488374727,0.9308996088657105,1.0,1.0,11/46,18.41%,ZC3H12A;ETF1;BAG6;EEF2;EIF6;EIF2S1;EIF2A;RACK1;EFL1;CCDC47;SRP19
prerank,exopeptidase activity (GO:0008238),0.22458876782816345,0.6180877424708926,0.9533954727030626,1.0,1.0,14/50,23.05%,ACE;DPP6;DPP10;METAP2;CPM;LAP3;XPNPEP3;DPP8;CTSH;LNPEP;ERAP1;FOLH1;MME;NUDT16
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.2630997164776684,-0.6157372196359863,0.8992805755395683,0.9677692912453748,1.0,3/10,14.35%,ECHDC3;EHHADH;ECHDC2
prerank,single-stranded DNA helicase activity (GO:0017116),0.26580708064503017,0.6136628487059328,0.9096385542168675,1.0,1.0,3/19,15.37%,WRNIP1;DHX9;RFC2
prerank,cardiolipin binding (GO:1901612),0.29604773542134916,0.6135190092341627,0.8862876254180602,1.0,1.0,1/10,5.77%,UQCC3
prerank,telomerase RNA binding (GO:0070034),0.2527534443774966,0.6114371604419375,0.9231950844854071,1.0,1.0,10/22,28.94%,DKC1;NHP2;XRN1;SMG7;EXOSC10;DHX36;WRAP53;HNRNPC;SMG5;NOP10
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.2493817410118462,0.610657445853051,0.9216867469879518,1.0,1.0,2/21,10.51%,P2RX7;GRIK2
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.25183270452510653,-0.6100212943664245,0.9280205655526992,0.9665215136179208,1.0,2/11,6.61%,HNRNPA2B1;RAD50
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.2786487956728339,0.6097815413911821,0.8760064412238325,1.0,1.0,2/13,8.80%,ENDOV;FEN1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2067771122382853,0.593139267717304,0.9816625916870416,1.0,1.0,14/69,19.09%,CERS4;GLYAT;LPCAT4;NMT1;CERS6;CERS5;LPCAT3;MOGAT1;LIPT1;ZDHHC14;ZDHHC5;PLAAT3;SOAT1;ELP3
prerank,neuropeptide receptor activity (GO:0008188),0.23456082513738058,0.590357205836128,0.9487179487179487,1.0,1.0,3/29,10.73%,GPR143;GAL;NPY5R
prerank,CXCR chemokine receptor binding (GO:0045236),-0.24200046796614239,-0.5898567847812308,0.9036458333333334,0.9725410163298406,1.0,6/11,43.34%,YARS1;CXCL12;CXCL5;CXCL1;PF4;PPBP
prerank,nucleotidase activity (GO:0008252),0.257111330559049,0.5858217390572352,0.9157566302652106,1.0,1.0,5/15,21.79%,BPNT1;NT5C3B;NT5C2;NT5C;NT5C3A
prerank,muscle alpha-actinin binding (GO:0051371),0.26031030337676386,0.5821689479258978,0.9293924466338259,1.0,1.0,4/15,22.17%,PDLIM5;MYPN;PDLIM1;PRICKLE4
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.2742112628873772,0.5807149720096605,0.9166666666666666,1.0,1.0,4/11,24.70%,RDH14;AKR1B10;RDH11;RDH12
prerank,3'-5' DNA helicase activity (GO:0043138),0.2564133307119006,0.5780043596982429,0.9372056514913658,1.0,1.0,6/16,26.35%,DHX9;ASCC3;BLM;WRN;HELQ;NAV2
prerank,pseudouridine synthase activity (GO:0009982),0.26099053776127,0.5776163819868687,0.9287974683544303,1.0,1.0,3/13,17.96%,DKC1;TRUB1;RPUSD2
prerank,purinergic nucleotide receptor activity (GO:0001614),0.2542527369050657,0.5774115185317957,0.9345637583892618,1.0,1.0,4/15,23.47%,P2RX7;P2RY1;GPR34;P2RY12
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.2603916156751188,0.5731132548218187,0.9319938176197836,1.0,1.0,6/14,23.75%,ETFDH;ISCA2;NUBPL;RSAD2;RSAD1;IREB2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.26652438641642096,0.5722132360010382,0.9300813008130081,1.0,1.0,11/11,73.37%,PRMT7;PRMT5;FBXO11;PRMT2;PRMT6;CARM1;NDUFAF7;PRMT3;PRMT1;PRMT9;PRMT8
prerank,inward rectifier potassium channel activity (GO:0005242),0.23006360419670874,0.570603526718062,0.948301329394387,1.0,1.0,1/24,2.72%,KCNN3
prerank,snoRNA binding (GO:0030515),0.22559930157247554,0.5701975043990498,0.9700149925037481,1.0,1.0,8/30,24.98%,DHX37;DKC1;NHP2;DDX21;RRP9;IMP4;NUDT16;NUDT16L1
prerank,serine-type endopeptidase activity (GO:0004252),0.1973925053971553,0.5696948713098694,0.9899749373433584,0.9982541078868309,1.0,6/80,11.60%,PRSS53;PCSK5;RHBDD1;FURIN;PROC;PIK3IP1
prerank,ribosomal small subunit binding (GO:0043024),0.24669417904760635,0.5671923461629552,0.9279279279279279,0.9972695389392864,1.0,3/17,15.60%,EIF1;NPM1;MTIF2
prerank,endoribonuclease activity (GO:0004521),0.2213919744510618,0.5656364828863284,0.9768451519536903,0.9958147631178854,1.0,8/32,20.19%,INTS11;ENDOV;ZC3H12A;EXOG;NOB1;KHNYN;ERN1;CPSF3
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.27283349679106716,0.5603357228097403,0.9336734693877551,0.9961519946991061,1.0,3/10,23.71%,CYBA;NCF2;NOX1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.25016193769759887,0.5570803103761381,0.9466019417475728,0.9954235494268563,1.0,3/14,17.57%,RPP38;ELAC2;POP1
prerank,methyltransferase activity (GO:0008168),0.19963444112176576,0.5395070273696941,0.9839786381842457,1.0,1.0,10/46,20.84%,COMTD1;MRM2;COQ3;GAMT;ARMT1;COQ5;FTSJ3;METTL4;NSUN4;LCMT1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.2046325807367787,0.5322668437463534,0.9820193637621023,1.0,1.0,6/34,19.75%,IQGAP1;IRGM;CALM3;RICTOR;MAP2K1;CAB39
prerank,endonuclease activity (GO:0004519),0.1937832192643139,0.5318492917121693,0.9879194630872483,0.9991998956997984,1.0,11/49,20.19%,APEX1;INTS11;ZC3H12A;FEN1;ERCC4;EXOG;NOB1;KHNYN;ERN1;ANG;CPSF3
prerank,peptide hormone receptor binding (GO:0051428),0.2481325717155232,0.5235420774786979,0.9527145359019265,0.9998417848698824,1.0,11/11,75.20%,PSMC5;PTHLH;GPHA2;UCN3;GHRH;GPHB5;UCN2;VIP;CCK;ADCYAP1;GNRH1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.21361367264299957,-0.49900898067839483,0.9779411764705882,0.9977425173457674,1.0,3/10,20.80%,CYLD;STAMBPL1;TNFAIP3
prerank,NAD+ binding (GO:0070403),0.22939098694557314,0.49511910318431557,0.9746031746031746,1.0,1.0,3/12,19.20%,GLUD1;HADH;ZC3HAV1
prerank,ribonuclease P RNA binding (GO:0033204),0.23414001127999493,0.48811692054024886,0.975609756097561,1.0,1.0,2/10,17.57%,RPP38;POP1
prerank,acetylcholine receptor activity (GO:0015464),0.2028553096721581,0.48546354050254625,0.9846860643185299,1.0,1.0,2/22,16.10%,CHRM3;HRH3
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.19339693497244087,-0.4670798104547337,0.9927184466019418,0.9986325264073063,1.0,1/11,4.28%,NUDT4
prerank,serine-type peptidase activity (GO:0008236),0.1551782960967878,0.4611615631962468,1.0,1.0,1.0,5/96,8.44%,PRSS53;PCSK5;RHBDD1;FURIN;PROC
prerank,ribonuclease P activity (GO:0004526),0.21612234997362506,0.4602712278285623,0.9915540540540541,1.0,1.0,2/11,17.57%,RPP38;POP1
prerank,CoA hydrolase activity (GO:0016289),-0.17421413183007906,-0.4598095893507557,0.9946091644204852,0.9950809037322593,1.0,2/16,16.28%,ACOT11;ACOT6
prerank,5'-nucleotidase activity (GO:0008253),0.20114804434482048,0.4381352738340838,0.988562091503268,1.0,1.0,4/13,21.79%,NT5C3B;NT5C2;NT5C;NT5C3A
prerank,phosphatase activator activity (GO:0019211),0.18943541729716354,0.413464887181555,0.9934959349593496,1.0,1.0,5/14,25.94%,PPP2R5C;CALM3;PPP2R5E;PPP1R15A;CALM1
prerank,U6 snRNA binding (GO:0017070),0.1821627191559173,0.3971992308721952,0.9983974358974359,1.0,1.0,3/14,18.99%,PRPF4;DDX39B;LSM2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.1734084680491348,0.3930972562184941,0.9984662576687117,1.0,1.0,2/16,14.86%,CD38;SARM1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.17507828958467572,0.39215727213692436,0.9953775038520801,1.0,1.0,2/14,14.82%,CYBA;NCF2
prerank,neuropeptide hormone activity (GO:0005184),0.15573137932471562,0.3775108462364303,1.0,0.998816947851313,1.0,21/22,73.33%,GAL;PENK;HCRT;GRP;CORT;OXT;AGRP;QRFP;GHRH;NPPA;UCN;CALCB;CRH;VIP;NMB;PNOC;NPFF;NPY;SPX;CCK;ADCYAP1
